Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	822	"heart muscle: 639.9"	"Group enriched"	"Detected in some"	21	"BEWO: 15.0;CACO-2: 50.9"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced									"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	639.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	50.9	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.2;SH-SY5Y: 11.7"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Region enriched"	"Detected in some"	5	"olfactory region: 21.2"	HPA058269	Enhanced				"Secreted to blood"	190000	190000			"HPA058269: AB_2683660"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.6	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.5	2.6	4.2	0.3	0.0	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.4	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	5.8	5.0	0.0	0.9	0.5	7.5	1.9	0.7	0.6	0.8	0.8	0.0	1.8	12.2	11.7	0.7	0.0	2.2	1.6	0.2	0.4	2.1	4.2	3.4	0.3	1.3	3.1	4.8	0.2	3.4	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	367	"heart muscle: 419.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 1.0"	"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		1700000	1700000	Cytosol	Cytosol	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.2	1.1	4.5	0.0	0.6	0.9	0.2	0.0	0.0	8.6	2.0	0.0	1.2	0.4	0.0	14.4	0.0	0.4	0.0	0.2	0.0	26.2	0.5	0.0	0.4	0.1	0.0	0.5	0.3	1.1	0.3	0.0	1.3	0.0	0.0	1.5	0.0	0.0	0.2	2.0	6.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	8	"BEWO: 33.4;CACO-2: 86.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to blood"									"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.5	0.2	86.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377762	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	241	"heart muscle: 679.2"	"Cell line enriched"	"Detected in some"	26	"RH-30: 185.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"CAB015371, HPA015774, HPA017888"	Enhanced		Uncertain	"Nucleoplasm,Nucleoli,Focal adhesion sites"		50000	50000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	0.1	0.3	0.1	0.1	0.7	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	679.2	0.9	0.0	1.9	0.0	0.7	0.3	0.1	1.1	0.1	0.3	0.0	0.2	0.7	0.1	0.7	0.0	0.0	0.2	0.1	2.0	1.3	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.4	0.0	0.0	185.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.1	0.9	0.0	0.1	1.1	0.1	0.0
MYBPC3	"CMH4, FHC, MYBP-C"	ENSG00000134571	"Myosin binding protein C, cardiac"	Q14896	11	47331397-47352702	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	108	"heart muscle: 199.6"	"Cell line enriched"	"Detected in single"	17	"U-937: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Region enriched"	"Detected in single"	33	"cerebellum: 38.5"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					44000	44000			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	199.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 37.6;EFO-21: 103.9;HUVEC TERT2: 35.4;LHCN-M2: 127.6;TIME: 177.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.4	0.9	37.6	1.4	0.0	103.9	0.1	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.6	2.3	0.0	0.0	3.7	0.0	0.7	1.8	35.4	0.0	0.0	127.6	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	177.6	0.3	13.6	0.2	13.9	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"heart muscle: 712.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 107.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 2.4;thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.2"	"Group enriched"	"Detected in many"	6	"amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8"	"Low region specificity"	"Detected in all"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		140000	140000	"Plasma membrane"	"Plasma membrane"	"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	0.1	0.0	0.0	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	712.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.8	3.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	107.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307041	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"heart muscle: 64.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Daudi: 1.5;Hep G2: 6.5;K-562: 1.7;RH-30: 3.8;THP-1: 1.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	1.3	0.0	64.6	0.4	0.1	0.0	0.0	0.7	0.0	1.4	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.8	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell line enriched"	"Detected in single"	9	"HSkMC: 5.7"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051039	Enhanced									"HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381990-23408277	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"heart muscle: 313.7"	"Cell line enriched"	"Detected in single"	23	"NTERA-2: 10.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced					20000000	20000000			"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: , HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.1	313.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	8.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39664187-39666555	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2"	"Cell line enhanced"	"Detected in many"		"NB-4: 6.8;SK-BR-3: 11.8"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.0"	"Low region specificity"	"Detected in many"			"CAB004591, HPA026477"	Enhanced					68000	68000			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (4.55e-4)"	3.2	0.2	0.2	0.1	0.5	0.2	0.2	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	11.1	8.6	0.1	0.1	298.7	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.1	0.2	0.1	0.2	0.1	0.0	4.1	0.1	0.0	12.3	0.1	708.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	5.8	249.2	11.5	0.2	0.1	0.3	0.0	0.0	0.2	0.3	2.4	0.1	0.2	3.1	2.4	3.6	0.5	0.5	0.8	0.5	0.1	0.5	0.8	1.2	2.1	1.3	2.5	0.3	1.3	1.1	0.1	0.2	1.1	3.1	1.3	1.6	0.3	0.7	0.7	0.4	1.0	0.6	1.0	0.3	0.2	2.4	0.8	0.2	1.3	1.0	6.8	1.6	0.8	1.0	2.5	0.8	0.5	0.4	1.5	2.4	1.7	11.8	1.4	0.8	1.4	1.2	1.0	1.7	2.2	0.7	5.2	2.9	0.7	1.1	1.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	2.4	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.5	0.4	0.2	0.2	0.2	0.6	0.0	0.0	0.0
LRRC10	"HRLRRP, LRRC10A"	ENSG00000198812	"Leucine rich repeat containing 10"	Q5BKY1	12	69608564-69611162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"heart muscle: 42.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (3.76e-4)"										"unprognostic (4.59e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.0	0.5	0.4	0.8	0.1	0.1	0.5	0.6	0.6	0.0	0.0	0.5	0.1	0.0	0.9	0.4	0.3	0.3	1.0	0.3	0.1	0.7	0.0	0.1	0.0	2.4	0.7	0.5	0.7	0.6	0.1	0.0	0.8	0.2	0.6	0.6	0.0	0.4	0.6	0.1	0.1	0.0	0.8	0.4	0.2	0.4	0.9	0.1	0.1	0.8	1.2	0.8	0.9	0.0	0.1	0.0	0.3	0.1	0.3	0.2	0.8	0.4	0.4	0.6	0.3	0.8	1.0	1.3	0.1	0.4	0.5	0.4	0.6	0.2	0.5	0.7	0.5	0.6	0.1	1.3	0.8	0.7	1.0	0.4	0.3	1.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428428	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 14.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	125	"NK-cell: 12.5"	"Lineage enriched"	"Detected in single"	125	"NK-cells: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			3.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.8	0.1	0.0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	5.5	230.8	11.4	0.1	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0
SBK2	SGK069	ENSG00000187550	"SH3 domain binding kinase family member 2"	P0C263	19	55529733-55537089	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"heart muscle: 45.7;tongue: 20.8"	"Cell line enhanced"	"Detected in some"		"A549: 4.3;Hep G2: 3.1;MCF7: 4.4;NTERA-2: 8.7;RH-30: 8.1;U-2 OS: 4.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030631	Enhanced									"HPA030631: AB_10602088"	"unprognostic (1.33e-1)"			"unprognostic (1.85e-3)"	"unprognostic (4.57e-1)"	"unprognostic (3.49e-1)"				"unprognostic (5.43e-3)"	"unprognostic (4.18e-3)"		"unprognostic (2.08e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-1)"			0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.7	20.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	8.7	0.0	0.0	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBA3E		ENSG00000152086	"Tubulin alpha 3e"	Q6PEY2	2	130191743-130198461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"heart muscle: 14.2;testis: 51.0"	"Group enriched"	"Detected in some"	12	"BEWO: 8.8;U-2 OS: 5.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules				Microtubules	Microtubules	"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.02e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.65e-7)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.94e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	1.1	0.4	0.1	0.7	0.1	14.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	51.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.0	0.5	0.1	0.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.4	0.4	0.0	0.9	0.5	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 61.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.4"	"Not detected"	"Not detected"							"CAB000060, HPA003123"	Enhanced					190000000	190000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	3.6	0.1	0.2	0.1	0.2	0.0	1.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.0	19.6	0.4	0.0	366.6	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.3	0.1	0.0	5.0	0.3	0.0	13.0	0.0	871.2	0.3	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0.0	4.4	0.7	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.2	0.0	0.8	0.3	0.1	2.6	0.0	2.2	0.5	0.0	6.5	61.5	0.0	13.7	0.0	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"		45000	45000	"Plasma membrane"	"Plasma membrane"	"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium voltage-gated channel subfamily J member 4"	P48050	22	38426327-38455199	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 25.9;heart muscle: 16.9"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 15.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7"	"Group enriched"	"Detected in many"	14	"amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2"													"unprognostic (4.76e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.07e-1)"		"unprognostic (3.15e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.41e-2)"		0.1	0.2	9.9	0.1	17.9	0.1	0.1	0.0	25.9	0.1	0.1			0.3	0.1	0.1	0.1	0.7	0.8	16.9	9.4	1.7	0.2	0.4	0.1	0.1	0.7		0.1	0.2	0.1	0.0	0.1		0.1	0.1		0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	1.1	0.0	0.5	0.0	2.3	0.0	0.1	0.0	0.0	15.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506877-196515366	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	22	"heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	48.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	2.1	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	66.9	2.5	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.5	0.5	0.4	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791297	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1"	"Group enriched"	"Detected in some"	28	"BJ hTERT+: 4.4;HeLa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"										"unprognostic (6.83e-2)"													0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.7	0.0	87.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		450000	450000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell line enriched"	"Detected in some"	10	"RH-30: 17.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012912			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell line enriched"	"Detected in single"	64	"THP-1: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Low region specificity"	"Detected in some"			"HPA070440, HPA073138"	Enhanced									"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin, alpha, cardiac muscle 1"	P68032	15	34788096-34796139	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"heart muscle: 243.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 36.4;LHCN-M2: 147.6;RH-30: 70.7"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB037330, HPA041264, HPA041271"	Enhanced					6200000000	6200000000			"CAB037330: , HPA041264: AB_2677383, HPA041271: "	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (9.32e-4)"	1.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0			0.0	0.1	0.0	0.2	0.0	0.0	243.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.9	0.0		0.6	12.5	8.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0			0.0		0.0	9.5	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	147.6	0.0	0.0	0.0	0.1	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4										
PERM1	"C1orf170, MGC13275, Perm1, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;HaCaT: 4.4;MCF7: 3.0;SK-BR-3: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA031711, HPA031712"	Enhanced									"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	23.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.9	0.0	68.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	24.7	0.9	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.4	1.5	0.0	0.5	0.0	4.4	0.0	0.0	0.0	1.4	0.5	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.9	0.0	0.1	1.3	4.6	1.0	0.4	0.0	0.9	0.7	0.9	0.0	0.7	0.5	0.0	0.0	1.8	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ABRA	STARS	ENSG00000174429	"Actin binding Rho activating protein"	Q8N0Z2	8	106759483-106770245	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 21.6;skeletal muscle: 77.6;tongue: 35.0"	"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (9.08e-3)"	"unprognostic (1.61e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.35e-2)"		"unprognostic (6.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.15e-2)"		"unprognostic (4.34e-1)"	"unprognostic (6.21e-3)"	1.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.3	0.1	0.0	0.8	0.1	0.6	1.7	2.1	0.2	0.1	21.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.6	0.7	0.1	0.0	2.6	1.6	77.6	0.1	0.1	0.5	0.1	0.1	0.1	0.9	0.0	0.0	2.6	35.0	1.2	0.6	2.2	0.7	0.5	2.6	0.6	0.6	0.5	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.2	0.0	0.2	0.0	0.5	0.1	0.4	0.0	0.0	0.7	0.4	0.4	0.1	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.6	0.5	0.3	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.2	0.0	1.2	0.2	0.6	0.1	0.1	0.1	0.2	0.6	1.3	0.1	0.4	0.0	0.2	0.4	0.1	0.2	0.7	0.5	0.5	2.6	0.6	0.5	0.5	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.0
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3"	"Cell line enriched"	"Detected in single"	13	"HSkMC: 9.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	26000	26000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.1	0.1	0.2	0.2	0.2	0.0	0.4	0.1	1.0	0.8	0.3	0.0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.2	0.2	9.6	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1.0	0.2	0.2	0.3	0.2	0.4	0.1
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3-like"	P0DJH9	14	103940426-103942308	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"heart muscle: 32.6"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced									"HPA067971: AB_2685935"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.1	0.2	0.0	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.2;HSkMC: 3.7;SK-MEL-30: 9.3;U-87 MG: 9.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588716-113664127	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA037953, HPA037954"	Enhanced									"HPA037953: AB_2675755, HPA037954: AB_10672394"	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		5.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.4	5.8	0.0	0.0	74.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.0	4.2	0.0	268.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.8	82.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPHKAP	SKIP	ENSG00000153820	"SPHK1 interactor, AKAP domain containing"	Q2M3C7	2	227979950-228181645	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 64.0;heart muscle: 33.2"	"Cell line enriched"	"Detected in some"	17	"BJ hTERT+: 31.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebellum: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042499, HPA048168"	Enhanced									"HPA042499: AB_2678027, HPA048168: AB_2680296"	"unprognostic (4.91e-3)"				"unprognostic (6.46e-2)"						"unprognostic (1.33e-1)"	"unprognostic (2.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-3)"		0.5	0.6	10.7	0.5	5.1	0.4	1.4	64.0	14.8	0.5	0.5	2.1	0.0	0.5	0.5	0.4	0.5	0.5	0.5	33.2	15.1	3.7	0.5	0.4	0.6	0.5	1.6	4.5	3.2	0.5	0.4	0.1	0.5	3.8	0.5	0.5	0.5	2.7	0.5	0.4	0.5	0.5	0.5	1.1	1.0	0.5	0.7	0.9	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	31.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	5.1	64.0	8.5	15.1	3.7	1.6	4.5	3.8	0.9
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
MYOM2		ENSG00000036448	"Myomesin 2"	P54296	8	2045040-2165552	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"heart muscle: 170.7;skeletal muscle: 75.9"	"Group enriched"	"Detected in some"	8	"HEK 293: 9.9;SCLC-21H: 4.2;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							"HPA001765, HPA005953"	Enhanced		Approved	Mitochondria		120000	120000	Mitochondria	Mitochondria	"HPA001765: AB_1079443, HPA005953: AB_1854258"	"unprognostic (2.81e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.30e-5)"	"unprognostic (1.10e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.14e-1)"	2.0	0.0	0.3	0.1	0.4	0.0	1.7	0.9	0.9	0.2	0.2	0.0	0.2	0.0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	1.2	1.0	75.9	0.2	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.6	8.9	1.2	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.9	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.2	0.0	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0.0	0.1	0.0
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139292139	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;HSkMC: 4.6;REH: 3.8;RPMI-8226: 5.3;U-698: 10.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	4	"B-cells: 5.3;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced									"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1.0	0.7	0.6	0.0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1.0	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1.0	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	1.0	0.1	0.0	0.0	2.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.3	0.7	0.8	0.2	0.5	3.8	1.7	5.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.9	2.2	1.4	0.1	0.1	0.0	0.1	1.2	2.0	10.1	0.3	2.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.9;HSkMC: 3.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced									"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233285-81266397	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;BEWO: 5.9;Hep G2: 5.1;HHSteC: 3.9;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051880	Enhanced					3200000	3200000			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	2.5	5.0	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3.0	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2.0	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0.0	3.3	103.6	2.9	1.0	0.6	0.4	0.1	0.0	0.4	3.8	0.3	0.0	0.1	0.9	0.0	0.9	3.6	0.7	5.9	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	3.1	0.0	0.7	5.1	3.9	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.2	0.1	0.7	0.4	0.8	0.9	0.0	0.0	0.1	0.7	0.7	0.5	0.4	0.8	9.5	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.2	0.0	3.8	0.0	0.1	0.2	0.0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol				Cytosol	Cytosol	"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.6	0.7	0.1	0.0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	1.0	0.0	54.0	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	18.1	1.4	0.0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2.0	2.3	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.1	2.1	4.0	0.9	0.0	4.8	0.0	0.0	0.4	0.7	5.3	2.2	5.6	1.8	0.0	1.3	0.9	0.1	0.2	0.0	0.6	0.0	2.0	3.6	0.0	1.2	0.7	2.3	1.8	1.0	1.3	1.5	1.0	0.2	2.2	1.9	1.6	1.0	1.0	1.5	1.6	1.7	0.8	2.9	1.5	1.0	1.8	8.3	3.5	1.4	1.8	4.8	0.7	2.3	0.8	0.8	1.0	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Group enriched"	"Detected in some"	11	"BEWO: 4.6;HSkMC: 6.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Supported	Cytosol				Cytosol	Cytosol	"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	8	"NB-4: 6.1;NTERA-2: 16.5;SK-MEL-30: 7.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdTCR: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.2"	HPA011268	Enhanced				"Intracellular and membrane"	45000000	45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.1	16.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593119-121630295	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 3.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.8"	"Low region specificity"	"Detected in many"														"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	1.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	1.3	2.3	0.0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	38.0	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.5	0.4	0.0	0.0	0.0	3.0	1.9	0.8	0.2	0.1	0.0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.5	0.2	0.0
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702827	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HSkMC: 1.3;Karpas-707: 1.1;NTERA-2: 1.4;RPMI-8226: 4.1;THP-1: 1.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018174	Enhanced									"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	1.5	1.6	12.9	1.3	29.0	1.3	1.9	2.3	15.2	1.5	1.4	36.5	0.0	1.3	1.7	1.5	2.7	2.0	1.5	184.7	14.5	8.9	1.4	1.3	1.5	1.4	51.6	10.5	1.4	1.8	1.4	0.9	1.4	25.9	1.9	1.4	5.4	4.7	1.4	93.6	1.6	1.4	1.4	57.1	1.4	1.3	1.7	39.9	0.0	9.3	7.2	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.3	0.0	1.4	0.0	0.5	0.0	4.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.5	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	29.0	2.3	15.2	14.5	8.9	51.6	10.5	25.9	39.9
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 27.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		15000000	15000000	"Nucleoli, Mitochondria"	"Nucleoli, Mitochondria"	"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		60000000	60000000	Nucleoplasm	Nucleoplasm	"HPA043801: , HPA050314: AB_2732558, HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 24.2"	"Cell line enhanced"	"Detected in some"		"A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA078322			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0			0.2	0.0	0.0	1.7	0.0	0.1	24.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	3.2	5.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	2.5	0.6	0.2	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Group enriched"	"Detected in some"	4	"LHCN-M2: 21.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.3	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.8	2.7	0.0	0.3	0.0	1.1	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	3.5	0.0	0.0	21.5	1.0	0.0	0.0	2.0	0.0	0.0	17.9	0.0	0.0	2.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"				"Actin filaments, Focal adhesion sites"	"Actin filaments, Focal adhesion sites"	"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.3	28.8	56.0	4.1	1.3	79.9	0.8	3.6	0.1	6.5	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110920722	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"heart muscle: 656.7;skeletal muscle: 672.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 9.2;U-2 OS: 18.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"memory B-cell: 3.8;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		190000	190000	Microtubules	Microtubules	"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavourable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		3.6	0.0	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	8.9	0.0	0.2	656.7	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.0	0.0	7.7	0.0	672.9	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	2.4	59.4	10.5	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.1	0.0	0.0	1.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4278601-4290724	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 14.8;brain: 23.1;heart muscle: 17.3"	"Group enriched"	"Detected in some"	46	"RH-30: 18.8;SH-SY5Y: 60.6"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	148	"plasmacytoid DC: 14.8"	"Lineage enriched"	"Detected in single"	148	"dendritic cells: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Centriolar satellite, Cytosol"	"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.5	0.7	4.0	1.4	2.5	1.2	0.4	4.1	23.1	0.4	0.9	2.4	0.0	0.7	0.4	0.4	0.4	0.4	0.6	17.3	3.3	4.5	0.4	1.7	0.5	1.2	4.7	2.3	0.4	0.5	0.4	0.2	0.4	6.1	0.5	0.7	0.0	0.5	0.4	0.8	0.4	0.6	0.4	2.5	0.6	0.4	0.5	1.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	18.8	0.0	0.0	0.0	0.1	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	4.0	2.5	4.1	20.4	3.3	4.5	4.7	2.3	6.1	1.1
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	15.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"heart muscle: 20.1;skeletal muscle: 52.0;tongue: 28.1"	"Cell line enhanced"	"Detected in single"		"A549: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	20.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	28.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LMAN1L	"ERGIC-53L, ERGL"	ENSG00000140506	"Lectin, mannose binding 1 like"	Q9HAT1	15	74812716-74825758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Daudi: 3.7;HEK 293: 2.3;SCLC-21H: 2.4;SK-BR-3: 2.4"	"Cancer enriched"	"Detected in single"	45	"prostate cancer: 2.2"	"Region enriched"	"Detected in some"	22	"cerebellum: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (4.51e-1)"							"unprognostic (2.44e-1)"		"unprognostic (4.26e-2)"	"unprognostic (3.09e-1)"			0.1	1.1	0.2	4.8	0.2	0.0	0.1	45.5	0.9	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.5	18.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	2.0	37.0	0.0	0.1	17.3	0.1	0.1	0.0	0.2	0.1	0.3	13.5	2.5	0.7	0.1	0.1	0.1	0.3	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.8	0.3	0.0	1.1	0.0	0.5	2.4	0.1	0.0	2.4	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	45.5	0.9	0.1	0.0	0.1	0.3	2.0	0.1
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Group enriched"	"Detected in some"	7	"BEWO: 22.4;NTERA-2: 18.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA049909: , HPA054792: AB_2682601, HPA072450: "				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"heart muscle: 106.0;skeletal muscle: 276.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.3;ASC TERT1: 50.7;K-562: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012678			Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	4.8	2.9	9.2	4.3	8.3	2.3	9.0	12.1	15.1	4.8	6.2	8.3	5.6	3.8	3.1	11.8	6.1	3.3	5.0	106.0	9.7	7.8	6.6	9.3	5.5	3.8	15.6	8.1	2.3	3.4	13.6	7.7	10.2	9.3	4.6	4.1	7.2	5.4	4.5	276.2	4.1	7.7	3.1	18.5	2.9	4.4	1.7	11.2	1.5	3.1	18.1	3.8	3.6	6.1	12.0	6.7	7.4	5.9	4.7	13.2	4.3	7.8	1.5	2.2	2.4	62.3	50.7	13.0	9.2	8.7	9.0	11.8	7.2	5.0	4.0	2.8	13.2	4.0	5.3	6.5	15.3	2.9	7.6	2.0	3.2	2.8	16.5	1.7	2.1	36.0	13.0	38.2	20.8	3.5	50.9	9.4	15.9	13.3	1.3	1.0	7.8	3.3	2.9	5.6	1.5	5.4	8.1	10.7	0.9	9.0	26.3	7.2	7.8	2.3	4.6	10.4	2.3	26.1	20.4	4.1	5.8	5.9	42.6	1.6	6.4	7.4	5.3	4.1	5.4	5.9	5.5	12.0	10.9	7.2	6.7	11.7	8.4	4.6	1.2	4.7	1.9	2.9	13.2	4.3	9.2	8.3	12.1	10.2	9.7	7.8	15.6	8.1	9.3	11.2
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell line enhanced"	"Detected in many"		"A-431: 7.7;LHCN-M2: 6.5;RH-30: 13.7;U-266/70: 8.6;U-87 MG: 12.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced									"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.7	0.0	0.1	1.9	0.0	0.3	0.4	0.4	0.9	0.7	3.3	0.4	0.3	0.4	1.6	1.7	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	0.0	0.1	0.3	6.5	1.1	0.5	1.0	0.9	0.3	1.3	13.7	2.2	0.0	0.0	2.6	3.3	0.8	0.2	1.1	0.2	0.6	0.0	4.9	3.0	0.1	0.0	8.6	0.2	0.1	12.6	0.7	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced									"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0
ASB11	DKFZp779E2460	ENSG00000165192	"Ankyrin repeat and SOCS box containing 11"	Q8WXH4	X	15281697-15315656	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.6"	"Cancer enriched"	"Detected in single"	20	"melanoma: 2.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0"	"Low region specificity"	"Detected in single"														"unprognostic (5.89e-3)"				"unprognostic (1.04e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.54e-2)"		"unprognostic (2.04e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"		"unprognostic (6.21e-2)"		2.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.2	1.3	0.1	0.0	51.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.0	2.2	0.0	50.7	0.5	0.1	0.0	0.1	0.1	2.8	0.1	0.0	0.0	0.3	29.8	2.3	0.1	0.1	0.6	0.6	0.8	0.3	1.4	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.4	0.4	0.3	0.1	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	0.8	1.4	0.1	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
BMP10		ENSG00000163217	"Bone morphogenetic protein 10"	O95393	2	68865481-68871517	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"heart muscle: 110.1"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	120000	120000																		"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 117.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		4400000	4400000	"Focal adhesion sites"	"Focal adhesion sites"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.2	0.2	22.6	117.9	1.1	0.9	8.7	0.1	3.1	0.2	0.8	0.2	12.5	2.4	0.3	0.9	0.0	0.1	0.1	0.5	0.3	1.1	2.3	1.5	0.2	0.0	10.4	0.0	2.3	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.2	6.0	0.4	0.1	1.2	0.0	2.8	0.0	0.3	0.0	0.5	0.0	13.5	0.1	1.4	0.3	0.2	0.1	2.1	0.1	0.1	0.4	0.1	0.5	0.1	0.2	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Cell line enhanced"	"Detected in single"		"THP-1: 3.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"					"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 95.0;skeletal muscle: 219.0"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.1;LHCN-M2: 2.3;RH-30: 6.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.7	1.9	0.0	0.4	95.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.3	1.1	0.0	0.0	1.3	0.0	219.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	4.9	18.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0
ASB18		ENSG00000182177	"Ankyrin repeat and SOCS box containing 18"	Q6ZVZ8	2	236194872-236264409	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"heart muscle: 9.8;skeletal muscle: 14.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.3;K-562: 2.7;MCF7: 3.1;RH-30: 2.4;SiHa: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (1.12e-1)"	"unprognostic (7.33e-3)"				"unprognostic (3.07e-1)"			"unprognostic (1.78e-6)"	"unprognostic (4.75e-2)"	"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	2.4	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.1	0.0	1.4	0.6	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Cell line enhanced"	"Detected in many"		"BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	15000000	15000000	Vesicles	Vesicles	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.0	92.8	26.6	30.2	1.3	0.4	0.0	6.6	86.9	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	16.9	0.0	0.0	6.7	8.7	9.0	22.2	28.1	0.0	0.0	36.7	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	9.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	49.8	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 524.6;skeletal muscle: 551.1"	"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 81.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA027639	Approved		Approved	Nucleoplasm		43000	43000	Nucleoplasm	Nucleoplasm	"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavourable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (1.26e-4)"	32.3	9.6	0.1	3.3	0.1	0.1	9.0	0.9	0.2	7.0	8.4	0.3	1.3	0.7	12.6	8.0	15.7	4.5	8.2	524.6	0.1	0.0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1.0	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1.0	2.1	20.1	0.4	0.3	6.1	1.3	0.0	0.0	9.6	70.1	7.2	12.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.1	0.8	0.3	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.4	0.0	2.9	0.0	0.0	0.3	0.0	3.8	0.1	0.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.0	0.2	0.3	0.9	0.0
METTL11B	"C1orf184, HOMT1B"	ENSG00000203740	"Methyltransferase like 11B"	Q5VVY1	1	170146001-170167790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"heart muscle: 7.0;skeletal muscle: 3.6"	"Cell line enriched"	"Detected in single"	12	"NTERA-2: 6.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028049	Uncertain									"HPA028049: AB_10610139"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.62e-2)"		"unprognostic (7.59e-2)"	"unprognostic (7.25e-2)"		"unprognostic (1.19e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.76e-3)"			"unprognostic (5.43e-2)"	"unprognostic (4.56e-1)"		"unprognostic (5.79e-4)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44759031-44781846	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 42.3;heart muscle: 11.2"	"Cell line enriched"	"Detected in some"	4	"HEK 293: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced									"HPA074550: AB_2732259"	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	1.2	0.5	8.5	0.6	7.5	1.0	0.6	42.3	23.1	0.9	0.8	0.7	0.0	0.8	4.0	1.1	1.1	1.2	1.5	11.2	11.4	4.2	0.7	0.6	0.7	0.7	2.7	9.8	0.9	0.6	0.7	0.6	0.7	5.5	1.6	0.6	0.2	0.5	2.2	0.8	2.5	0.7	2.6	1.5	0.7	0.7	2.3	1.1	0.0	0.6	0.0	0.6	0.7	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.6	4.8	0.2	0.0	0.3	0.1	0.0	1.3	0.4	0.7	0.2	0.1	0.3	0.0	0.0	3.6	0.0	0.4	1.4	20.5	0.2	0.4	0.3	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.1	4.1	0.0	2.4	0.8	1.3	2.8	0.0	0.3	0.0	0.1	3.7	1.9	0.0	0.1	1.0	1.4	0.7	0.0	0.6	1.7	1.8	0.4	0.7	0.2	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	8.5	7.5	42.3	21.0	11.4	4.2	2.7	9.8	5.5	1.1
FAM237A		ENSG00000235118	"Family with sequence similarity 237 member A"	A0A1B0GTK4	2	206642412-206649011	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"brain: 3.0;heart muscle: 1.1;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"																		"unprognostic (3.02e-1)"													0.0	0.0		0.0		0.0	0.0		3.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	1.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;RPMI-8226: 3.9;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"												"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.1	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.2	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.3	0.9	3.9	0.0	0.3	5.0	0.3	2.1	0.2	0.8	0.7	0.1	0.2	0.4	2.0	0.4	0.1	1.1	0.1	0.2	0.4	0.6	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148451032-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Cell type enriched"	"Detected in single"	8	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040591	Enhanced									"HPA040591: AB_2677028"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.74e-2)"		"unprognostic (2.37e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.68e-2)"			"unprognostic (1.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.83e-5)"	0.4	1.4	1.9	1.1	18.1	0.1	0.2	0.1	3.2	0.6	4.3	0.0	0.0	8.0	0.3	0.1	0.3	0.4	1.5	7.2	5.2	0.6	0.1	0.2	0.3	0.2	0.5	1.3	0.2	0.1	0.1	5.9	0.1	0.1	0.1	4.9	0.0	0.2	0.2	0.2	0.2	14.6	1.1	0.3	0.2	0.2	0.2	2.4	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	1.9	18.1	0.1	3.2	5.2	0.6	0.5	1.3	0.1	2.4
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.8;RT4: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 3.1;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 14.9"												"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.6	0.5	2.1	1.2	2.7	0.6	0.5	2.6	2.6	0.4	1.5	0.8	1.0	1.1	0.7	1.3	1.4	1.2	1.1	13.1	2.2	0.7	1.1	0.4	0.5	0.5	0.7	2.2	0.5	3.7	0.4	0.5	0.5	1.6	0.8	1.5	1.4	1.7	0.8	44.5	0.7	1.0	1.0	0.5	0.4	1.9	0.9	1.2	0.0	0.4	16.6	0.7	1.0	0.4	0.3	0.4	3.1	0.3	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.1	0.6	0.2	0.2	0.0	0.1	0.1	1.8	2.4	0.5	0.2	0.2	0.1	0.0	0.3	0.1	0.6	0.3	0.2	0.5	0.1	0.4	0.3	0.0	0.2	0.0	0.3	3.1	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	1.5	0.2	0.1	0.4	0.0	0.0	2.1	2.7	2.6	2.6	2.2	0.7	0.7	2.2	1.6	1.2
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8"	"Cell line enhanced"	"Detected in many"		"HEL: 19.7;HMC-1: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6"	"Group enriched"	"Detected in many"	5	"B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2"	"Group enriched"	"Detected in many"	5	"amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles				Vesicles	Vesicles	"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	86.5	3.5	15.5	2.0	54.5	0.9	10.4	8.3	26.1	1.8	2.4	2.6	0.0	1.4	2.3	2.4	1.2	2.2	1.9	74.8	19.6	5.0	1.0	1.0	1.4	3.7	4.2	11.3	5.7	1.6	1.2	3.3	1.8	4.3	1.6	2.7	1.7	4.6	2.1	3.8	3.0	1.6	1.8	2.1	2.8	1.6	4.1	9.8	0.0	1.3	0.8	3.9	1.6	0.7	4.6	0.5	1.9	1.2	0.0	0.4	0.4	1.6	2.4	2.5	3.1	1.0	1.1	0.6	1.1	1.0	0.6	0.9	3.6	3.2	1.6	0.9	0.7	1.7	0.8	0.4	0.6	2.2	1.9	19.7	2.4	1.8	0.9	1.3	12.2	2.6	1.7	1.0	1.3	1.0	5.7	1.7	0.9	1.1	0.7	3.8	0.7	0.6	0.9	0.2	1.2	0.9	1.0	7.2	1.1	0.8	0.5	2.3	2.0	0.8	2.1	1.3	2.1	0.5	1.1	1.7	1.7	1.6	1.4	5.0	0.2	0.0	0.1	1.9	0.1	1.2	0.4	2.9	0.3	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.5	0.5	0.3	0.4	15.5	54.5	8.3	26.1	19.6	5.0	4.2	11.3	4.3	9.8
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7"	"Group enriched"	"Detected in some"	6	"A549: 5.0;Hep G2: 19.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		680000	680000	Vesicles	Vesicles	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favourable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	6.3	2.7	0.2	0.0	59.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.7	0.0	104.6	0.4	1.5	0.0	0.0	0.0	0.0	1.9	0.1	0.0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	2.1	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	19.3	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0.0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235357	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 95.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.2	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.0	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	20.5	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.3	4.2	0.0	9.1	0.0	0.0	0.0	3.9	16.9	5.2	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10P1	"OR10P1P, OR10P2P, OR10P3P, OST701"	ENSG00000175398	"Olfactory receptor family 10 subfamily P member 1"	Q8NGE3	12	55636860-55637854	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 2.0;heart muscle: 3.2"	"Cell line enhanced"	"Detected in single"		"THP-1: 2.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;T-reg: 1.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.7	0.1										
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	7	"AF22: 10.8;Daudi: 8.1;SH-SY5Y: 8.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA007919: "	"prognostic unfavourable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.6	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696807-38816217	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"heart muscle: 1.5;testis: 2.0"	"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.57e-2)"										"unprognostic (7.85e-2)"		"unprognostic (2.09e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 131.5"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																															0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	131.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.3	0.0	0.9	1.0	0.7	1.2	0.6	0.2	0.3	1.2	0.0	0.2	0.2	1.2	0.8	0.6	0.3	0.3	0.6	0.3	0.1	0.4	0.6	0.0	0.8	1.5	1.5	0.2	1.3	0.7	0.1	0.5	0.2	0.3	0.2	0.8	1.2	0.2	0.2	0.5	0.9	0.7	0.2	0.6	0.9	0.5	2.7	0.6	0.2	0.7	0.5	0.1	0.1	0.4	0.5	0.7	1.2	0.9	0.8	0.8	1.1	0.3	0.8	0.5	0.9	0.6	0.6	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0
TENM2	"KIAA1127, ODZ2, Ten-M2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.1;heart muscle: 24.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.1;HBEC3-KT: 17.1;HDLM-2: 16.7;U-138 MG: 30.6;U-2 OS: 26.6;U-251 MG: 19.6"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA038018: , HPA038420: , HPA068691: "	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavourable (7.52e-4)"	0.2	0.4	2.5	0.0	3.5	0.0	1.8	0.5	15.1	0.6	0.3	0.0	0.0	0.3	0.2	0.4	1.4	0.2	0.3	24.7	6.5	0.9	2.7	1.2	0.3	0.0	0.5	1.7	0.7	0.2	0.0	0.4	0.0	2.3	2.2	0.0	0.2	0.3	1.0	0.2	2.3	0.2	0.0	0.6	0.2	0.3	1.2	0.4	0.0	0.4	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	26.1	0.0	0.0	17.1	0.3	16.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.2	3.0	0.1	2.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	30.6	26.6	0.0	19.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.5	15.1	6.5	0.9	0.5	1.7	2.3	0.4
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 23.8;EFO-21: 23.9;HeLa: 15.7;Hep G2: 15.9;HSkMC: 24.8;U-2 OS: 36.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Region enriched"	"Detected in single"	7	"midbrain: 8.5"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		260000	260000	"Nucleoplasm, Actin filaments, Mitochondria"	"Nucleoplasm, Actin filaments, Mitochondria"	"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	23.8	11.9	0.2	23.9	3.4	0.1	0.0	0.1	0.0	0.4	0.5	0.1	15.7	15.9	0.1	0.1	0.0	24.8	0.4	0.0	0.2	0.0	0.0	1.8	0.7	0.0	0.0	0.2	0.1	0.2	0.0	1.0	0.8	1.1	4.5	0.0	0.0	0.1	2.4	0.0	9.6	0.2	0.0	0.0	36.7	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;HSkMC: 2.7;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"																				"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.6	0.0	0.0	1.3	0.3	1.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.7	1.6	0.2	0.0	0.5	0.0	0.8	1.1	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773661-49921950	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;heart muscle: 12.8;ovary: 12.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055243	Approved				"Secreted to extracellular matrix"					"HPA055243: AB_2682755"	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.5	0.3	3.6	0.4	3.9	0.4	0.5	17.0	6.9	0.6	0.5	1.4	0.0	0.5	1.9	0.4	0.5	0.8	0.5	12.8	1.7	2.8	0.4	0.3	0.6	0.4	2.1	1.8	12.5	0.3	0.3	0.2	0.3	3.8	0.4	0.5	0.6	0.4	0.5	0.4	1.2	0.7	1.5	0.8	0.6	0.4	0.5	0.8	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.9	0.4	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.9	1.0	0.2	0.0	0.0	0.0	3.6	3.9	17.0	6.9	1.7	2.8	2.1	1.8	3.8	0.8
AKAP6	"ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6"	ENSG00000151320	"A-kinase anchoring protein 6"	Q13023	14	32329273-32837681	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 7.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001983, HPA048741"	Enhanced									"CAB001983: , HPA048741: AB_2680506"	"unprognostic (1.99e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.81e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.54e-1)"	"unprognostic (3.33e-16)"	"unprognostic (8.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.79e-3)"	2.1	5.9	17.9	2.9	28.0	1.2	4.5	32.5	34.3	2.3	4.1	28.3	0.0	2.3	4.2	5.9	5.6	3.2	4.0	46.6	16.8	13.7	3.4	2.6	2.8	1.3	27.5	22.2	3.0	1.5	5.3	3.1	4.5	47.0	2.5	2.7	2.3	2.6	1.8	37.0	1.8	2.8	7.3	16.5	1.4	2.1	5.5	29.8	0.0	5.0	6.6	1.4	3.2	1.4	7.8	0.8	1.2	0.3	0.3	1.2	0.5	0.6	0.9	1.2	1.1	0.2	2.0	0.3	1.4	4.1	0.2	0.5	1.3	1.1	1.5	1.1	17.3	0.9	1.3	1.5	0.6	1.4	1.1	1.4	1.8	1.2	0.6	0.1	0.4	2.0	1.5	0.0	0.5	0.1	0.3	4.6	1.2	0.8	0.8	0.3	0.2	1.2	0.8	5.5	0.6	0.5	1.4	5.9	4.7	1.2	0.8	3.7	3.3	0.1	0.3	0.2	0.9	0.9	0.5	2.9	2.5	0.6	1.8	0.1	6.1	0.5	0.3	0.1	0.1	0.2	0.2	0.5	0.1	0.4	0.4	7.8	0.8	1.2	1.2	0.3	0.2	0.8	0.1	0.5	17.9	28.0	32.5	34.3	16.8	13.7	27.5	22.2	47.0	29.8
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085679-104115581	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 29.7;liver: 88.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.4;HMC-1: 3.1;RPTEC TERT1: 1.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA069761	Enhanced									"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	0.7	0.5	0.4	0.4	0.5	0.0	2.1	0.4	0.5	1.5	2.3	0.5	0.4	0.5	1.6	1.0	10.2	2.0	0.8	29.7	0.4	0.0	9.8	88.7	1.3	0.9	0.4	0.4	4.9	0.4	0.7	0.4	0.8	0.7	0.4	0.8	1.2	0.8	0.4	0.4	5.2	0.8	1.1	0.4	0.4	1.6	0.9	0.4	0.4	1.3	0.6	1.7	0.5	2.8	0.2	0.0	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	1.8	0.8	2.6	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.7	0.0	0.7	0.6	1.8	1.9	1.4	1.2	0.0	0.1	0.8	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.7	0.4
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.4;Karpas-707: 13.0;REH: 12.8;SCLC-21H: 48.3;SH-SY5Y: 20.8"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved								"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: "	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavourable (3.44e-4)"	"prognostic favourable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.2	8.5	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.3	1.6	20.4	0.9	0.1	0.2	6.0	0.0	0.2	3.8	1.1	1.7	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.1	0.0	0.0	13.0	0.1	0.3	3.7	0.0	1.1	5.2	12.8	7.0	0.6	0.0	0.2	48.3	20.8	0.1	1.5	0.0	1.2	0.9	0.0	1.1	1.1	0.0	0.3	1.3	0.9	4.6	1.9	7.1	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897774-4903074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 53.3;pituitary gland: 19.0"	"Group enriched"	"Detected in some"	13	"HEL: 5.9;HMC-1: 14.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdTCR: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	14	"basal ganglia: 5.7"												"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0.0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19.0	0.4	0.2	0.1	0.0	0.5	0.5	0.1	1.0	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1.0	0.3	1.0	0.4	1.6	5.9	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	5.9	0.0	0.7	0.5	0.0	14.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.9	0.2	0.0	0.0	0.0	2.1	0.2	1.0	0.1	1.6	0.2	1.6	0.4	0.3	0.0	1.5	0.1	0.1	0.3	0.4	0.1	0.0	0.3	0.1	0.2	0.1
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"				"Nucleoplasm, Cell Junctions, Intermediate filaments"	"Nucleoplasm, Cell Junctions, Intermediate filaments"	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favourable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	9.3	5.3	51.5	4.0	47.6	1.6	7.3	37.7	69.1	4.5	5.4	38.7	0.9	3.4	4.3	13.9	13.9	7.6	7.1	82.8	42.3	46.5	2.7	2.5	4.8	2.3	44.7	21.0	5.4	12.3	1.4	6.1	3.6	51.0	14.6	5.6	3.4	5.7	15.9	90.2	1.8	3.9	15.2	106.3	3.9	3.6	4.7	39.5	0.0	9.3	6.5	2.4	12.8	1.7	1.4	7.0	0.4	1.3	1.0	6.7	1.7	0.2	0.1	7.5	0.0	4.8	13.4	1.2	2.0	7.3	0.3	0.9	1.7	0.0	0.0	4.4	0.8	0.6	0.9	3.9	0.7	0.0	5.2	0.0	0.4	3.5	3.9	0.1	0.1	10.2	0.8	6.3	2.2	3.2	1.1	0.9	2.1	17.5	0.1	0.0	19.5	4.0	0.0	3.7	11.9	0.3	0.1	27.5	3.2	0.0	0.7	2.0	10.7	2.6	0.1	8.7	4.7	0.1	2.7	0.6	0.9	0.4	28.1	0.0	3.7	0.4	1.3	0.0	1.4	0.0	1.9	1.4	2.7	1.9	7.0	1.1	2.8	2.0	0.1	1.0	0.0	0.2	6.7	1.7	51.5	47.6	37.7	35.7	42.3	46.5	44.7	21.0	51.0	39.5
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139395-192767764	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7"	"Cell line enhanced"	"Detected in some"		"AF22: 11.6;NTERA-2: 7.9;SCLC-21H: 18.6;U-251 MG: 11.1;WM-115: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.2	21.5	8.8	0.7	15.8	0.6	1.0	17.7	31.9	0.9	0.9	1.9	0.0	1.0	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2.0	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1.0	2.7	6.8	0.9	1.7	2.8	0.0	1.4	0.0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0.0	0.8	11.6	0.0	0.0	0.0	0.0	0.0	0.1	1.1	1.4	0.0	0.1	0.6	5.6	0.2	0.1	0.0	0.0	1.3	0.1	0.1	2.4	4.9	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	3.2	0.0	0.0	7.9	0.2	0.0	0.1	0.0	3.6	1.3	18.6	0.0	0.0	0.4	0.0	0.8	0.1	0.3	4.8	2.5	0.0	11.1	0.1	1.8	0.0	1.0	0.0	13.4	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24131275-24132849	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9"	"Cell line enriched"	"Detected in some"	17	"RH-30: 26.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019842	Uncertain									"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	0.8	1.7	0.0	0.2	0.0	0.6	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0.0	0.0	0.2	13.1	0.2	0.3	0.0	0.0	0.2	11.9	0.2	0.2	0.2	0.0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0.0	2.5	0.3	0.3	0.0	0.0	0.5	79.9	3.6	0.3	0.0	0.8	0.3	0.0	1.1	0.4	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.1	0.0	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.3	0.2	26.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0.0	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589893-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.1;heart muscle: 16.8"	"Cell line enhanced"	"Detected in many"		"A549: 17.6;MCF7: 16.4;U-138 MG: 12.3;U-87 MG: 25.4"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	1.1	4.8	12.0	1.4	29.1	1.5	1.0	8.5	38.1	1.1	1.2	8.2	0.0	1.2	1.0	1.3	2.2	1.0	1.1	16.8	18.3	11.7	1.5	1.1	1.1	1.5	22.0	6.6	1.0	1.5	1.2	3.0	1.1	11.4	1.2	1.1	0.6	1.4	1.2	1.1	1.7	1.2	1.2	24.5	1.3	1.3	3.7	7.3	0.0	1.1	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	17.6	0.2	0.6	1.9	1.3	0.6	1.2	1.4	0.5	0.1	2.5	0.1	0.0	3.9	1.7	0.1	0.4	0.1	0.0	2.9	7.5	0.0	9.4	0.2	1.4	0.2	3.4	3.4	0.3	0.1	0.0	0.1	1.0	0.1	1.3	16.4	0.0	0.0	0.8	0.5	0.1	0.1	0.4	0.3	0.5	6.8	3.5	4.3	0.0	1.3	3.5	0.6	1.6	12.3	1.8	0.2	4.8	0.3	0.2	0.1	25.4	0.8	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	12.0	29.1	8.5	19.6	18.3	11.7	22.0	6.6	11.4	7.3
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 28.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.0	28.5	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0
LRRC39	MGC14816	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148449-100178273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 30.7;skeletal muscle: 113.7;tongue: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077159	Enhanced									"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	1.8	3.2	1.6	0.4	1.3	0.4	0.5	0.6	3.0	0.2	0.3	0.5	0.0	0.3	0.4	2.6	1.3	0.3	0.4	30.7	0.8	0.5	0.3	0.5	0.3	0.6	0.8	1.3	0.3	0.3	0.3	0.5	1.3	0.5	1.3	0.3	9.5	1.1	0.3	113.7	1.1	0.3	0.3	0.7	0.5	0.3	1.7	0.6	0.1	0.5	28.5	1.2	0.3	0.1	1.1	0.4	0.2	0.6	0.2	0.9	0.0	0.6	0.9	3.0	4.2	0.7	1.8	2.5	1.3	0.6	0.6	1.4	0.2	1.8	3.3	1.4	0.6	1.9	0.3	0.4	1.3	0.4	2.8	1.4	3.1	0.6	0.5	1.0	1.8	3.2	0.7	0.7	0.3	0.7	1.4	2.9	1.1	0.6	1.7	4.0	1.3	1.1	1.5	1.4	1.3	0.6	1.0	1.3	4.2	1.0	1.1	11.8	1.0	2.2	0.9	1.6	1.6	2.4	2.7	5.6	2.8	1.0	3.1	2.1	0.4	0.0	0.4	0.2	0.4	0.6	0.6	0.9	0.4	0.4	0.1	1.1	0.9	0.9	0.2	0.2	0.3	0.4	0.4	0.0	1.6	1.3	0.6	3.0	0.8	0.5	0.8	1.3	0.5	0.6
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"					"Low region specificity"	"Detected in all"														"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.5	0.0	0.8	1.0	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412738-23435718	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 644.7;skeletal muscle: 596.4"	"Cell line enriched"	"Detected in single"	32	"HSkMC: 16.0"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced					31000000	31000000			"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	5.4	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	7.2	0.0	0.1	644.7	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	3.3	0.0	0.0	11.8	0.0	596.4	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.9	109.6	16.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.0
MYH7B	"dJ756N5.1, KIAA1512, MHC14, MYH14"	ENSG00000078814	"Myosin heavy chain 7B"	A7E2Y1	20	34975403-35002437	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 48.1;skeletal muscle: 63.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 4.4;U-138 MG: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.05e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.02e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-1)"	"prognostic favourable (8.44e-5)"	0.4	0.4	2.2	0.4	2.6	0.3	0.4	1.8	3.5	0.4	0.4	1.1	0.4	0.7	0.7	0.8	0.9	0.4	0.4	48.1	2.8	2.3	0.4	0.4	0.4	0.4	3.2	0.4	0.8	0.4	0.1	0.4	0.4	1.0	1.1	0.2	0.8	3.4	0.4	63.0	0.6	0.4	0.4	2.9	0.5	0.3	5.1	0.9	0.4	1.0	8.5	1.1	0.4	0.4	0.3	0.1	2.0	0.4	1.1	0.7	0.0	2.5	0.8	0.7	1.1	0.2	0.6	1.9	0.1	0.0	0.0	0.0	4.4	1.4	0.6	1.7	0.0	1.5	0.0	0.0	0.3	0.3	0.7	1.5	1.3	2.1	0.4	0.6	0.9	0.8	0.4	0.1	0.0	0.0	0.8	1.6	0.4	1.1	0.4	2.7	0.5	0.4	0.5	0.8	0.4	0.3	0.8	0.9	1.1	0.2	0.6	0.6	3.6	0.8	1.1	4.5	2.0	0.7	0.5	2.6	0.5	1.0	1.2	0.5	1.0	1.6	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.3	0.7	2.0	1.1	0.1	0.1	0.2	0.0	2.2	2.6	1.8	3.5	2.8	2.3	3.2	0.4	1.0	0.9
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	1.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3220108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6"	"Group enriched"	"Detected in some"	9	"HAP1: 16.2;HMC-1: 4.4;HSkMC: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					32000	32000			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	6.2	0.6	1.3	0.9	1.2	0.3	0.8	0.6	0.7	1.0	2.4	0.3	0.4	0.5	2.9	10.1	6.0	1.3	3.0	111.4	1.1	1.3	0.4	16.6	0.4	0.4	2.2	0.1	0.9	6.4	0.3	0.3	0.5	0.9	2.6	0.7	3.4	4.6	1.1	153.1	0.3	0.9	9.3	2.0	0.3	0.7	1.2	0.1	0.0	1.6	51.6	4.6	5.0	0.5	0.7	3.0	0.6	0.4	0.8	2.1	1.1	0.0	0.1	0.3	0.0	0.8	1.0	0.3	0.5	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.2	0.0	16.2	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	4.4	7.9	0.4	0.3	0.1	0.1	0.0	0.5	0.3	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.6	0.9	0.4	0.5	0.7	0.6	0.5	0.5	0.6	1.0	2.1	0.5	0.8	0.0	3.0	0.2	1.1	1.3	1.2	0.6	0.7	1.1	1.3	2.2	0.1	0.9	0.1
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 90.5"	"Cell line enriched"	"Detected in single"	27	"SH-SY5Y: 25.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024255	Enhanced									"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	1.3	0.3	0.2	1.0	0.2	0.0	0.6	0.3	0.2	1.8	16.0	0.2	7.6	0.6	2.0	1.3	3.3	1.8	6.1	90.5	0.2	0.0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5.0	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3.0	0.3	2.2	0.4	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	25.5	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.7	0.0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1.0	0.1	0.9	2.2	0.7	0.1	0.3	3.0	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.3	0.2
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.3	0.5	0.0	0.0	7.7	10.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	2.7	3.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Plasma membrane, Cell Junctions, Cytosol"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.3	0.1	3.9	20.0	0.0	0.0	1.2	0.0	0.0	0.0	10.3	0.0	0.0	1.9	0.0	0.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118161951-118176673	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 1.5;U-2 OS: 2.5;U-2197: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	1.8	3.0	14.7	1.4	31.5	1.0	1.9	31.1	37.0	2.9	2.0	3.1	0.0	1.7	3.2	2.9	3.6	2.9	2.7	17.5	22.5	11.6	1.6	1.0	2.5	1.0	8.7	30.6	2.8	1.1	1.0	0.8	1.0	12.8	2.4	1.9	0.4	1.8	2.7	9.7	1.4	2.5	3.5	13.9	1.1	1.3	1.3	6.9	0.0	1.9	0.7	1.0	1.5	0.6	0.3	0.2	2.1	0.3	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	2.5	5.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.1	0.3	0.9	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	1.3	0.2	0.0	0.2	0.1	0.0	14.7	31.5	31.1	37.0	22.5	11.6	8.7	30.6	12.8	6.9
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.4	1.1	1.2	1.0	1.3	0.3	1.1	1.7	1.8	1.4	1.0	0.5	1.5	1.0	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1.0	1.1	1.5	6.8	0.8	2.8	1.9	1.0	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.4	1.8	2.0	37.8	4.0	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.8	2.8	2.1	6.5	2.7	2.6	7.6	2.6	2.3	2.7	3.8	9.0	6.8	4.0	9.1	0.9	2.8	2.3	3.7	5.6	9.0	1.8	6.0	1.3	5.7	3.1	5.4	4.8	3.3	6.7	4.2	3.8	0.3	4.2	1.6	2.7	3.5	2.9	5.2	3.6	2.9	3.1	5.5	3.8	3.7	4.2	5.4	1.9	3.5	3.9	8.5	3.2	2.9	0.2	4.3	3.1	3.3	3.3	3.9	9.9	3.3	4.4	9.0	6.4	0.0	0.0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443539-206621130	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 21.8;RPMI-8226: 56.8;U-266/70: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 5.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Intracellular and membrane"	24000	24000			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	2.0	4.7	8.5	2.5	30.5	2.3	1.7	14.2	27.4	3.4	2.4	3.4	0.3	2.0	2.5	3.8	3.8	1.2	4.0	19.3	8.7	11.4	1.5	1.4	2.0	2.3	9.8	13.5	2.4	5.7	67.6	4.8	1.0	22.4	1.8	2.6	2.4	1.5	2.8	8.1	1.6	2.4	4.2	3.9	1.4	2.0	6.5	4.0	0.8	1.3	1.6	2.7	3.2	2.4	0.4	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.3	7.6	0.0	4.1	6.0	0.3	0.8	0.9	1.1	0.2	8.9	0.1	1.0	0.0	1.2	11.4	4.9	0.2	0.1	4.3	4.2	0.0	0.6	0.1	4.0	0.0	0.5	2.2	0.0	0.0	0.0	13.2	0.0	0.0	2.7	0.1	0.1	0.0	14.9	1.5	0.0	21.8	56.8	0.0	5.5	5.9	2.4	0.0	0.0	4.2	0.0	0.0	11.4	3.8	3.5	2.0	1.7	15.5	0.0	0.0	7.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.5	30.5	14.2	25.6	8.7	11.4	9.8	13.5	22.4	4.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	930000	930000	"Golgi apparatus"	"Golgi apparatus"	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					38000000	38000000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	34.9	69.8	35.4	28.4	23.5	30.2	51.0	43.7	55.0	44.3	29.9	50.5	37.3	43.2	37.0	41.5	51.2	58.5	69.0	50.4	35.7	29.3	37.7	28.0	29.5	40.0	43.0	36.5	31.7	48.6	56.3	54.6	34.2	43.9	21.2	36.0	33.6	23.2	26.7	40.3	35.3	24.6	31.8	35.7	21.8	72.3	37.4	28.1	54.9	45.2	25.5	60.7	23.2	36.7	41.1	22.1	27.3	33.3	43.6	53.0	48.5	37.4	18.6	46.5	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1
C15orf41	"FLJ22851, HH114, MGC11326"	ENSG00000186073	"Chromosome 15 open reading frame 41"	Q9Y2V0	15	36579611-36810248	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 79.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.3	4.1	3.4	4.1	8.9	0.8	2.4	4.2	4.1	5.5	4.0	2.8	3.5	4.9	8.8	2.7	7.0	3.3	4.7	79.9	2.5	2.4	2.3	2.8	2.9	1.9	3.1	2.3	3.6	1.9	2.7	3.5	1.8	2.8	5.4	2.7	2.7	3.5	5.3	7.9	4.2	3.0	16.0	3.4	2.0	2.8	4.9	3.7	2.8	2.2	7.2	3.9	7.7	6.2	3.6	2.4	0.4	2.1	4.9	7.8	2.0	12.8	7.0	8.8	3.3	9.7	11.8	3.6	6.3	3.1	7.9	6.5	9.6	5.2	2.0	6.4	15.2	23.8	9.1	5.3	9.1	1.0	6.3	6.8	6.4	7.0	8.8	5.9	5.0	8.8	5.9	6.7	3.7	7.5	8.6	2.2	10.8	5.9	1.7	3.3	4.8	3.6	5.4	2.5	1.4	5.1	17.8	5.1	3.2	4.2	4.2	3.3	3.9	9.0	5.3	7.8	4.3	5.2	1.7	5.3	7.2	9.5	9.9	10.3	7.2	0.0	0.8	0.4	4.3	2.1	3.9	3.6	3.4	4.2	2.4	3.5	4.1	3.5	0.1	4.9	0.8	1.8	7.8	2.0	3.4	8.9	4.2	4.1	2.5	2.4	3.1	2.3	2.8	3.7
CLEC6A	"CLECSF10, dectin-2"	ENSG00000205846	"C-type lectin domain containing 6A"	Q6EIG7	12	8455926-8478330	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 8.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 8.4;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.5;monocytes: 8.4"	"Low region specificity"	"Detected in many"																		"unprognostic (1.44e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.27e-4)"		"unprognostic (6.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"		"unprognostic (7.30e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-2)"	0.2	0.2	0.1	4.9	0.2	0.5	0.2	0.1	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.8	0.2	0.3	0.2	2.3	0.5	0.2	0.4	0.8	6.2	5.0	0.2	0.0	0.1	0.3	0.0	0.2	0.9	0.4	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.4	0.9	0.1	0.5	0.0	0.7	0.2	0.0	1.7	1.1	0.2	0.0	3.5	0.5	8.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.2	0.1	0.1	0.5	0.2	0.2	0.0	0.4	0.0
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				Cytosol	Cytosol	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.4	10.2	9.9	6.4	5.7	5.7	4.2	3.5	8.5	12.6	12.6	7.9	3.8	14.6	8.1	8.9	2.3	11.4	2.0	7.5	2.2	12.7	6.8	9.3	8.2	7.8	5.3	4.1	5.9	3.3	9.3	3.7	6.6	4.5	6.0	11.6	3.3	7.6	19.1	8.4	5.9	16.4	10.8	9.6	6.9	1.5	14.3	15.5	12.2	2.5	3.8	3.9	5.9	4.6	2.4	7.0	6.7	3.6	12.6	13.5	7.1	7.0	5.0	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.3	31.8	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480170	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 180.3"	"Cell line enhanced"	"Detected in many"		"A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 24.0;T-reg: 29.2"	"Group enriched"	"Detected in many"	19	"B-cells: 17.9;T-cells: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		490000	490000	Nucleoli	Nucleoli	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	22.8	11.5	27.5	9.1	24.6	1.6	16.9	3.6	30.3	20.2	10.1	9.4	33.7	7.9	15.3	30.6	25.6	29.5	24.5	180.3	22.6	18.7	20.0	6.9	28.5	9.3	13.5	16.9	12.5	12.6	4.3	20.4	29.1	10.4	14.6	3.8	8.8	18.4	28.0	10.7	28.4	9.1	24.9	10.3	13.0	11.3	10.9	7.8	1.0	17.8	23.8	13.3	23.8	17.5	17.9	0.9	0.2	0.5	1.2	29.2	3.4	0.4	37.7	5.5	15.0	0.9	3.9	1.6	1.7	0.4	0.5	0.1	1.1	7.0	0.0	38.6	12.3	21.6	0.7	9.2	0.0	0.2	0.2	0.0	23.7	14.3	4.0	0.0	3.2	1.9	0.8	0.9	5.1	36.1	0.0	0.3	5.4	55.4	0.1	0.1	1.5	22.7	0.0	0.7	1.6	25.4	0.1	8.4	20.9	2.4	43.4	0.3	37.2	0.0	14.0	12.5	5.9	0.3	7.0	0.1	0.1	0.1	3.6	0.0	25.2	0.0	0.5	0.0	2.4	0.2	2.3	14.4	24.0	5.3	0.9	17.9	5.9	1.6	0.2	1.2	0.1	0.1	29.2	3.4	27.5	24.6	3.6	30.3	22.6	18.7	13.5	16.9	10.4	7.8
CTAG1A	"ESO1, LAGE2A"	ENSG00000268651	"Cancer/testis antigen 1A"	P78358	X	154585143-154586821	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 3.0;testis: 8.1"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 120.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB013061	Enhanced									"CAB013061: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.8	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.7	4.2	7.1	5.4	5.2	4.6	5.5	5.3	6.5	5.0	5.7	15.0	4.1	4.9	1.7	6.1	9.8	7.6	4.0	7.2	3.2	12.8	8.3	19.2	4.1	2.7	12.6	6.2	6.8	6.7	5.6	4.5	4.2	4.6	4.7	4.8	4.8	8.6	20.8	4.5	6.6	9.0	11.7	6.5	3.7	4.5	31.6	7.0	4.1	14.2	3.9	8.1	5.9	7.0	6.6	9.0	5.0	7.6	14.0	5.9	9.8	15.0	5.6	4.4	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721418	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.0;heart muscle: 52.0;parathyroid gland: 13.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.4;REH: 24.2;SH-SY5Y: 14.4;THP-1: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.2;naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.3	2.9	12.8	1.7	20.1	1.2	2.0	20.6	48.0	3.4	1.7	3.0	0.1	1.7	6.9	2.8	5.2	2.8	1.3	52.0	14.8	8.5	2.5	0.7	1.0	1.2	10.0	16.2	1.8	6.1	13.5	8.2	1.0	19.1	3.1	1.6	2.4	6.0	2.3	1.4	1.6	1.8	6.8	2.9	2.2	2.6	4.2	1.3	0.0	1.0	1.8	1.3	1.6	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.6	12.3	0.4	1.7	0.0	4.1	1.4	0.2	0.0	0.7	0.2	0.0	0.5	10.9	0.0	5.1	0.0	0.0	0.0	8.0	0.2	0.4	0.4	0.5	0.0	22.4	0.7	2.6	0.0	0.1	0.0	7.2	3.6	1.4	1.8	0.1	0.2	7.7	1.7	24.2	0.0	5.8	0.0	0.0	1.6	14.4	0.1	0.5	7.7	0.5	16.9	0.0	2.8	3.5	0.1	1.3	8.5	5.9	4.4	6.1	0.2	12.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	20.1	20.6	48.0	14.8	8.5	10.0	16.2	19.1	1.3
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell line enriched"	"Detected in some"	10	"WM-115: 57.4"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037749	Approved				"Intracellular and membrane"	68000	68000			"HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 65.0;heart muscle: 35.5;kidney: 41.5"	"Cell line enhanced"	"Detected in some"		"BJ: 19.3;BJ hTERT+: 14.4;BJ hTERT+ SV40 Large T+: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 28.8;hTEC/SVTERT24-B: 20.1;LHCN-M2: 13.4;U-2 OS: 14.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (3.45e-5)"	"unprognostic (3.01e-4)"	7.3	3.5	44.2	2.0	43.1	1.5	9.7	10.5	59.9	1.8	1.7	65.0	0.0	1.6	3.1	8.7	2.3	2.1	2.7	35.5	47.4	33.0	41.5	2.0	2.9	1.4	62.6	13.8	1.5	1.4	3.4	1.6	2.3	36.3	2.2	1.8	0.8	5.8	2.6	2.3	2.0	1.7	2.6	57.7	5.5	1.1	2.2	48.6	0.0	4.9	0.8	2.2	1.7	0.4	1.2	1.0	1.8	0.6	0.1	2.3	0.2	2.3	0.1	0.1	0.7	0.5	1.5	0.8	19.3	14.4	16.0	20.2	0.1	0.1	0.5	1.4	6.6	0.3	0.0	1.5	28.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.7	0.5	20.1	1.2	0.0	0.0	0.7	13.4	0.3	0.0	0.4	0.6	0.6	0.1	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.4	0.2	0.0	0.1	0.4	2.6	14.4	0.3	9.1	0.3	0.1	0.1	3.6	0.1	0.7	0.3	0.3	1.8	2.3	0.1	1.8	0.4	0.8	0.9	0.2	1.2	0.9	1.9	1.7	0.1	0.6	1.0	0.5	0.2	44.2	43.1	10.5	22.6	47.4	33.0	62.6	13.8	36.3	48.6
FRMD5	MGC14161	ENSG00000171877	"FERM domain containing 5"	Q7Z6J6	15	43870761-44195252	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.5;heart muscle: 48.9"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.8;HUVEC TERT2: 14.6;WM-115: 33.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.6;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.54e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.26e-7)"	"unprognostic (3.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.00e-3)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (7.01e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.31e-1)"	1.0	7.2	8.9	1.4	12.3	1.6	1.3	8.2	15.1	1.0	1.7	24.5	0.0	1.0	0.9	1.3	1.2	2.0	1.3	48.9	10.9	6.9	1.2	0.8	1.0	1.1	14.7	4.8	1.0	1.1	1.1	1.6	0.9	10.7	1.2	1.8	2.9	2.0	1.2	0.8	1.2	1.3	1.1	13.4	1.2	2.2	4.3	11.5	0.0	1.2	0.0	0.8	1.1	0.2	1.6	0.3	0.0	0.0	0.0	1.6	0.0	3.3	1.9	1.2	0.7	1.4	0.1	0.2	0.7	1.1	2.1	4.2	5.5	3.7	0.2	0.7	0.5	4.0	1.8	3.9	1.8	0.2	2.0	0.5	1.6	2.3	0.1	0.0	0.2	0.0	0.4	5.8	11.8	14.6	0.1	0.4	2.3	0.3	0.5	0.0	1.0	1.8	0.0	2.6	0.0	2.0	1.2	7.7	2.6	0.4	0.0	7.9	0.1	0.1	0.5	4.1	7.0	1.0	10.4	0.2	0.9	0.4	5.8	0.2	33.4	0.0	0.0	0.0	0.8	0.0	1.6	1.6	1.2	0.4	0.0	0.5	0.6	0.9	0.0	0.0	0.0	0.3	1.6	0.0	8.9	12.3	8.2	12.4	10.9	6.9	14.7	4.8	10.7	11.5
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787535-28063509	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;heart muscle: 19.3"	"Group enriched"	"Detected in some"	7	"HMC-1: 13.3;THP-1: 4.9"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced									"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.7	0.8	8.7	0.6	14.6	0.7	0.6	1.8	13.3	0.8	1.1	2.7	0.0	1.1	1.1	1.0	0.6	3.4	0.5	19.3	6.0	6.8	1.1	1.1	0.9	0.6	10.0	3.3	0.4	0.7	0.4	0.2	2.0	6.5	0.8	0.7	1.2	0.8	0.6	1.0	1.8	1.2	0.5	3.5	0.9	2.5	2.2	3.3	0.0	1.0	0.0	0.5	0.5	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.3	0.0	0.3	0.2	0.2	0.2	0.3	0.3	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.5	0.8	0.1	0.3	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.6	0.1	4.9	1.2	0.0	0.8	0.0	0.2	1.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	8.7	14.6	1.8	10.7	6.0	6.8	10.0	3.3	6.5	3.3
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155424	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 155.8;skeletal muscle: 82.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 6.3;HSkMC: 6.4;K-562: 8.5;THP-1: 15.2;U-266/84: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004833	Enhanced				"Intracellular and membrane"	23000	23000			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	2.4	0.8	0.2	0.1	0.5	0.0	0.8	0.0	0.6	1.6	0.3	0.3	0.3	0.2	1.8	4.3	1.3	1.0	0.5	155.8	0.2	0.2	0.7	0.4	0.3	0.4	0.4	0.3	0.7	0.3	0.4	0.2	0.4	0.3	1.4	0.2	1.3	1.4	0.6	82.1	0.3	0.3	0.5	0.2	0.1	0.2	0.7	0.1	0.0	1.7	25.9	2.0	0.4	0.6	0.5	0.1	0.9	0.5	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	6.3	0.0	0.0	1.2	6.4	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.2	0.2	0.0	0.0	0.3	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.2	0.4	0.1	0.2	0.0	0.2	0.5	0.0	0.6	0.2	0.2	0.4	0.3	0.3	0.1
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	160000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
KCNE1B		ENSG00000276289	"Potassium voltage-gated channel subfamily E regulatory subunit 1B"	A0A087WTH5	21	7816675-7829926	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.9;SK-MEL-30: 2.5;U-266/70: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.0;eosinophil: 4.0"	"Group enriched"	"Detected in many"	17	"granulocytes: 4.0;monocytes: 1.6"																				"unprognostic (5.41e-4)"	"unprognostic (8.78e-2)"		"unprognostic (7.14e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.34e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.24e-1)"		"unprognostic (1.73e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.49e-1)"			0.0	0.0		0.0		0.0	1.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	8.2	0.0	8.3			3.8	0.4	1.2	0.0			0.0	0.0	0.8		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.9		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	4.0	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.7	0.5	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	3.0	1.6	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.2										
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 67.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA012127, HPA023592"	Uncertain									"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.7	14.7	1.7	6.2	3.9	6.9	4.2	3.4	3.6	3.8	4.0	3.9	7.6	4.0	2.3	5.4	4.0	4.1	5.3	67.7	3.4	2.1	4.1	8.3	4.4	8.3	1.8	3.3	3.3	4.1	7.5	4.4	2.3	3.7	4.6	4.1	4.5	4.2	10.0	4.8	2.6	6.0	2.5	3.1	10.4	4.6	6.7	2.3	6.2	4.6	3.0	6.5	4.8	2.6	4.9	7.1	5.7	6.2	8.0	7.0	4.3	2.0	3.5	2.2	1.7	3.4	6.4	4.9	2.8	4.1	4.6	3.7	2.8	23.7	7.1	6.1	3.4	9.2	2.3	6.4	3.6	9.5	7.3	5.9	9.7	2.0	5.0	5.5	7.8	8.7	0.7	8.1	2.6	2.5	6.1	6.5	2.9	3.5	3.4	8.3	2.7	3.1	8.4	5.4	13.0	6.0	4.0	2.4	3.6	3.1	4.3	8.8	7.8	8.3	1.9	2.9	1.8	2.9	2.9	10.7	9.2	6.7	2.6	5.7	2.9	2.2	6.2	5.7	6.6	4.5	5.7	4.6	3.7	7.0	5.4	4.9	5.1	4.1	1.8	8.0	3.4	7.1	2.2	4.3	1.7	3.9	3.4	3.6	3.4	2.1	1.8	3.3	3.7	2.3
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.6;HEL: 6.1;LHCN-M2: 6.1;TIME: 4.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064844			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.0	0.2	0.3	1.0	2.2	0.1	0.8	1.5	0.5	0.8	0.0	0.2	0.3	0.2	10.6	0.2	3.7	0.0	1.4	0.5	0.1	6.1	0.4	0.2	0.2	0.2	0.1	0.2	0.1	4.3	0.0	0.2	0.1	0.4	6.1	0.1	0.8	0.1	1.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 17.7;SK-MEL-30: 17.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	2.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	17.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 19.0;HUVEC TERT2: 12.1;SCLC-21H: 28.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA015313: AB_1854343, HPA017587: "	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	3.6	59.2	28.7	2.9	49.4	1.6	2.3	65.4	134.1	3.8	3.5	11.0	15.6	3.4	10.2	5.1	10.0	3.9	3.4	112.6	30.5	32.0	2.3	1.9	6.5	3.4	33.7	35.4	2.1	2.6	10.8	11.6	2.6	81.2	2.1	3.2	8.7	2.9	18.2	5.3	3.9	3.2	8.7	11.7	11.7	2.6	19.9	7.4	0.0	2.6	0.3	3.5	2.7	8.0	1.5	0.1	0.2	0.0	0.1	0.9	0.2	0.1	9.6	9.2	1.8	0.2	1.7	0.7	3.0	4.7	1.4	0.9	3.6	2.5	0.2	19.0	2.3	0.8	0.7	0.5	1.3	0.0	1.9	0.4	1.6	2.6	2.6	0.1	0.1	2.1	0.2	0.9	0.0	12.1	0.1	0.1	1.3	2.4	0.9	0.1	0.8	7.1	0.2	2.5	0.2	0.4	6.0	28.7	10.8	0.3	0.8	0.1	0.3	0.1	4.3	1.2	3.6	0.3	0.4	0.5	0.2	3.1	6.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.2	28.7	49.4	65.4	63.4	30.5	32.0	33.7	35.4	81.2	7.4
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"					"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 60.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	16.9	3.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.7	15.3	0.0	10.4	0.0	15.1	2.1	13.4	0.0	0.0	4.8	0.1	0.7	15.9	9.5	0.9	0.2	0.0	12.7	0.0	14.7	0.5	3.0	4.8	1.4	4.4	0.0	0.1	9.3	2.9	0.0	7.4	5.0	4.5	8.0	1.9	1.6	0.7	3.5	0.0	7.7	0.2	0.1	0.0	6.8	0.0	4.1	4.0	0.0	0.1	0.0	0.0	0.8	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 337.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.4;Karpas-707: 1.6;NB-4: 1.9;U-2197: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005597, HPA026900"	Enhanced									"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (5.59e-4)"	9.0	1.8	0.4	2.7	0.5	0.0	5.4	0.4	0.6	22.3	22.2	0.0	9.8	2.0	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0.0	1.6	6.0	68.4	1.5	14.0	30.8	1.2	0.6	6.5	12.3	0.0	0.0	2.8	23.7	0.8	32.2	6.6	0.3	0.0	1.3	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.2	0.0	0.2	1.6	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.1	1.0	0.0	0.7	0.2	0.8	0.4	0.1	0.0	0.4	0.0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.5	0.0	1.1	0.1	0.0	0.4	1.3	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.3	1.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0.0
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.6	0.4	0.1	2.7	6.9	0.6	2.7	2.8	4.7	5.8	0.0	1.5	0.1	1.1	5.4	0.0	1.3	1.2	3.9	0.0	2.9	0.0	1.0	0.0	0.1	0.0	0.0	2.7	0.2	7.6	1.0	0.3	2.8	8.1	13.2	0.0	0.0	1.0	3.0	4.6	0.4	14.7	0.0	0.0	0.0	6.7	12.2	0.0	0.0	9.5	0.0	5.2	6.0	2.9	0.0	1.9	9.9	0.0	0.0	0.0	13.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819764-126821786	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"heart muscle: 8.9;tongue: 26.7"	"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8"	"Low region specificity"	"Detected in many"			HPA048386	Uncertain									"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.1	3.4	0.0	8.9	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	1.7	0.0	3.1	0.1	0.0	0.3	0.5	0.3	0.0	0.0	0.1	0.0	0.0	26.7	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.9	0.1
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 3.9;Karpas-707: 2.4;NTERA-2: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046925	Uncertain				"Secreted - unknown location"					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	3.9	0.4	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	3.6	0.0	1.2	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell line enriched"	"Detected in some"	15	"RH-30: 24.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA040809: AB_10796228, HPA066746: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	24.5	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 15.9;RPMI-8226: 5.7;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	5.7	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180952-23325165	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 37.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA007476	Enhanced									"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	8.6	0.1	0.1	0.2	0.1	0.0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0.0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	37.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.2	2.7	5.4	2.9	0.3	4.9	2.7	0.9	3.3	3.3	7.0	1.8	2.3	1.9	3.2	2.6	10.3	2.8	2.1	4.0	8.8	1.6	4.9	8.2	6.0	1.4	1.6	2.2	7.0	5.0	1.4	2.4	3.8	1.8	2.0	5.1	1.6	3.1	4.3	7.0	2.6	1.4	3.3	7.4	5.0	8.7	6.6	3.2	1.4	12.4	2.5	1.2	1.8	0.2	1.5	1.6	3.4	7.8	3.5	3.0	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393828-92468728	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.7;heart muscle: 10.0"	"Cell line enhanced"	"Detected in some"		"AF22: 21.8;LHCN-M2: 6.4;RH-30: 9.8;RPMI-8226: 7.1;WM-115: 6.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054518	Approved		Approved	"Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"	"Centriolar satellite"	"HPA054518: AB_2682514"	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.3	1.1	1.3	0.2	2.2	0.1	1.2	1.5	3.7	2.6	0.3	0.0	0.0	0.1	1.3	2.5	0.4	0.1	0.7	10.0	3.0	3.6	0.3	0.1	0.1	0.2	2.2	1.4	0.1	0.1	0.1	0.9	0.1	17.7	0.3	0.2	1.0	0.8	0.5	2.1	0.1	0.4	0.2	0.2	0.1	0.2	0.8	0.1	2.5	0.2	1.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.0	3.5	0.0	0.0	9.8	7.1	0.0	0.0	0.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.6	3.0	3.6	2.2	1.4	17.7	0.1
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	27	"B-cells: 3.3"	"Group enriched"	"Detected in many"	6	"amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1"	"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: "	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4.0	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4.0	5.7	2.6	6.2	17.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.1	1.0	0.9	25.8	3.9	5.4	1.3	1.1	6.0	2.8	0.0	21.3	5.6	2.5	0.0	3.8	0.5	0.0	0.0	0.0	10.4	1.3	5.8	0.0	0.2	1.1	6.2	1.5	1.1	20.9	0.0	0.0	1.2	0.4	0.0	0.1	0.8	3.3	0.1	0.2	0.0	1.0	0.5	2.4	11.5	5.6	6.2	0.2	0.4	1.8	50.7	5.1	15.9	0.1	1.0	0.2	0.0	0.3	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.9	1.4	24.9	16.6	4.0	4.5	5.6	3.7	3.9
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced					94000000	94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Group enriched"	"Detected in some"	13	"BEWO: 9.6;HAP1: 7.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 62.2;U-266/70: 42.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		280000000	280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.4	0.5	3.5	14.4	7.2	7.4	0.7	3.8	8.6	2.9	18.1	4.3	0.7	3.5	4.6	3.4	9.7	2.3	23.6	5.5	3.0	2.2	6.7	2.7	7.4	6.8	2.4	7.8	6.8	3.3	0.3	5.9	1.3	4.6	18.8	2.5	3.5	2.8	8.1	5.4	3.9	2.4	0.4	62.2	0.4	1.0	9.2	16.4	2.2	17.7	0.1	9.6	5.5	0.9	0.3	1.4	0.5	0.6	42.9	12.3	2.6	28.1	7.0	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4
CMYA5	"C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689877-79800240	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 119.1;skeletal muscle: 329.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;RT4: 3.0;THP-1: 10.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077831	Enhanced									"HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	2.4	0.2	0.3	0.0	0.3	0.0	0.9	0.3	0.4	0.4	0.4	0.0	0.0	0.0	1.4	2.6	2.0	0.5	0.2	119.1	0.3	0.3	0.6	0.3	0.3	0.0	0.3	0.0	3.6	0.2	2.2	1.1	0.3	0.3	1.4	0.0	0.0	2.4	0.5	329.3	0.5	0.2	1.1	0.4	0.2	0.3	0.2	0.1	0.0	2.3	54.0	2.5	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.9	1.3	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.1	1.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.0	0.1	0.0	0.2	1.9	10.4	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.1
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152869	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 114.9;skeletal muscle: 404.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 24.0;ASC TERT1: 17.6;BJ: 16.1;BJ hTERT+: 13.4;fHDF/TERT166: 24.6;HHSteC: 16.0;HSkMC: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8.0	0.8	2.6	2.0	3.9	6.1	6.6	3.1	5.0	114.9	3.3	2.4	5.0	1.6	4.0	2.7	2.6	4.6	4.2	3.5	6.0	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2.0	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7.0	4.7	0.0	1.3	1.4	1.9	0.0	0.1	0.3	0.1	2.6	0.2	0.0	24.0	17.6	0.1	16.1	13.4	0.5	0.0	0.0	0.8	0.6	6.7	24.6	0.3	0.0	0.0	0.1	0.0	0.8	0.1	0.9	0.1	16.0	0.0	0.2	16.6	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.4	0.0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210573	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 223.9;skeletal muscle: 156.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;RH-30: 1.5;U-2 OS: 2.7"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042581	Enhanced					240000	240000			"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	3.4	0.0	0.0	223.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	4.5	0.0	156.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	46.9	2.3	0.0	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.6	3.5	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	2.7	0.5	0.7	0.0	0.2	0.4	0.8	0.9	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912518-67696169	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.0;RPMI-8226: 3.9;SCLC-21H: 2.6;U-266/70: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.2;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced									"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	1.8	1.4	6.3	3.6	19.3	0.8	1.5	6.6	10.3	2.1	2.5	26.0	0.0	1.1	2.5	0.8	2.9	1.7	1.6	27.5	7.6	2.3	1.1	12.9	1.1	0.9	25.9	5.8	3.4	1.1	1.2	1.1	1.2	16.2	1.2	1.6	0.0	1.2	1.0	16.2	1.2	1.9	4.5	26.8	1.1	1.8	3.6	28.8	0.0	1.4	7.9	1.1	1.3	1.9	0.7	1.4	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	4.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.1	0.0	3.0	1.2	0.2	0.0	3.9	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	11.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	6.3	19.3	6.6	10.3	7.6	2.3	25.9	5.8	16.2	28.8
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419656-171457623	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 23.0"	"Cell line enriched"	"Detected in some"	57	"EFO-21: 65.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018795	Uncertain				"Secreted in other tissues"					"HPA018795: "	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	4.4	0.6	0.6	2.8	0.6	0.1	2.0	0.4	1.2	1.3	0.8	0.5	0.0	1.1	1.6	1.5	0.9	2.0	1.4	23.0	0.5	0.4	1.3	0.4	2.9	0.5	0.4	0.0	1.6	0.9	0.1	1.8	0.9	1.6	2.2	0.3	0.3	1.0	0.7	5.4	1.8	2.2	1.2	0.9	1.1	0.7	1.0	0.3	0.2	2.2	2.5	0.8	2.2	0.5	0.9	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	65.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.6	0.4	1.2	0.5	0.4	0.4	0.0	1.6	0.3
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302838-44311169	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 56.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	8.8	9.9	5.0	2.6	5.7	1.2	9.5	7.1	8.2	4.0	4.5	4.3	3.8	3.8	3.7	7.7	3.1	3.5	3.3	56.7	4.9	5.1	7.7	8.0	3.6	2.0	4.7	5.5	4.3	7.8	13.0	4.5	1.9	6.6	5.8	5.3	4.7	5.3	4.2	6.9	4.5	3.7	4.6	4.7	2.5	3.8	3.6	5.1	0.2	5.5	4.4	2.4	3.9	3.8	2.0	2.7	1.7	3.0	3.8	6.2	2.5	4.4	6.9	2.9	4.2	20.9	8.6	3.0	7.3	5.3	5.8	3.2	8.5	3.2	3.1	4.3	8.2	10.1	3.7	4.9	6.3	0.9	1.7	0.9	4.3	14.2	4.4	1.9	2.6	6.5	11.2	4.0	3.1	4.1	1.7	9.1	5.8	13.9	0.7	2.1	0.7	8.9	1.2	5.5	3.0	3.3	4.2	1.8	2.1	15.5	8.7	6.5	10.7	1.5	5.0	18.6	8.3	10.7	4.3	3.4	8.7	0.8	8.2	3.1	9.2	1.4	3.0	1.7	3.4	2.7	3.5	1.8	3.6	2.8	2.7	2.0	6.2	4.8	1.4	3.8	2.1	1.7	3.2	2.5	5.0	5.7	7.1	8.2	4.9	5.1	4.7	5.5	6.6	5.1
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274870	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.8;SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 7.6"												"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.4	0.4	5.6	0.4	12.0	0.4	2.1	7.3	4.1	1.4	0.6	12.7	0.0	0.4	0.9	7.9	0.4	11.1	0.4	6.3	6.4	4.0	1.1	0.4	1.5	0.4	3.1	1.3	0.8	0.7	0.4	0.5	0.7	14.2	1.8	1.0	11.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	0.4	0.4	1.5	6.5	0.0	2.3	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.8	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.0	7.3	1.7	6.4	4.0	3.1	1.3	14.2	6.5
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	30.3	8.8	0.8	3.6	0.1	0.0	0.0	0.0	0.2	2.4	0.9	0.0	0.6	0.7	0.4	0.0	2.1	0.8	0.4	0.0	1.1	3.5	0.2	0.2	12.5	0.0	0.1	0.3	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.1	3.9	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.6	0.4	5.0	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 17.6"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041597	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73369264	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.3;heart muscle: 12.5;testis: 9.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;CACO-2: 3.1;HDLM-2: 2.1;NTERA-2: 9.4;U-2 OS: 4.1"	"Group enriched"	"Detected in some"	8	"testis cancer: 3.1;thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073174	Approved									"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.2	1.3	4.3	0.2	1.1	0.1	0.1	0.9	3.4	0.2	0.4	2.1	0.0	1.2	0.1	0.2	0.1	0.3	0.2	12.5	0.6	2.0	0.4	0.1	0.3	0.1	1.8	0.9	0.1	0.2	0.1	2.1	0.1	3.9	0.6	0.3	0.2	0.1	1.0	0.1	0.2	0.4	0.2	0.7	0.1	0.6	9.6	1.9	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	1.5	0.0	0.2	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.1	0.9	3.4	0.6	2.0	1.8	0.9	3.9	1.9
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647901-53665708	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.5;RH-30: 2.8;SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	13.1	0.5	0.1	0.3	0.3	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.0	1.6	0.0	57.7	0.6	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	40.9	2.2	0.3	0.2	0.7	0.0	0.0	0.1	0.9	0.6	0.0	1.0	0.7	0.2	0.2	0.0	0.0	0.5	0.0	0.2	0.2	0.1	1.1	2.5	0.0	0.2	0.0	1.9	0.7	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0.0	2.1	2.5	0.0	0.5	0.0	0.0	0.2	0.0	0.8	0.8	0.0	0.3	0.7	0.1	2.8	0.1	0.8	0.9	3.6	0.3	0.2	0.6	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.1	0.0	0.3	2.1	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038644	Enhanced		Supported	Vesicles,Microtubules				Microtubules	Microtubules	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.1	0.0	0.2	1.9	6.7	0.1	0.3	1.3	0.1	0.6	11.8	23.9	4.8	17.9	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.6	0.0	0.2	0.0	1.7	0.0	0.4	0.0	0.0	0.1	0.0	19.8	8.2	0.0	0.1	2.4	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	1.6	17.5	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.2	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6
NEBL	"LASP2, LNEBL"	ENSG00000078114	Nebulette	O76041	10	20779973-21174187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 123.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 13.6;SCLC-21H: 27.5;SH-SY5Y: 16.6;SK-BR-3: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA013994, HPA013995"	Approved									"HPA013994: AB_1854359, HPA013995: AB_1854360"	"unprognostic (3.79e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.20e-3)"	"unprognostic (2.36e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (2.77e-8)"	"unprognostic (3.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (5.56e-4)"	1.3	6.9	16.4	1.0	17.2	0.7	13.2	21.1	16.1	2.6	2.9	9.8	0.1	1.0	1.3	1.0	10.8	1.1	1.7	123.6	16.5	12.7	12.0	1.7	14.1	0.9	12.7	13.3	1.5	6.0	6.6	16.0	5.1	12.6	7.3	4.0	2.2	18.8	8.1	0.8	16.2	1.3	1.4	10.6	0.8	4.0	2.8	12.5	0.5	30.8	3.9	3.8	2.1	4.4	0.0	0.0	1.4	0.8	0.0	0.5	0.2	0.6	5.1	7.8	0.3	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.6	0.7	1.5	8.0	0.0	4.7	0.5	0.0	0.0	0.0	3.3	0.0	2.5	0.0	12.3	0.0	0.0	13.6	12.7	0.0	1.3	0.3	0.3	2.1	0.0	12.0	0.1	0.0	5.7	3.1	0.0	0.1	0.0	1.9	1.1	27.5	16.6	1.4	26.0	0.0	8.8	0.0	10.8	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.5	0.2	16.4	17.2	21.1	14.1	16.5	12.7	12.7	13.3	12.6	12.5
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.6	2.2	5.1	1.7	0.0	0.0	1.5	9.6	0.0	0.0	0.0	5.0	2.0	2.5	1.4	0.0	1.4	0.0	0.0	0.0	0.3	3.6	1.5	3.0	2.5	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.0	0.7	2.0	3.5	4.6	2.9	1.0	5.3	2.9	0.0	0.6	0.7	6.8	2.3	5.2	4.3	0.5	1.9	4.0	9.8	1.0	7.6	8.6	2.0	2.1	1.5	36.9	4.5	9.1	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Cell line enhanced"	"Detected in some"		"BJ: 15.0;fHDF/TERT166: 48.3;U-251 MG: 26.1;WM-115: 34.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.0	6.1	7.1	5.8	0.0	0.0	0.0	0.0	48.3	0.4	0.0	0.0	9.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.8	0.6	0.0	1.4	0.0	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	2.9	0.1	26.1	0.0	0.0	0.0	0.7	0.1	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6
PPP1R1C	Inhibitor-1-like	ENSG00000150722	"Protein phosphatase 1 regulatory inhibitor subunit 1C"	Q8WVI7	2	181954241-182131398	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.5;heart muscle: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA055043			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA055043: AB_2797251"	"unprognostic (1.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.75e-3)"	0.2	0.1	0.7	0.1	3.5	0.1	0.2	3.5	1.8	0.1	0.2	3.0	0.0	0.2	0.2	0.1	0.3	0.2	0.5	27.8	1.5	1.1	0.2	1.2	0.3	0.2	0.8	0.6	0.1	0.6	0.1	0.4	0.2	7.5	1.4	0.2	0.5	0.5	0.2	4.3	0.2	0.7	0.1	2.5	0.2	0.4	0.6	1.3	0.0	0.2	3.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.2	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.5	3.5	1.8	1.5	1.1	0.8	0.6	7.5	1.3
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533718	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	6.1	5.7	9.9	3.5	12.3	3.0	3.7	5.2	11.3	4.8	4.7	12.6	4.4	2.1	6.6	5.0	4.8	5.0	4.3	43.8	9.6	7.5	3.8	3.0	5.5	2.3	21.1	5.8	7.2	3.2	5.7	3.6	7.1	11.1	6.2	2.2	4.9	8.0	7.8	66.2	6.2	2.7	9.8	14.4	3.8	3.0	2.9	15.1	0.3	8.2	9.7	1.9	4.7	5.3	1.6	1.2	4.6	1.2	1.2	2.0	0.7	6.0	8.5	7.7	6.0	8.7	8.2	8.1	10.9	6.1	6.0	5.3	5.3	1.4	0.3	5.5	10.6	6.6	5.7	5.2	2.4	6.1	10.4	0.8	5.5	7.7	15.2	0.3	2.3	9.3	10.4	6.7	9.7	6.0	4.8	0.4	6.0	10.0	0.7	1.9	5.6	9.0	1.0	4.2	0.3	4.2	6.3	1.2	7.2	5.8	5.1	13.0	6.8	0.2	12.0	7.8	3.9	11.3	6.9	1.3	0.6	0.2	8.0	0.1	4.9	1.4	1.0	0.7	0.9	0.5	0.8	0.9	1.0	0.8	0.3	1.6	2.0	1.6	4.6	1.2	1.2	1.2	0.9	0.7	9.9	12.3	5.2	9.9	9.6	7.5	21.1	5.8	11.1	15.1
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 42.7;SK-MEL-30: 146.4"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced					240000	240000			"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.5	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.1	0.0	1.1	0.0	0.0	0.0	0.4	0.4	1.0	0.6	42.7	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	3.4	0.5	0.0	1.2	0.1	0.5	0.2	0.3	3.0	0.4	1.0	0.8	1.6	0.7	0.2	0.3	1.3	146.4	4.4	2.2	0.3	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.7	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;CAPAN-2: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	30.4	28.0	59.8	40.9	199.5	115.1	12.2	3.2	72.1	7.8	41.8	24.1	138.2	12.8	2.6	7.6	54.4	32.9	116.8	6.9	4.3	13.6	7.2	17.8	48.2	38.6	10.0	7.8	62.6	35.4	30.4	53.6	14.8	20.0	39.2	3.1	47.6	11.3	12.0	20.7	8.1	5.3	22.1	40.2	34.2	34.1	3.7	14.4	6.4	30.5	62.7	34.2	21.6	5.9	0.7	9.3	0.7	6.7	11.0	5.8	19.8	14.3	31.3	5.0	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958317-5019158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;RPMI-8226: 4.1;SCLC-21H: 6.4;T-47d: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0.0	1.4	0.9	1.2	2.0	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1.0	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11.0	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0.0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0.0	0.1	0.2	2.9	0.0	0.4	0.6	0.3	0.6	4.1	0.5	0.1	0.0	0.1	0.0	0.5	0.2	0.2	0.3	0.5	0.6	0.2	0.1	0.0	0.0	0.5	1.9	0.4	1.0	0.2	0.0	0.4	0.6	0.8	0.1	0.1	0.1	0.2	0.4	0.1	0.3	0.0	0.2	1.3	0.3	0.1	0.4	4.1	0.3	0.1	6.4	0.2	0.4	0.3	0.4	4.2	0.0	0.5	0.2	0.4	0.3	0.0	0.2	0.0	0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.1	0.0	0.4	0.0	2.9	7.4	17.5	2.2	20.0	13.5	6.1	25.8	8.8	15.2	15.6
SOX11		ENSG00000176887	"SRY-box 11"	P35716	2	5692667-5701385	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7"	"Cell line enhanced"	"Detected in some"		"AF22: 25.9;NTERA-2: 12.7;REH: 9.2;RH-30: 9.9;SCLC-21H: 15.9;SH-SY5Y: 24.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.5	0.5	4.2	0.5	7.1	0.6	0.6	0.3	12.3	0.4	3.3	5.8	0.0	0.6	0.7	0.6	0.5	0.5	0.6	5.3	4.4	5.1	0.5	0.5	0.6	0.5	3.3	5.0	0.5	0.4	0.5	0.7	0.5	4.5	0.5	0.8	0.0	0.9	0.4	1.0	0.6	0.7	1.3	6.3	1.0	0.6	3.7	3.6	0.0	0.6	0.0	0.6	0.5	0.1	1.1	0.8	3.1	1.5	1.6	1.1	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	12.7	0.0	9.2	9.9	0.3	0.0	0.0	15.9	24.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.8	0.3	0.6	0.0	0.0	6.0	3.1	0.5	1.0	0.5	0.8	1.1	1.1	0.6	0.7	0.6	0.7	0.9	0.9	1.6	1.6	1.5	0.8	0.9	0.5	4.2	7.1	0.3	6.4	4.4	5.1	3.3	5.0	4.5	3.6
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 96.9"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Group enriched"	"Detected in some"	9	"hippocampal formation: 0.8;pons and medulla: 1.1"	"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	96.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.3	1.5	0.0	0.0	13.1	25.2	0.0	5.1	14.3	2.9	5.2	0.0	5.1	0.0	0.8	6.4	0.1	0.0	6.0	5.8	0.0	0.0	0.0	0.3	0.1	25.8	0.0	0.0	29.7	1.6	10.5	29.7	13.1	0.0	2.3	17.1	2.8	0.0	0.0	0.0	20.2	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.8	0.4	0.0	32.9	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3
AC007325.4		ENSG00000278817			Unmapped	131494-137392	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"heart muscle: 15.9;skeletal muscle: 32.8"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;AN3-CA: 8.9;HEK 293: 9.3;T-47d: 10.6"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							0.3	0.8		0.0		0.0	1.5		5.0	0.0	0.0			0.0	0.0	0.0	0.5	0.0	0.0	15.9			0.1	1.7	0.1	0.0			0.0	3.6	0.0		0.0		0.3	0.0		2.7	0.0	32.8	1.3	0.0	0.0		0.0	0.0	0.5			2.3		0.0	0.0		1.0	6.3	5.0	9.6	0.8	5.0	5.6	0.6	14.6	0.2	8.9	2.3	0.0	0.5	1.4	0.0	1.6	0.1	0.7	3.1	0.0	3.7	0.0	0.1	0.7	0.8	0.1	1.2	9.3	0.1	1.7	0.0	6.9	1.5	0.0	0.6	2.3	0.0	0.1	0.8	0.8	6.5	0.1	2.9	0.0	0.4	0.3	6.5	0.6	7.2	0.1	1.8	0.0	0.1	1.6	4.9	2.4	3.7	10.6	0.8	0.0	0.1	1.0	0.1	0.2	1.5	0.1	0.0	0.9	4.0	2.1	1.9	7.6	5.0	2.1	8.8	5.0	1.0	3.8	2.4	6.3	1.0	4.9	4.2	0.4	0.8	9.6	0.5	3.5	5.6										
AC009119.2		ENSG00000260300			16	83908132-83951445	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"heart muscle: 6.3;liver: 3.9;pancreas: 3.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"																				"unprognostic (3.40e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.36e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	0.8	0.0		0.1		0.0	0.5		0.0	0.0	0.3			0.6	0.1	0.5	0.0	0.0	0.0	6.3			1.3	3.9	0.1	0.1			0.5	3.9	0.0		0.0		0.0	0.7		0.1	0.9	1.7	0.0	0.0	0.1		0.0	0.0	0.3			0.0		0.0	0.0		0.1	0.3	2.5	0.6	0.0	0.2	0.1	0.9	2.6	2.3	2.1	1.6	0.0	3.6	0.9	1.2	0.7	0.5	0.0	1.8	0.0	3.1	0.8	1.1	0.8	0.7	0.8	0.1	2.5	0.6	1.1	3.0	4.6	1.4	2.0	0.0	0.8	0.3	0.1	0.7	1.1	0.2	1.4	1.4	0.2	2.0	2.0	0.0	1.9	1.4	0.5	1.2	0.0	1.2	0.1	2.9	1.9	3.9	4.2	3.9	0.0	2.7	0.5	1.0	0.0	2.4	0.5	1.6	0.8	0.2	2.8	2.5	0.2	0.7	0.1	0.6	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.1										
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		4000000	4000000	Mitochondria	Mitochondria	"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	16.1	18.8	18.9	39.0	32.6	21.3	26.5	14.9	18.8	25.1	23.5	27.7	21.1	37.1	24.4	22.1	37.1	35.1	27.2	13.2	24.5	25.0	18.0	26.3	29.4	28.5	47.9	27.6	37.8	21.9	26.0	27.7	24.8	23.2	40.5	19.7	30.3	24.4	16.2	12.9	37.7	33.2	13.0	51.4	32.3	32.1	13.6	11.6	36.6	43.3	27.6	25.1	25.6	17.6	21.4	24.0	19.5	16.3	24.1	29.9	25.9	34.6	20.9	23.1	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in all"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		69000000	69000000	"Actin filaments"	"Actin filaments"	"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.7	11.9	0.0	7.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	2.1	2.0	2.4	6.1	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.5	0.1	0.0	2.0	0.0	76.1	0.9	0.6	0.5	0.3	6.9	0.0	0.2	1.6	0.0	0.0	1.3	1.3	0.4	4.8	2.2	0.0	0.1	0.2	0.0	7.0	1.3	0.0	0.1	0.9	0.1	8.5	2.8	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.8;RPMI-8226: 8.0;SH-SY5Y: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	67000000	67000000	Vesicles	Vesicles	"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.8	0.6	8.0	0.0	0.0	1.2	25.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;RPMI-8226: 3.1;RPTEC TERT1: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	1.5	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.3	0.2	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	1.0	0.1	0.0	0.4	3.1	6.3	0.6	2.2	2.0	0.0	0.6	0.1	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.6;skeletal muscle: 68.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.6;T-47d: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Low region specificity"	"Detected in some"			HPA066478	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA066478: AB_2685673"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (4.88e-4)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	1.8	1.0	0.6	0.2	1.1	0.0	0.8	0.5	3.0	0.4	1.4	0.3	0.0	0.9	0.4	4.0	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0.0	1.8	1.4	0.3	0.9	0.5	0.0	1.9	0.1	68.1	0.9	3.0	0.2	0.5	0.3	1.0	1.3	0.0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1.0	3.9	9.5	0.9	3.0	3.1	5.0	2.7	1.5	0.7	0.5	0.4	2.6	9.8	1.4	5.7	1.7	2.2	3.7	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1.0	0.3	1.7	1.7	2.3	3.1	0.4	0.1	1.1	0.4	3.9	8.6	0.6	2.4	2.1	5.0	6.3	2.5	3.6	1.0	0.4	14.6	3.3	1.0	4.7	1.2	26.2	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.6	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1.0	0.6	1.1	0.5	3.0	0.5	0.8	0.7	1.1	0.3	0.0
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114044056-114046908	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.0;placenta: 41.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.0;THP-1: 6.8;TIME: 8.7;U-937: 5.1"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9"	"Low region specificity"	"Detected in many"			HPA067972	Enhanced									"HPA067972: AB_2685936"	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.3	1.0	6.9	1.1	14.0	1.3	5.9	1.0	10.7	0.8	3.1	0.8	0.0	1.8	0.9	0.9	1.9	0.8	0.9	48.0	5.6	2.4	1.7	2.5	18.3	0.9	3.5	4.4	0.8	2.4	0.9	1.2	41.7	2.6	6.5	1.6	4.5	10.7	0.8	3.1	0.9	2.3	0.9	1.3	1.7	1.4	1.0	2.5	0.0	1.0	0.0	1.1	1.1	0.4	1.4	1.9	0.1	1.3	0.0	0.5	0.1	2.0	1.2	0.2	1.3	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.5	1.6	0.3	0.4	0.0	0.4	0.1	0.1	0.3	10.0	0.6	0.4	0.2	0.2	0.0	0.4	0.7	0.0	1.1	0.0	2.0	0.2	0.1	0.1	0.2	1.2	1.6	1.4	0.4	3.9	0.3	0.4	0.1	0.0	1.7	0.2	0.3	0.0	0.8	0.1	0.3	6.8	8.7	0.3	0.1	0.2	0.2	0.0	0.1	0.5	0.0	5.1	0.2	0.0	1.3	0.0	0.5	0.9	0.0	0.6	0.1	0.3	1.9	1.4	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.1	6.9	14.0	1.0	10.7	5.6	2.4	3.5	4.4	2.6	2.5
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell line enhanced"	"Detected in many"		"BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in many"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	6.9	0.5	0.0	0.2	1.8	0.1	26.0	15.8	11.0	9.5	1.6	0.0	0.0	2.7	23.5	0.0	0.0	0.0	11.3	5.6	0.0	0.0	2.1	0.9	1.4	0.0	0.0	1.6	0.0	3.3	0.1	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.3	5.8	1.8	4.4	10.7	9.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4;skeletal muscle: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;HDLM-2: 6.9;HUVEC TERT2: 9.9;LHCN-M2: 13.6;NTERA-2: 8.3;RH-30: 24.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026558	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	3.7	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	1.4			0.0	0.1	1.7	0.8	0.2	0.3	18.4	0.0	0.6	1.6	1.3	1.0	0.0	0.1		0.0	2.1	8.8	6.9	0.6		0.4	0.0		0.4	0.2	47.6	0.0	0.2	0.8	0.0	0.0	1.2	0.0			0.6		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.1	0.1	0.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	6.9	1.1	1.1	0.2	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	9.9	0.0	0.0	13.6	0.5	0.0	0.1	8.3	0.0	0.0	24.4	0.1	0.0	2.5	0.0	0.1	0.0	1.3	0.0	0.0	6.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	22193176-22283357	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 7.1;HEK 293: 8.9;NTERA-2: 4.9;RPTEC TERT1: 4.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain									"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favourable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	1.0	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1.0	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1.0	3.3	26.9	5.0	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1.0	3.0	2.3	1.7	0.0	3.9	14.2	0.6	3.2	1.9	0.0	0.9	0.0	1.5	0.0	0.1	0.1	0.0	6.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	4.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	4.4	0.1	3.9	3.6	0.0	0.0	0.0	3.3	2.5	0.0	0.0	2.9	0.0	0.0	2.8	5.2	0.0	4.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"																				"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	77.5	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6
ATP5MC1	"ATP5G, ATP5G1"	ENSG00000159199	"ATP synthase membrane subunit c locus 1"	P05496	17	48892765-48895871	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"heart muscle: 117.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (3.43e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (6.60e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (9.42e-3)"	"unprognostic (9.78e-2)"	"prognostic favourable (8.24e-6)"	"unprognostic (2.07e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-1)"	11.7	19.2	29.2	16.4	34.2	12.4	17.6	15.8	35.4	13.6	46.8	9.5	11.1	28.3	13.5	24.7	22.2	16.0	13.0	117.9	26.2	21.6	47.9	33.0	11.2	18.3	23.0	28.5	11.0	27.7	15.5	15.0	10.4	27.8	12.3	47.0	10.8	29.5	16.4	103.8	14.3	43.2	19.7	16.1	11.4	21.3	6.1	13.2	8.7	17.3	106.0	21.5	10.4	12.9	67.5	86.3	13.8	52.9	39.3	49.6	49.7	61.6	83.4	26.5	38.6	29.3	35.8	39.1	34.1	28.6	45.5	45.1	55.3	44.5	68.0	82.3	29.4	56.4	47.6	59.5	67.8	55.9	63.6	65.9	55.1	110.5	20.5	78.5	33.1	28.9	40.7	48.2	53.6	51.2	39.3	46.1	52.4	63.5	74.3	36.7	16.6	82.4	47.3	69.1	109.4	86.5	35.1	39.4	28.6	25.5	54.9	28.9	80.7	53.6	28.2	28.8	39.5	43.3	43.3	42.1	47.4	90.0	41.4	62.3	34.0	9.1	52.9	13.8	32.2	44.5	38.8	67.5	37.0	34.6	70.1	54.5	49.6	43.1	2.9	39.3	25.7	86.3	31.2	49.7	29.2	34.2	15.8	35.4	26.2	21.6	23.0	28.5	27.8	13.2
ATP5MC3	ATP5G3	ENSG00000154518	"ATP synthase membrane subunit c locus 3"	P48201	2	175176258-175184607	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 189.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (4.45e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (9.90e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.31e-6)"	"unprognostic (2.86e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.31e-2)"	26.1	26.7	26.6	26.3	28.7	19.8	34.3	26.9	50.9	15.7	51.1	11.4	23.6	61.7	17.4	22.2	38.9	15.5	28.7	189.6	25.8	27.4	63.9	60.8	21.2	34.8	31.1	31.5	13.6	28.4	36.7	19.0	16.8	27.6	17.1	53.3	16.6	34.2	25.0	115.7	20.0	47.3	24.6	18.5	17.6	31.9	12.3	15.8	21.8	19.1	95.9	27.7	19.3	20.2	38.5	78.8	22.6	59.9	34.5	37.2	66.1	33.4	29.9	45.2	49.9	38.7	34.4	50.8	31.0	32.7	43.9	38.3	89.3	28.1	83.5	36.7	34.6	44.2	56.8	53.6	46.5	35.0	52.3	67.1	43.7	112.9	29.8	86.6	40.6	37.0	41.4	49.5	31.6	44.0	72.3	40.1	48.0	45.8	66.9	73.2	59.3	93.7	52.4	41.7	81.9	85.5	76.0	40.5	25.8	25.0	67.9	67.6	40.9	70.8	29.3	7.3	35.1	0.2	42.6	31.7	40.0	72.2	42.1	52.3	32.6	17.6	53.4	22.6	33.3	59.9	33.6	38.5	35.3	36.1	78.8	30.4	33.5	35.9	6.2	34.5	53.7	58.3	37.2	66.1	26.6	28.7	26.9	50.9	25.8	27.4	31.1	31.5	27.6	15.8
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 73.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	20.6	32.0	32.9	7.5	34.5	7.9	14.0	15.9	31.0	11.1	15.2	16.1	9.3	12.0	7.8	10.8	10.6	9.8	9.0	73.4	22.3	20.8	33.3	31.9	7.5	8.6	28.2	24.9	10.6	18.8	39.5	14.6	11.0	28.5	11.6	16.9	11.9	15.9	10.8	66.9	5.7	11.7	12.7	18.6	6.9	12.8	13.4	18.2	10.8	13.0	13.1	9.4	9.8	6.1	3.1	2.4	5.8	4.2	9.2	6.6	1.8	20.4	16.7	22.6	20.1	24.7	20.0	18.9	15.3	19.2	23.1	18.7	13.3	8.9	12.1	20.6	19.3	15.9	35.5	19.9	31.2	26.5	28.1	21.4	20.8	23.1	19.9	21.1	1.3	19.5	23.9	24.7	21.6	14.4	9.8	24.1	17.6	18.5	31.1	11.8	35.5	25.2	13.5	6.1	26.4	26.3	16.3	26.7	20.0	25.9	27.6	39.9	25.5	29.9	12.4	7.9	19.6	15.9	20.8	30.0	27.2	8.3	13.0	8.2	14.8	0.0	2.5	5.8	3.5	4.2	4.6	3.1	3.7	4.0	2.4	1.7	5.2	2.4	2.1	9.2	1.7	1.8	6.6	1.8	32.9	34.5	15.9	31.0	22.3	20.8	28.2	24.9	28.5	18.2
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 16.9;RT4: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles		290000	290000	Vesicles	Vesicles	"HPA041204: "	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.6	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.2	8.1	2.8	4.4	5.0	0.0	14.8	3.0	1.5	0.0	6.4	2.6	0.1	0.0	3.6	2.8	0.0	4.7	0.1	0.1	9.9	1.9	2.2	0.5	11.8	0.0	0.0	3.3	10.7	0.0	0.0	7.4	16.9	0.1	0.0	0.1	3.8	51.5	6.2	0.0	9.3	3.4	2.7	14.2	5.4	0.0	0.1	6.5	0.2	0.1	1.5	0.0	0.0	5.7	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0
B3GALT2	beta3Gal-T2	ENSG00000162630	"Beta-1,3-galactosyltransferase 2"	O43825	1	193179045-193186654	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;gallbladder: 19.0;heart muscle: 25.1"	"Group enriched"	"Detected in some"	4	"AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 11.9"	"Lineage enriched"	"Detected in single"	57	"T-cells: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078659			Approved	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"	"Plasma membrane, Microtubules"	"HPA078659: AB_2686887"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.34e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.14e-4)"	"unprognostic (4.41e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-3)"	0.7	2.0	11.3	1.3	8.9	0.7	0.9	1.4	32.9	0.8	1.7	1.2	0.9	1.6	0.6	1.8	1.2	0.7	19.0	25.1	10.1	7.9	1.7	0.8	2.6	0.7	5.7	19.1	13.8	0.8	0.4	0.9	0.9	5.0	6.5	2.0	0.3	0.5	7.1	0.6	0.7	4.1	0.8	6.5	1.4	2.1	1.4	4.7	0.0	1.8	0.0	1.6	2.0	0.7	0.0	0.2	0.1	0.0	0.0	11.9	0.3	0.0	0.0	16.0	0.0	0.4	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.3	11.3	8.9	1.4	32.9	10.1	7.9	5.7	19.1	5.0	4.7
BCO2	"B-DIOX-II, BCDO2, FLJ34464"	ENSG00000197580	"Beta-carotene oxygenase 2"	Q9BYV7	11	112175467-112224699	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.9;liver: 44.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;HHSteC: 16.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061542	Supported									"HPA061542: "	"unprognostic (2.92e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	2.3	14.7	4.0	0.9	6.8	0.8	1.3	1.9	4.6	1.2	1.5	5.9	0.3	1.1	2.0	2.8	2.1	9.5	6.0	28.9	3.5	3.9	1.6	44.0	1.8	0.9	10.5	2.6	1.5	1.3	0.8	16.3	3.9	9.5	1.3	1.1	12.4	1.1	1.5	17.3	1.5	1.6	4.4	11.0	1.0	1.1	2.4	9.8	0.0	1.9	1.0	1.3	1.3	2.7	0.3	0.5	0.3	0.6	2.8	0.2	0.0	0.1	1.3	0.6	0.7	0.5	0.5	0.0	0.4	0.3	0.1	0.7	0.0	7.4	0.5	0.6	0.8	1.6	0.0	0.3	0.4	0.1	0.2	1.0	0.7	0.5	16.0	0.5	0.3	0.1	3.0	0.2	0.4	0.1	0.2	0.4	0.1	0.1	0.6	1.6	0.1	0.2	0.4	0.2	0.2	0.2	0.3	0.6	0.3	0.6	0.3	0.0	0.4	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.0	3.3	0.4	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.3	2.8	0.2	0.2	0.0	0.0	4.0	6.8	1.9	4.6	3.5	3.9	10.5	2.6	9.5	9.8
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.4;WM-115: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA014788: AB_1845504, HPA018176: "	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.7	0.8	6.9	9.5	2.1	3.5	2.5	5.5	7.3	0.3	0.0	0.0	0.0	6.6	0.0	2.0	1.2	5.1	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.3	5.5	4.3	8.5	0.7	2.4	0.0	11.9	12.1	0.1	0.1	0.6	1.0	0.0	3.4	18.4	0.0	0.0	0.0	6.2	10.7	2.2	0.0	4.7	0.0	12.0	5.4	8.8	0.0	0.0	9.2	1.1	0.4	0.0	5.2	0.0	18.5	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3
C10orf142		ENSG00000277288	"Chromosome 10 open reading frame 142"	B7Z368	10	44292569-44294649	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 3.8;pancreas: 2.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;RPMI-8226: 4.2;U-2 OS: 1.5;U-2197: 10.5;U-87 MG: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.32e-3)"				"unprognostic (2.46e-2)"		"unprognostic (2.75e-1)"	"unprognostic (7.31e-2)"		"unprognostic (4.17e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-3)"		1.5	0.0		0.1		0.0	0.0		0.5	0.0	0.0			0.3	1.1	0.0	0.3	0.0	1.0	3.8			0.0	0.8	0.1	1.8			0.0	2.6	0.0		0.0		0.0	0.0		1.1	0.1	1.3	0.7	0.1	0.0		2.0	0.0	2.3			0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.5	10.5	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
C14orf180	"C14orf77, NRAC"	ENSG00000184601	"Chromosome 14 open reading frame 180"	Q8N912	14	104579684-104590515	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;heart muscle: 55.1"	"Cell line enriched"	"Detected in single"	20	"ASC diff: 8.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Region enriched"	"Detected in single"	11	"pons and medulla: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.48e-2)"				"unprognostic (1.55e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"		"unprognostic (1.60e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.80e-2)"		23.2	1.2	0.0	1.7	0.2	0.1	9.8	0.0	0.1	0.5	3.8	0.7	6.7	0.3	0.3	4.7	0.2	0.4	0.7	55.1	0.0	0.3	0.7	1.9	0.2	0.3	0.0	0.0	0.3	0.7	0.1	0.6	0.7	3.9	0.4	0.2	2.0	1.7	1.2	2.5	0.1	0.5	0.5	0.0	0.2	0.5	0.4	0.0	0.0	0.2	1.3	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.9	0.0
C15orf59	"INSYN1, LOC388135, MGC131524"	ENSG00000205363	"Chromosome 15 open reading frame 59"	Q2T9L4	15	73735431-73752747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 24.1;heart muscle: 16.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favourable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	1.2	1.9	9.3	0.4	9.7	0.0	0.9	5.5	24.1	2.2	0.7			0.3	1.0	2.4	9.4	6.5	1.5	16.2	9.1	8.3	3.5	0.0	1.7	0.0	14.4		4.8	1.0	0.0	0.7	0.2		4.5	0.2		0.7	10.1	1.4	8.4	1.0	2.1	4.2	0.0	0.8	1.9			0.4		0.4	1.6	3.8	0.8	0.6	1.5	0.5	0.8	0.5	0.0	0.0	0.5	2.8	1.8	11.3	0.2	0.0	1.5	0.0	0.9	0.0	0.0	0.0	0.1	0.9	7.5	2.9	2.4	0.0	0.0	0.0	7.8	0.4	0.0	0.0	0.8	0.0	0.2	0.8	0.1	0.1	0.0	0.0	0.0	0.2	0.7	1.0	0.0	0.2	4.8	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.6	6.7	0.7	3.1	0.2	0.1	1.8	6.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.1	0.8	0.5	0.5	1.5	0.8	0.3	0.6	0.3	0.0										
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35.4;skeletal muscle: 118.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favourable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	3.2	2.9	4.5	4.2	5.7	4.7	4.4	5.8	9.1	3.5	3.3	9.2	3.6	3.8	3.8	3.1	7.4	2.8	3.5	35.4	4.2	3.8	2.9	4.4	3.4	4.5	6.2	5.0	3.6	3.8	3.7	3.7	4.8	5.6	4.5	2.5	3.6	4.9	4.6	118.0	5.2	3.6	3.7	4.8	3.7	3.0	10.0	5.3	5.0	3.8	6.4	4.7	4.1	5.0	2.1	1.6	20.2	1.6	1.7	2.3	1.3	12.9	19.9	8.4	9.1	5.0	4.5	11.6	13.4	6.2	12.7	15.4	16.5	5.4	15.1	7.5	6.3	6.5	10.2	12.3	5.3	18.5	12.5	12.3	12.4	12.5	3.7	12.4	8.0	4.5	7.3	17.1	6.1	7.7	15.0	8.9	10.7	12.6	18.5	7.0	5.4	7.6	18.4	13.8	7.6	4.1	11.4	10.8	8.8	14.4	13.6	5.2	8.1	10.3	10.1	16.0	11.2	10.8	18.3	10.7	14.7	15.0	6.8	11.9	11.0	20.2	1.6	4.7	1.3	1.4	1.6	1.6	2.3	2.1	1.6	2.1	1.6	1.2	5.7	1.7	1.6	1.6	1.6	1.3	4.5	5.7	5.8	9.1	4.2	3.8	6.2	5.0	5.6	5.3
C1orf105		ENSG00000180999	"Chromosome 1 open reading frame 105"	O95561	1	172420688-172468831	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 28.8;testis: 23.0"	"Cell line enriched"	"Detected in some"	12	"BEWO: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Not detected"	"Not detected"																		"unprognostic (2.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.27e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.47e-2)"		"unprognostic (8.22e-2)"	"unprognostic (1.92e-1)"		"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (3.85e-1)"		"unprognostic (1.94e-1)"	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	7.0	0.3	0.0	0.0	28.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.1	1.1	0.0	0.1	1.2	0.0	1.7	0.6	0.4	0.0	0.1	0.0	0.0	23.0	0.0	0.2	0.1	3.6	0.3	0.0	0.0	0.1	0.0	2.6	0.2	0.0	0.5	0.2	0.0	0.2	0.3	0.1	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.6	0.2	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.5	0.4	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.7;BJ hTERT+: 19.4;HHSteC: 31.3;HSkMC: 16.6;U-87 MG: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	30000	30000	Nucleoplasm	Nucleoplasm	"CAB025429: , HPA051101: AB_2681343"	"unprognostic (2.58e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.81e-3)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (9.09e-9)"	"unprognostic (1.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.95e-2)"	62.4	18.3	1.7	7.4	4.3	0.4	60.5	1.3	5.1	14.3	10.3	5.2	30.8	2.5	11.0	14.2	10.2	14.4	19.1	77.5	2.0	4.1	9.5	19.4	9.7	16.6	4.8	2.5	25.2	7.5	10.1	4.2	34.0	7.6	13.3	3.3	19.6	13.8	51.8	11.9	8.6	6.1	6.9	2.5	14.3	6.1	8.8	2.8	1.3	26.9	13.3	5.0	14.8	27.5	0.5	0.3	1.9	0.3	1.2	0.4	0.0	0.0	8.0	0.0	0.0	82.7	7.4	0.0	4.1	19.4	1.7	3.4	0.6	3.9	0.0	0.4	1.2	0.2	0.2	0.1	1.3	0.0	0.9	0.0	3.0	0.3	31.3	0.0	0.0	16.6	0.0	3.7	0.2	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.8	8.4	0.0	5.4	0.0	0.0	0.1	0.3	1.5	2.6	0.4	7.7	0.0	0.0	0.3	8.8	0.2	0.9	1.2	0.0	0.0	0.0	19.5	0.0	0.7	1.9	0.3	0.5	0.3	0.2	0.2	0.2	0.4	0.2	0.1	0.5	0.2	0.4	0.4	1.2	0.2	0.3	0.0	0.0	1.7	4.3	1.3	4.2	2.0	4.1	4.8	2.5	7.6	2.8
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.2;skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"					"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	5.6	0.3	0.2	2.4	0.9	0.3	4.9	0.1	0.2	0.7	2.8	0.1	0.1	1.1	1.6	1.6	4.8	0.3	1.9	15.2	0.9	0.3	0.3	0.8	0.4	0.4	0.2	0.1	0.4	1.2	0.5	0.2	4.8	0.1	2.6	0.7	0.1	0.9	1.0	14.1	0.6	1.2	1.8	0.2	0.6	1.1	1.6	0.1	0.3	0.5	5.2	0.9	1.0	7.1	0.5	0.7	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.3	0.7	0.5	0.3	0.0	0.2	0.1	0.0	0.5	0.5	0.8	0.0	0.4	0.0	0.0	0.2	0.5	0.3	0.1	0.0	0.5	0.0	0.3	1.7	0.0	1.9	0.7	1.2	0.2	1.4	0.2	0.2	0.0	0.6	0.5	0.1	0.2	0.5	0.0	0.2	0.4	0.3	0.0	0.4	0.6	1.1	0.4	0.9	0.4	0.6	0.7	0.7	1.1	0.1	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.7	0.0	0.0	0.2	0.9	0.1	0.1	0.9	0.3	0.2	0.1	0.1	0.1
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 32.5"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 4.2;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved								"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.8	2.5	8.6	6.0	7.7	1.4	2.4	7.1	11.7	11.2	26.5	1.3	7.4	2.4	29.7	4.5	5.2	4.3	7.1	32.5	5.5	4.0	2.7	1.4	4.7	2.0	2.4	6.6	2.7	3.2	1.5	8.1	5.1	3.9	7.9	3.8	6.5	2.4	8.1	2.3	1.7	5.2	28.8	1.9	3.5	7.2	11.3	1.7	0.0	2.0	1.1	1.7	12.6	5.4	0.0	0.1	0.0	0.1	4.2	1.2	0.2	0.0	0.0	0.0	0.0	1.6	1.0	0.1	1.7	2.0	1.1	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	46.5	0.4	0.6	0.0	0.0	1.1	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	2.5	0.0	0.0	0.0	0.0	2.1	0.1	0.6	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.5	0.7	0.0	0.0	0.9	0.7	0.0	4.2	0.1	0.1	0.4	0.2	8.6	7.7	7.1	11.7	5.5	4.0	2.4	6.6	3.9	1.7
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		680000	680000	"Plasma membrane"	"Plasma membrane"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: , HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0.0	1.0	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	5.2	0.0	0.2	0.1	2.3	0.1	0.9	0.1	0.0	0.0	41.0	2.2	0.2	0.0	0.0	1.9	0.1	0.2	0.2	0.3	0.2	0.0	0.5	0.4	0.1	0.1	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700007-115768781	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9"	"Cell line enriched"	"Detected in single"	20	"HSkMC: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 48.4"	"Low region specificity"	"Detected in many"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.25e-5)"	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3.0	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5.0	0.3	0.5	0.2	0.3	1.0	12.1	3.1	4.6	1.8	3.6	46.5	1.0	3.2	45.9	0.5	0.2	3.5	1.9	0.0	0.0	1.4	17.2	1.8	36.4	1.8	0.0	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1.0	0.0
CCDC141	"CAMDI, FLJ39502"	ENSG00000163492	"Coiled-coil domain containing 141"		2	178829757-179050086	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 47.5;lung: 17.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;Daudi: 4.1;HEL: 9.3;RH-30: 5.0;U-266/70: 6.0;U-698: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 12.9"	"Group enriched"	"Detected in many"	9	"B-cells: 7.6;T-cells: 12.9"									HPA012718			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012718: "	"unprognostic (1.58e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (8.62e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.03e-3)"	"unprognostic (7.71e-8)"	"unprognostic (2.50e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-1)"	1.6	0.6	0.5	7.5	0.6	0.9	4.9	0.5	0.5	0.7	1.2	0.1	0.5	0.2	0.8	2.2	2.5	0.6	6.3	47.5	0.6	0.6	0.5	0.5	17.6	4.4	0.6	0.0	0.8	3.8	0.2	0.5	0.8	1.1	1.0	0.3	1.8	0.6	0.3	9.3	0.5	0.7	1.7	0.7	1.8	0.6	1.6	0.0	11.0	0.7	2.1	7.4	1.4	1.2	7.6	0.0	0.4	0.0	1.1	12.9	0.4	0.2	0.0	0.1	0.3	0.0	0.1	1.9	0.0	0.1	0.0	0.2	6.2	0.5	4.1	0.1	0.0	0.2	0.1	0.0	0.0	3.4	0.2	9.3	0.3	0.0	0.0	1.6	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.1	0.3	3.3	0.7	0.2	5.0	1.5	0.0	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.4	0.1	0.3	0.2	0.3	0.0	6.0	0.1	8.3	0.3	0.5	0.6	0.3	0.0	0.2	0.3	0.0	0.2	6.6	2.1	1.4	0.0	7.6	6.4	4.8	0.4	1.1	0.0	0.0	12.9	0.4	0.5	0.6	0.5	0.5	0.6	0.6	0.6	0.0	1.1	0.0
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285668-34288334	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2"	"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favourable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	2.6	0.4	0.2	29.2	0.2	0.0	0.2	0.2	0.2	4.5	29.6	0.4	0.6	17.3	3.5	0.0	20.7	0.8	12.0	31.0	0.2	0.2	7.0	1.2	7.3	0.3	0.2	0.0	2.6	11.6	0.2	1.1	0.0	0.2	16.1	8.0	0.0	0.2	0.3	0.5	0.2	18.7	10.2	0.2	1.2	18.2	0.6	0.0	0.7	0.4	0.0	0.8	12.1	5.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	13.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	940000	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691133-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 359.1;breast: 433.0;heart muscle: 347.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"		34000000	34000000	"Golgi apparatus"	"Golgi apparatus"	"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	45.7	14.1	85.8	14.4	100.5	11.1	433.0	45.7	60.9	243.9	31.8	4.5	4.5	19.9	258.4	18.3	26.1	22.2	35.2	347.0	103.4	14.7	66.4	24.6	24.5	16.6	161.0	56.6	187.4	28.9	3.3	67.0	138.7	185.5	30.5	20.6	4.5	18.1	37.7	18.9	28.0	23.8	31.1	359.1	18.5	21.7	23.3	101.3	4.5	15.2	4.5	16.1	24.7	208.8	32.7	62.6	4.3	47.1	32.1	107.1	103.6	23.8	27.4	30.6	41.4	124.2	94.2	18.4	64.0	100.3	40.2	58.6	39.5	16.8	1.6	12.5	88.7	9.3	12.2	16.1	33.4	32.4	30.8	4.6	19.1	34.3	39.4	7.3	36.5	58.5	19.9	22.0	15.5	73.3	5.7	0.0	37.9	18.7	63.6	24.9	10.0	29.9	10.8	25.6	45.2	23.2	16.4	0.1	13.5	15.4	13.8	38.4	12.2	22.8	67.6	49.6	8.4	47.3	21.5	0.1	0.0	10.4	33.2	18.3	30.9	1.8	47.1	1.5	107.1	11.6	60.4	32.7	72.6	94.6	44.6	20.2	26.8	57.1	4.3	32.1	2.6	62.6	74.3	103.6	85.8	100.5	45.7	60.9	103.4	14.7	161.0	56.6	185.5	101.3
CDH19	CDH7	ENSG00000071991	"Cadherin 19"	Q9H159	18	66501083-66604138	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.1"	"Group enriched"	"Detected in some"	12	"SK-MEL-30: 19.7;WM-115: 35.1"	"Cancer enriched"	"Detected in some"	21	"melanoma: 16.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056332	Uncertain					160000	160000			"HPA056332: AB_2683102"	"unprognostic (1.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"		"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.58e-3)"	"unprognostic (8.16e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-5)"	4.5	7.5	4.1	5.4	17.4	0.5	2.3	0.9	10.2	6.4	17.9	5.7	4.6	3.8	1.6	3.2	11.7	2.4	4.7	37.1	5.2	2.3	1.1	7.0	2.1	0.5	22.0	5.5	2.0	2.2	0.6	1.1	5.2	13.1	4.7	5.2	6.9	4.5	7.6	6.0	2.6	5.9	7.2	12.5	4.0	5.8	1.9	20.0	0.0	1.7	2.7	0.4	5.7	12.6	0.2	0.0	1.3	0.1	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.7	0.8	0.0	0.0	0.0	0.2	0.1	0.0	2.2	0.1	0.0	0.1	0.0	35.1	0.0	0.1	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	4.1	17.4	0.9	10.2	5.2	2.3	22.0	5.5	13.1	20.0
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		160000000	160000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.4	0.0	8.9	1.8	0.0	40.7	12.4	16.6	15.2	0.0	0.0	0.0	21.9	84.2	6.0	9.2	0.0	23.6	0.1	5.9	0.0	15.2	14.0	8.5	0.0	0.0	0.8	0.1	38.1	6.7	14.5	0.0	0.0	12.9	0.0	10.2	0.0	7.5	4.9	0.0	6.7	7.7	0.0	1.8	14.7	25.5	0.0	0.0	4.5	0.0	0.0	2.2	36.0	11.5	0.5	29.4	0.0	0.0	0.0	6.9	0.0	27.7	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.9;HeLa: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	12.2	0.8	0.1	0.6	0.0	0.0	13.2	0.2	2.5	0.6	3.2	5.5	9.2	7.3	1.8	0.1	11.0	2.7	20.9	0.5	2.0	2.4	1.7	18.4	5.6	2.3	0.0	0.0	1.4	1.1	0.0	0.4	0.0	0.1	8.8	0.1	9.9	0.7	0.3	10.4	0.4	0.9	0.0	9.1	2.0	7.8	4.3	1.7	3.7	1.8	8.1	8.2	3.5	0.0	0.0	5.0	0.1	0.0	2.5	1.2	1.5	0.1	5.2	2.1	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360702	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.3;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009079	Approved									"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.2	1.2	1.0	0.2	9.5	0.1	0.5	0.6	2.6	0.9	0.2	5.3	0.8	0.1	1.1	4.5	0.2	15.1	0.3	14.8	4.0	1.9	1.1	0.2	3.5	0.2	0.9	2.0	3.3	0.5	1.0	15.0	0.2	11.4	0.5	0.2	0.1	0.3	0.4	23.9	0.5	0.3	0.3	0.7	0.2	0.3	25.5	1.1	0.0	1.1	0.0	0.2	0.2	0.2	0.0	1.5	0.0	0.0	0.6	2.3	0.0	0.4	1.3	0.2	0.5	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.0	0.7	4.2	0.1	0.0	0.1	0.2	0.0	0.1	1.1	1.5	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.3	2.1	0.7	0.0	9.5	0.2	0.2	0.4	3.7	0.7	0.0	0.7	0.0	0.4	0.6	0.3	1.4	0.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.0	9.5	0.6	2.6	4.0	1.9	0.9	2.0	11.4	1.1
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		90000000	90000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.6	15.9	10.2	6.6	10.4	39.0	5.8	30.8	35.5	29.5	31.5	11.9	7.6	6.3	12.6	49.1	3.5	21.8	6.5	52.0	0.8	9.0	1.3	18.8	28.2	17.0	1.6	1.0	29.5	2.3	25.1	13.9	29.2	1.9	5.0	36.2	5.0	1.2	0.8	3.3	24.4	1.1	32.5	0.9	10.7	3.6	2.1	8.8	20.1	4.3	10.4	9.6	1.5	25.6	29.4	19.6	13.8	14.7	7.0	4.5	2.4	10.8	2.3	6.9	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1
CHCHD10	"C22orf16, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23768443	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 127.0;skeletal muscle: 226.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favourable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	23.1	14.9	25.8	16.4	33.9	5.7	20.0	11.8	31.0	17.3	39.4	9.6	18.3	30.6	6.1	15.5	20.2	7.6	11.3	127.0	23.7	23.5	40.4	86.1	8.3	16.9	25.8	18.4	4.8	24.3	36.4	12.7	11.7	14.5	11.7	31.6	24.3	33.7	22.2	226.6	7.2	30.2	12.8	12.2	13.0	17.3	4.1	9.6	3.0	27.8	73.1	15.8	13.8	9.3	9.4	7.3	7.6	7.8	0.8	5.0	1.0	6.0	16.4	5.1	21.2	11.2	7.1	8.2	2.1	5.8	6.0	7.0	30.6	8.2	18.5	5.7	10.4	19.5	27.8	8.7	5.5	6.0	30.3	4.7	13.0	28.9	19.1	13.6	22.0	13.8	23.1	9.1	2.4	7.3	8.4	11.9	5.4	30.5	4.3	8.6	3.7	41.6	16.0	0.8	42.6	28.4	13.7	9.0	4.8	2.9	36.5	28.0	13.0	10.7	3.2	0.2	0.2	3.7	0.0	4.7	2.0	12.8	5.0	11.4	2.7	0.2	3.9	7.6	2.8	7.8	1.9	9.4	3.2	4.0	1.7	7.8	5.0	3.6	0.1	0.8	6.9	7.3	3.7	1.0	25.8	33.9	11.8	31.0	23.7	23.5	25.8	18.4	14.5	9.6
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868669-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 43.7"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022338, HPA029795"	Approved									"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6.0	0.9	8.9	0.0	0.0	0.9	0.8	0.3	0.8	0.8	25.5	35.0	0.9	0.9	0.8	1.2	1.0	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0.0	0.8	0.2	0.8	0.8	3.7	32.8	5.0	0.8	2.7	2.3	1.5	0.0	0.8	0.0	0.2	14.0	1.8	0.0	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	9.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.2	0.0	0.0	3.6	1.9	0.8	6.0	0.9	0.9	0.9	2.2	15.7	1.5
CIB2	"DFNB48, KIP2, USH1J"	ENSG00000136425	"Calcium and integrin binding family member 2"	O75838	15	78104606-78131544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 45.5;intestine: 48.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;HAP1: 18.4;NTERA-2: 15.3;SCLC-21H: 19.0;SH-SY5Y: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	51	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 16.1"	"Low region specificity"	"Detected in all"							HPA036697	Approved									"HPA036697: AB_10672475"	"unprognostic (5.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.73e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.18e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.64e-3)"	5.8	8.8	9.7	3.4	6.7	1.2	6.0	5.1	8.2	9.6	11.0	3.5	2.8	16.0	6.1	3.2	4.2	4.3	3.2	45.5	7.2	6.8	7.0	0.8	1.9	3.3	6.9	4.9	6.9	13.0	9.2	7.1	4.8	9.1	7.9	6.3	4.2	6.8	8.2	6.3	4.2	48.5	7.5	4.1	3.7	2.7	13.4	2.0	35.0	3.0	1.9	5.4	6.0	7.9	0.0	16.1	0.1	0.0	0.0	0.3	0.1	1.8	4.1	11.8	21.0	0.5	0.7	9.0	1.2	0.4	1.0	2.1	0.0	4.6	0.2	2.4	5.4	1.0	18.4	3.6	0.3	10.4	13.2	1.2	0.7	0.6	2.1	0.0	1.7	1.1	1.6	1.7	1.0	2.1	4.2	0.1	1.9	0.3	0.5	0.2	15.3	0.1	7.8	0.0	0.5	1.3	0.4	19.0	20.0	3.1	1.5	1.6	0.3	1.2	0.1	0.0	10.2	1.1	0.1	0.2	0.2	3.4	0.5	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	16.1	0.0	0.1	9.7	6.7	5.1	8.2	7.2	6.8	6.9	4.9	9.1	2.0
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 18.4;U-251 MG: 29.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB020709: , HPA048761: AB_2680514, HPA058627: "	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.3	2.7	1.7	8.9	1.0	0.0	3.8	4.1	7.6	0.1	0.3	0.0	11.6	0.4	0.1	2.9	0.0	6.7	0.2	3.5	1.1	4.1	3.0	17.6	14.8	0.2	1.0	16.3	0.4	0.4	0.1	0.7	0.0	0.0	0.2	18.4	0.2	4.8	11.5	12.3	0.0	0.1	0.0	0.1	6.9	12.4	2.6	1.6	0.7	0.8	2.2	0.0	11.1	2.0	4.0	29.2	5.9	12.7	8.0	17.9	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Group enriched"	"Detected in some"	8	"CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		1000000	1000000	"Plasma membrane"	"Plasma membrane"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.3	0.0	9.4	0.0	0.3	0.0	0.1	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;SH-SY5Y: 1.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045239	Uncertain				"Secreted to extracellular matrix"	490000	490000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	2.3	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0			0.0	0.7	0.3	1.2	0.3	0.0	5.6	0.0	0.0	0.0	0.9	11.1	0.0	0.0		0.2	0.0	0.0	5.7	0.8		0.0	0.0		2.2	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0										
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					5400000	5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favourable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	34.5	38.5	47.7	41.6	29.4	34.0	52.5	31.5	27.9	40.4	37.8	42.8	43.9	79.3	38.8	27.1	68.5	112.6	45.8	33.9	44.8	105.1	65.8	40.1	53.2	36.9	75.1	41.4	34.5	49.7	25.2	57.1	47.2	60.4	54.0	40.3	27.2	62.7	57.8	50.6	57.0	58.5	45.7	92.1	59.0	58.6	69.9	30.0	47.7	71.7	98.6	35.9	61.3	31.9	30.6	28.9	38.2	49.9	61.9	113.5	87.9	32.8	99.8	27.8	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899438-77907373	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA058041	Uncertain									"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favourable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favourable (2.43e-4)"	9.4	11.5	23.7	9.2	26.8	18.0	18.2	15.4	32.3	13.1	22.5	4.1	19.8	18.0	8.1	16.4	17.1	10.4	10.7	81.4	21.9	20.6	34.6	28.8	9.7	9.9	24.0	22.9	7.2	15.1	11.1	11.7	8.6	21.3	9.6	22.9	6.9	14.5	18.1	69.4	9.2	19.7	15.9	19.0	8.1	14.5	3.0	12.9	4.8	12.2	62.7	10.8	11.3	9.7	16.5	23.0	19.4	25.9	17.2	22.2	19.1	8.1	20.7	11.8	12.1	13.4	11.4	8.1	6.7	10.3	13.2	15.4	24.1	13.8	12.6	10.2	10.9	13.3	31.9	18.4	15.6	5.7	31.3	13.7	29.3	22.9	11.2	21.4	8.6	14.5	15.7	15.8	14.0	14.0	15.8	22.8	14.1	24.0	12.8	20.6	12.1	56.4	11.6	17.6	34.7	35.8	26.3	11.5	7.5	17.4	22.5	10.6	8.7	11.6	9.2	5.9	8.8	13.0	5.9	5.1	13.1	15.8	13.9	28.5	7.7	19.4	20.8	14.0	15.6	25.9	21.1	16.5	20.1	19.0	23.0	13.4	20.7	22.2	15.5	17.2	24.5	17.1	18.4	19.1	23.7	26.8	15.4	32.3	21.9	20.6	24.0	22.9	21.3	12.9
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Group enriched"	"Detected in some"	4	"Daudi: 32.3;HUVEC TERT2: 13.3;U-266/70: 11.1;U-266/84: 8.9;U-698: 15.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	32.3	0.3	0.4	0.3	0.1	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	13.3	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.5	3.0	0.2	0.4	0.0	1.3	11.1	8.9	15.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2
CPT1B	"CPT1-M, M-CPT1"	ENSG00000205560	"Carnitine palmitoyltransferase 1B"	Q92523	22	50568861-50578465	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 162.2;skeletal muscle: 59.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029583	Approved									"HPA029583: AB_10600864"	"unprognostic (1.66e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.76e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.15e-5)"	4.3	1.5	1.7	2.9	2.7	3.3	2.8	9.1	2.0	1.7	3.1	1.8	1.6	3.8	1.6	2.9	3.7	0.9	1.6	162.2	2.1	1.9	4.0	4.2	1.9	3.5	2.5	1.6	1.6	3.1	17.2	4.5	2.3	2.2	2.5	2.9	5.2	4.3	1.6	59.8	3.8	3.7	1.6	2.2	5.0	3.8	19.7	2.3	1.9	5.2	39.6	4.5	2.0	1.6	0.5	2.3	0.7	0.4	2.3	1.6	0.3	5.2	4.8	15.5	5.7	3.5	2.1	12.2	0.6	2.0	2.6	3.0	2.3	4.6	10.4	1.7	1.2	8.7	8.2	1.8	2.3	4.2	9.1	5.2	14.1	2.4	0.9	5.4	15.2	1.2	14.1	1.9	3.1	0.4	1.8	17.6	2.5	7.4	2.1	10.6	3.4	3.2	9.6	5.1	2.3	6.6	12.4	4.3	8.4	3.9	6.3	6.5	6.9	11.4	1.1	7.6	8.1	5.0	1.8	15.0	3.4	5.4	3.5	9.7	5.1	0.0	0.4	0.5	1.0	0.1	0.0	0.5	1.6	0.3	2.3	0.2	0.4	0.2	0.7	2.3	0.2	0.3	0.1	0.3	1.7	2.7	9.1	2.0	2.1	1.9	2.5	1.6	2.2	2.3
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308797	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;heart muscle: 24.8;liver: 29.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 4.8;HeLa: 5.0;Hep G2: 9.0;NTERA-2: 8.2;RPMI-8226: 6.7;THP-1: 3.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	14	"myeloid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036198	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.4	0.5	4.2	5.6	5.8	2.5	2.1	9.4	3.0	0.8	0.8	0.6	3.1	2.2	0.8	2.7	0.9	1.0	4.6	24.8	3.5	3.5	10.4	29.0	0.6	5.3	2.3	2.2	1.0	2.4	0.8	1.1	0.7	2.1	4.1	0.5	1.0	0.7	9.5	0.5	1.8	4.5	1.0	1.7	4.4	0.3	13.5	0.4	0.6	1.1	0.4	6.1	1.8	0.5	1.7	25.5	0.5	1.5	0.2	0.0	0.9	0.0	1.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.9	4.0	0.1	0.0	0.0	4.8	0.0	5.0	9.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	0.0	0.0	6.7	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.5	0.0	1.0	0.0	1.4	0.0	0.0	25.5	1.7	0.0	0.0	0.4	0.2	1.3	0.2	0.0	0.9	4.2	5.8	9.4	3.0	3.5	3.5	2.3	2.2	2.1	0.4
CRLS1	"C20orf155, CLS1, dJ967N21.6, GCD10"	ENSG00000088766	"Cardiolipin synthase 1"	Q9UJA2	20	6006090-6040053	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 84.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.54e-2)"	"prognostic favourable (8.02e-4)"	23.0	30.4	9.1	13.2	9.2	9.9	15.0	6.8	9.9	11.5	30.4	8.2	18.5	24.0	11.6	10.8	11.7	10.5	17.2	84.2	7.9	7.5	32.9	67.4	16.4	8.3	7.9	7.7	12.6	27.0	10.2	10.1	13.3	9.5	14.4	14.8	9.1	18.3	13.4	48.5	7.2	33.1	10.5	6.8	11.0	19.3	12.3	7.1	13.1	17.2	23.7	9.6	11.7	8.6	4.9	3.7	1.1	2.4	3.6	5.2	1.1	20.0	15.2	9.7	12.5	27.1	24.7	10.4	12.7	16.4	13.1	15.7	20.0	13.9	21.9	9.2	16.4	13.1	18.7	22.9	19.7	6.2	10.9	29.9	6.1	73.2	18.4	28.4	9.9	14.5	18.3	13.7	23.4	17.6	20.8	10.0	14.6	8.0	18.8	25.4	17.1	11.9	12.4	14.2	23.3	19.6	7.9	15.7	13.4	12.8	32.4	21.6	11.0	18.2	11.3	14.4	10.1	14.5	16.9	9.8	21.5	22.6	5.7	24.1	13.2	0.0	2.4	1.1	2.6	2.0	5.2	4.9	1.7	2.2	2.6	1.9	3.6	1.9	0.1	3.6	1.0	3.7	1.5	1.1	9.1	9.2	6.8	9.9	7.9	7.5	7.9	7.7	9.5	7.1
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 230.1;fHDF/TERT166: 75.0"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		12000	12000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.3	230.1	10.1	1.6	6.4	0.2	0.1	0.2	0.1	0.0	0.0	3.8	75.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	1.9	0.0	0.0	8.1	1.0	0.0	0.5	0.0	0.5	0.2	18.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.8	3.4	0.5	0.0	0.1	29.8	10.7	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 30.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		110000	110000	Cytosol	Cytosol	"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.4	7.0	0.0	0.7	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.0	0.0	0.0	0.2	30.5	0.0	1.2	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41560763-41577741	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 84.8;ovary: 48.5"	"Group enriched"	"Detected in some"	6	"HeLa: 7.9;U-2 OS: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favourable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	2.5	39.0	4.7	2.1	9.6	1.1	1.2	30.5	15.3	16.8	2.6	2.7	5.5	1.6	18.4	2.0	2.2	4.1	2.6	84.8	6.0	8.5	9.9	1.2	2.8	1.1	9.0	6.0	48.5	25.5	1.1	4.1	1.3	17.7	5.3	1.4	5.6	1.4	11.7	1.5	1.1	1.5	9.1	10.5	1.2	1.6	11.1	3.4	0.0	1.1	0.3	1.0	5.8	6.2	1.0	1.0	1.7	1.1	0.4	1.6	0.7	0.0	0.1	1.0	0.1	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	3.1	0.1	0.0	0.0	0.0	0.0	2.0	0.0	7.9	0.9	2.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	29.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	1.0	1.0	1.7	1.3	1.1	0.5	1.0	0.8	0.7	1.0	1.0	1.5	0.7	1.0	0.4	0.9	0.2	1.6	0.7	4.7	9.6	30.5	14.7	6.0	8.5	9.0	6.0	17.7	3.4
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Group enriched"	"Detected in some"	37	"K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavourable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		190000000	190000000	Mitochondria	Mitochondria	"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	43.0	24.1	26.1	36.3	15.0	11.6	26.9	41.5	17.1	31.1	36.2	39.9	29.5	49.6	20.4	18.1	51.2	53.0	39.1	55.0	14.7	23.8	41.3	28.6	28.3	23.6	94.3	36.8	15.4	35.0	31.1	67.5	27.8	75.6	52.6	33.0	19.9	51.5	36.7	48.9	45.7	36.3	31.4	47.4	48.4	42.3	53.0	25.2	21.6	92.4	33.4	47.9	56.5	20.1	28.6	52.1	44.1	76.6	54.4	63.0	110.8	38.1	68.7	79.2	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Group enriched"	"Detected in some"	6	"RT4: 35.6;SK-BR-3: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.7	0.2	1.6	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.9	1.6	0.0	3.8	0.0	1.9	35.6	0.5	2.3	0.0	9.6	0.3	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 20.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"			Mitochondria	Mitochondria	"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.2	0.2	0.0	0.3	0.2	0.1	1.1	20.5	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426739	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 45.7"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		1300000	1300000	"Intermediate filaments"	"Intermediate filaments"	"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33.0	149.8	531.0	0.1	0.1	2.1	0.3	4.8	3.0	0.3	0.8	20.3	0.7	0.0	0.1	2.4	0.8	101.0	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0.0	0.0	9.4	161.2	12.5	343.7	34.4	0.0	0.2	0.4	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	17.6	0.0	0.0	0.0	0.0	0.6	0.0	35.2	0.0	0.0	9.2	0.1	0.0	0.0	81.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0.0
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.8;NB-4: 14.4;THP-1: 42.2;TIME: 18.8;U-2197: 13.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.1	0.2	0.5	2.6	8.8	0.4	0.0	0.0	0.0	0.0	14.4	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.2	18.8	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.3	7.5	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favourable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.0	6.1	8.1	10.8	11.4	8.5	9.7	8.3	4.8	9.2	10.4	19.3	17.8	24.8	16.3	7.6	13.0	16.9	8.9	10.5	8.9	10.5	15.7	6.5	11.9	8.2	19.9	9.0	10.3	9.8	9.2	9.3	8.4	25.7	11.9	10.8	4.7	9.0	23.9	9.5	11.8	14.0	11.0	27.9	16.9	6.4	15.6	9.5	10.0	28.3	6.3	21.0	12.4	5.6	9.2	10.0	9.2	10.6	3.9	6.2	37.6	2.6	21.8	7.2	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 63.2;skeletal muscle: 69.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.4;HeLa: 18.2;RT4: 33.9;SCLC-21H: 21.8;SiHa: 17.0;THP-1: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	7.3	10.1	29.6	7.6	33.7	28.6	7.6	20.1	25.8	8.6	8.7	10.5	10.4	7.8	5.1	25.3	9.1	21.7	6.6	63.2	22.3	33.8	7.7	1.9	7.0	6.0	26.0	28.1	3.6	3.2	9.5	11.9	5.5	29.2	15.4	10.6	7.2	6.8	9.6	69.0	15.5	9.0	10.7	16.0	5.1	10.8	26.8	14.9	2.0	6.3	15.2	6.9	12.6	62.3	1.9	1.1	2.7	1.0	0.4	4.7	1.6	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.2	0.0	17.4	0.0	0.1	1.2	12.5	0.0	0.0	0.0	0.0	0.0	7.8	18.2	0.0	3.9	0.0	8.4	1.5	1.7	1.0	0.0	2.6	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.9	21.8	0.0	17.0	3.4	1.5	13.1	15.7	0.2	0.0	3.6	1.6	0.1	0.2	0.9	0.0	0.0	1.6	0.0	0.0	0.8	2.7	1.8	0.9	2.6	1.9	2.5	2.5	1.1	0.4	4.7	3.9	0.0	0.4	1.0	0.6	1.4	1.6	29.6	33.7	20.1	25.8	22.3	33.8	26.0	28.1	29.2	14.9
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favourable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favourable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	1.0	0.0	3.4	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	27.1	0.0	1.1	0.2	0.1	0.0	5.3	0.2	1.8	2.3	0.4	0.1	2.2	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4
DPYSL4	"DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186900-132205776	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;heart muscle: 19.0"	"Cell line enhanced"	"Detected in many"		"AF22: 23.2;AN3-CA: 30.4;SH-SY5Y: 31.6"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA049066: AB_2680619"	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (3.11e-4)"	1.5	4.4	11.8	2.0	12.3	1.1	1.5	8.9	32.0	1.7	1.4	6.5	0.2	1.1	6.4	2.2	1.4	1.4	2.1	19.0	13.6	9.6	1.0	1.0	1.5	1.4	9.0	9.1	3.0	1.9	1.0	5.0	1.3	6.0	4.8	1.0	4.6	1.5	4.2	2.5	1.6	1.2	2.7	8.1	2.5	1.8	6.7	4.8	0.0	1.0	0.0	1.3	1.4	0.4	0.7	0.0	0.0	0.6	1.1	2.5	0.8	0.0	6.5	23.2	30.4	0.0	0.2	0.0	1.9	0.2	1.2	0.3	0.0	0.2	0.0	0.8	1.0	0.0	4.5	4.4	0.1	0.0	0.8	0.0	0.0	2.4	4.1	0.0	4.6	2.1	2.1	0.7	0.1	2.3	0.0	0.2	3.3	1.9	0.0	0.0	4.0	2.2	0.0	0.0	3.6	0.0	0.4	3.6	31.6	0.7	0.0	4.0	0.1	0.0	3.8	5.8	9.7	0.0	5.4	0.0	1.5	0.0	9.7	0.0	0.6	0.0	0.1	0.0	1.4	0.6	0.0	0.0	1.1	0.1	0.0	0.7	2.5	0.7	0.0	1.1	0.5	0.0	0.0	0.8	11.8	12.3	8.9	18.7	13.6	9.6	9.0	9.1	6.0	4.8
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924231-34462774	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 49.6;skin 1: 44.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;RPTEC TERT1: 15.2;RT4: 47.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 50.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 19.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064895			Supported	Cytosol				Cytosol	Cytosol	"HPA064895: AB_2685384"	"unprognostic (3.58e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.38e-2)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.39e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.30e-2)"	6.3	0.8	12.9	4.8	10.6	0.4	6.0	3.0	11.9	7.3	14.3	13.4	4.9	19.3	5.9	2.8	10.4	5.4	7.8	49.6	10.9	7.3	6.1	2.4	3.0	3.0	10.7	8.1	2.5	6.5	0.4	1.5	19.6	9.9	9.9	11.3	3.5	4.2	11.3	9.7	44.1	21.7	11.7	9.7	2.8	19.9	1.0	12.5	3.4	1.2	1.3	5.3	25.6	16.1	0.0	19.0	1.2	0.0	0.8	1.0	0.6	11.8	3.1	0.3	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	4.0	0.0	0.3	5.9	11.5	0.0	1.2	3.1	3.2	8.7	0.4	0.0	0.0	0.1	1.6	5.8	0.0	0.0	0.0	6.3	0.0	0.1	1.0	0.2	0.0	9.6	1.1	0.0	17.8	4.2	15.2	47.8	2.5	2.8	0.8	4.6	1.2	4.7	0.0	0.0	0.1	1.3	0.0	0.6	0.1	2.5	0.0	2.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.8	1.9	0.0	0.1	0.0	0.1	0.8	0.0	19.0	0.0	0.6	12.9	10.6	3.0	9.8	10.9	7.3	10.7	8.1	9.9	12.5
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A, Y-linked"	O14602	Y	20575725-20593154	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 78.3;skeletal muscle: 124.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;HEL: 45.7;U-266/84: 32.3;U-698: 73.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA002561	Uncertain	Supported	Approved	Cytosol				Cytosol	Cytosol	"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	5.9	8.3	7.0	18.6	8.3	29.2	5.0	4.5	10.9	0.0	12.6	10.0	22.2	9.0	0.1	20.2	9.9	0.0	10.5	78.3	6.5	10.4	9.1	23.0	13.3	22.8	8.2	0.0	0.1	15.0	0.2	11.4	10.3	13.4	17.4	16.1	8.8	13.1	22.9	124.6	4.2	17.9	28.2	9.2	45.8	6.5	13.1	0.0	28.7	6.2	48.9	15.9	8.9	0.0	22.1	23.0	44.5	8.0	7.8	11.9	5.0	0.1	5.4	0.0	0.0	0.0	0.0	11.3	12.1	8.1	8.4	8.3	0.0	0.0	37.3	0.0	6.4	0.0	0.0	0.0	11.6	20.1	0.0	45.7	0.0	13.6	8.4	0.0	0.0	4.5	9.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	29.4	0.0	8.1	0.0	0.0	15.3	14.8	11.8	14.1	10.8	0.0	0.0	0.0	8.3	0.0	6.4	12.0	6.5	0.1	0.0	13.1	22.5	32.3	73.3	2.5	0.0	0.0	10.0	6.7	9.3	5.2	7.7	7.3	19.2	9.5	6.1	5.7	22.1	11.9	9.0	44.5	7.8	8.0	23.0	10.9	5.0	7.0	8.3	4.5	10.9	6.5	10.4	8.2	0.0	13.4	0.0
EIF1B	GC20	ENSG00000114784	"Eukaryotic translation initiation factor 1B"	O60739	3	40309684-40312424	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 156.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.54e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.64e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (3.16e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.33e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.87e-2)"	21.9	35.7	36.1	17.3	39.2	70.4	36.2	42.4	57.5	20.5	21.8	20.1	11.9	15.6	24.9	23.8	16.3	24.4	23.3	156.7	39.4	40.5	36.5	34.3	21.6	22.7	35.1	43.0	38.0	22.7	28.9	43.7	19.8	58.6	19.9	16.6	17.0	17.5	22.9	52.1	14.3	17.9	23.9	53.7	20.0	21.1	31.7	24.7	12.7	22.7	16.0	21.6	23.4	21.0	31.3	24.3	44.7	18.7	12.9	19.0	12.9	10.2	8.4	28.8	16.3	34.9	34.3	17.2	21.1	27.8	20.9	27.3	13.2	13.9	21.1	11.7	14.3	7.0	19.6	10.3	21.4	32.0	19.9	34.1	9.0	30.1	55.5	20.5	17.6	24.9	31.9	18.4	31.5	22.0	28.4	26.2	24.1	6.5	16.4	22.3	39.0	22.5	11.4	16.1	17.1	20.4	13.1	12.3	20.2	15.2	8.9	56.5	11.3	20.9	16.8	12.1	12.5	24.5	14.7	24.3	42.9	30.7	15.2	22.5	17.2	24.3	16.4	43.7	13.0	18.7	15.5	31.3	16.0	16.5	15.0	29.2	19.0	16.4	44.7	12.9	17.2	24.3	18.8	12.9	36.1	39.2	42.4	57.5	39.4	40.5	35.1	43.0	58.6	24.7
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;RPTEC TERT1: 1.5;U-266/70: 2.4;U-266/84: 3.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	3.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0										
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell line enriched"	"Detected in all"	4	"Hep G2: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		640000	640000	Mitochondria	Mitochondria	"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favourable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favourable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.2	34.2	4.7	13.0	15.2	17.8	7.5	9.0	6.9	7.3	7.3	28.7	21.8	13.2	9.2	14.5	11.7	9.4	19.2	2.2	19.7	36.6	10.4	20.9	185.6	16.7	9.9	7.8	27.6	5.7	9.9	10.2	6.2	15.6	14.9	9.4	26.8	10.3	9.4	3.0	42.3	11.5	12.8	24.7	10.0	15.2	10.6	5.1	19.9	5.7	10.3	14.9	9.6	8.7	7.6	8.0	8.2	8.2	22.9	13.9	11.8	39.0	14.8	19.6	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9
EXOC6B	"KIAA0919, SEC15B, SEC15L2"	ENSG00000144036	"Exocyst complex component 6B"	Q9Y2D4	2	72175984-72826041	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 51.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034546, HPA063991"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA034546: AB_2674218, HPA063991: AB_2685168"	"unprognostic (5.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.29e-2)"	12.1	14.2	17.9	5.7	23.0	1.9	9.5	19.8	23.3	10.2	7.2	18.0	6.0	8.4	11.8	7.5	16.5	8.7	7.8	51.7	18.3	14.4	8.8	4.8	7.9	3.8	18.5	17.0	17.4	6.0	18.6	11.2	34.7	19.8	9.7	7.0	7.3	7.6	10.9	11.2	27.5	10.7	11.6	15.0	6.0	8.0	7.7	20.4	3.1	11.7	7.8	7.3	9.5	12.6	3.0	1.7	3.2	2.0	1.6	3.4	1.2	10.8	8.3	7.6	9.2	22.0	9.1	13.2	8.0	11.3	6.9	4.5	11.2	1.7	2.8	5.0	13.3	18.2	6.4	13.1	10.0	2.1	5.2	8.4	5.8	6.4	11.8	1.2	2.9	7.7	19.1	7.7	12.1	11.2	0.9	0.0	9.0	3.7	3.1	1.4	7.9	4.6	1.7	13.7	1.1	6.6	25.5	3.8	3.3	13.6	4.2	5.5	2.9	1.1	12.3	8.0	6.8	6.8	4.8	2.9	2.8	0.0	9.3	0.6	6.3	3.2	1.9	0.2	2.7	1.7	2.1	2.4	2.1	1.7	1.7	3.0	2.4	3.4	0.0	1.6	2.0	0.6	2.6	1.2	17.9	23.0	19.8	22.8	18.3	14.4	18.5	17.0	19.8	20.4
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69505241-69532508	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HAP1: 15.2;Hep G2: 5.5;NTERA-2: 21.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain									"HPA036093: AB_10673613"	"prognostic unfavourable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (1.83e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.0	0.5	1.4	0.0	1.1	0.0	0.1	3.5	1.4	0.1	0.0			0.0	0.2	0.3	0.0	0.7	0.1	25.0	1.1	2.1	0.5	0.0	0.0	0.0	1.3		0.0	1.8	0.9	1.1	0.0		0.9	0.0		1.1	6.7	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8			10.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.0	4.2	0.0	0.0	15.2	0.6	0.0	0.0	4.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.7	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM69C	C18orf51	ENSG00000187773	"Family with sequence similarity 69 member C"	Q0P6D2	18	74434099-74457944	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;heart muscle: 10.8"	"Cell line enriched"	"Detected in some"	9	"SK-MEL-30: 10.7"	"Group enriched"	"Detected in some"	18	"glioma: 11.1;melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048928	Enhanced									"HPA048928: AB_2680560"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.91e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.40e-3)"	1.1	0.9	13.8	0.7	20.5	0.6	1.1	3.5	29.1	3.4	1.0	9.5	0.0	0.7	0.9	0.8	0.8	1.0	1.3	10.8	11.0	9.0	0.8	1.1	0.6	0.7	15.5	5.2	0.7	0.9	0.8	0.1	0.9	9.9	1.1	0.9	3.7	0.9	1.7	2.3	7.0	0.9	0.9	5.3	0.8	3.0	7.3	18.8	0.0	0.8	0.0	0.7	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	20.5	3.5	10.3	11.0	9.0	15.5	5.2	9.9	18.8
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 73.8;fHDF/TERT166: 48.4;HMC-1: 58.9;HSkMC: 42.8;U-2197: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	28000000	28000000	"Plasma membrane"	"Plasma membrane"	"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.5	0.0	73.8	10.0	4.5	23.0	18.4	23.1	15.3	1.4	0.0	0.0	1.1	48.4	0.0	0.0	0.1	4.3	0.0	0.0	18.2	0.4	0.0	5.0	0.0	58.9	42.8	0.3	3.6	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"									"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FHOD3	"FHOS2, FLJ22297, FLJ22717, KIAA1695"	ENSG00000134775	"Formin homology 2 domain containing 3"	Q2V2M9	18	36297714-36780055	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 70.0;seminal vesicle: 33.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;HDLM-2: 31.7;SH-SY5Y: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021827, HPA024696"	Uncertain				"Intracellular and membrane"					"HPA021827: AB_1848571, HPA024696: AB_1848573"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.11e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-2)"	"prognostic favourable (1.19e-5)"	"unprognostic (1.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.20e-1)"	2.0	13.2	11.4	1.5	6.3	0.4	6.2	2.1	10.9	2.8	5.6	3.2	5.6	1.2	1.9	22.0	5.1	6.0	3.9	70.0	9.5	6.7	10.7	0.8	1.1	0.9	6.0	8.5	4.6	1.4	0.5	4.4	1.0	20.1	14.1	2.1	6.6	6.1	33.3	23.3	3.1	2.4	5.1	4.8	1.0	1.6	2.8	1.8	0.0	2.2	1.7	2.2	6.3	3.3	0.0	0.6	0.0	0.1	0.0	0.6	0.0	6.1	2.2	14.2	3.3	0.1	0.0	1.0	13.8	29.6	2.8	2.7	0.0	10.0	1.1	3.7	6.6	7.9	4.7	6.0	1.6	31.7	1.6	0.0	0.4	0.0	0.1	0.0	0.4	1.9	2.9	1.5	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	3.1	2.0	0.0	0.0	7.5	13.4	6.8	7.9	18.6	3.0	0.0	1.9	0.0	0.0	16.0	8.9	0.7	0.4	11.7	13.2	0.0	0.0	10.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	11.4	6.3	2.1	10.9	9.5	6.7	6.0	8.5	20.1	1.8
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493738	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.6;smooth muscle: 44.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.5;HUVEC TERT2: 2.6;RPTEC TERT1: 2.9;U-266/70: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	11.0	1.3	2.0	6.3	3.0	0.2	2.5	0.6	2.5	8.2	10.9	0.0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0.0	0.0	2.3	10.8	0.7	30.7	6.0	1.4	0.9	1.8	0.8	0.6	0.9	0.0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	10.5	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.2	0.1	0.0	0.2	0.2	1.4	0.1	0.2	0.0	2.6	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	2.9	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	10.4	1.0	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0.0	2.0	3.0	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0.0
FPGT-TNNI3K		ENSG00000259030	"FPGT-TNNI3K readthrough"		1	74198235-74543982	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"heart muscle: 28.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 4.9;CAPAN-2: 4.5;SiHa: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA072331			Approved	Vesicles				Vesicles	Vesicles	"HPA072331: "	"unprognostic (6.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.87e-3)"	8.5	5.5	5.4	3.1	6.3	2.7	6.1	16.1	8.2	6.4	6.3	6.6	3.4	2.5	9.3	4.2	6.0	5.7	4.2	28.0	5.4	4.9	6.3	3.7	6.1	3.5	8.0	5.2	5.6	3.1	4.7	15.0	3.8	7.4	5.5	3.7	5.2	5.4	6.0	11.2	8.0	5.1	6.3	8.5	5.9	4.9	4.1	7.1	2.9	5.1	3.0	3.5	5.5	4.9	2.4	2.4	4.9	4.7	0.8	4.9	3.5	0.0	1.1	0.7	1.5	0.8	4.9	0.1	2.0	1.0	0.2	0.4	1.1	4.5	0.0	3.2	0.2	0.0	0.3	3.0	0.4	0.1	0.2	1.7	0.1	0.1	0.8	0.4	0.3	2.0	2.0	0.2	0.2	0.2	0.0	1.6	1.0	0.0	0.1	0.2	0.1	0.9	2.2	3.8	0.0	0.4	0.0	1.1	3.3	6.4	0.3	0.3	0.0	2.2	0.1	0.7	0.2	0.2	0.8	0.2	0.1	1.7	1.0	1.0	1.1	3.6	4.1	3.5	1.1	4.7	3.5	2.1	3.9	2.2	2.4	2.4	4.9	2.5	4.9	0.8	1.2	2.1	3.8	3.5	5.4	6.3	16.1	8.2	5.4	4.9	8.0	5.2	7.4	7.1
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favourable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.2	1.9	0.1	0.4	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.6	0.4	2.4	0.9	0.1	0.1	0.0	0.0	0.1	0.1	11.6	2.5	1.4	0.1	0.0	0.1	0.5	0.0	0.0	0.1	1.3	0.0	0.0	2.5	0.3	0.0	0.0	0.2	3.6	0.0	1.5	39.2	3.2	5.1	14.5	7.0	0.7	0.1	0.4	0.8	0.4	2.2	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.8	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;HHSteC: 17.4;SH-SY5Y: 16.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	16.8	0.1	0.0	13.4	0.5	0.4	0.1	1.0	15.4	42.5	0.0	0.0	0.0	26.5	0.1	0.8	0.0	0.0	63.4	49.9	0.0	0.1	4.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	13.8	18.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.9	17.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.3	16.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 107.1;smooth muscle: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 24.8;RH-30: 7.0;RT4: 7.8;TIME: 10.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.4;pons and medulla: 3.9"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;naive CD4 T-cell: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;monocytes: 1.5;T-cells: 4.0"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	6.7	4.6	1.2	1.9	1.4	2.9	10.3	10.4	1.3	4.1	3.6	0.1	2.3	3.6	5.2	1.2	9.9	1.3	2.3	107.1	1.2	1.6	1.2	0.9	7.6	1.7	1.2	0.0	2.3	5.6	0.4	1.0	9.1	3.9	10.2	1.3	0.0	4.6	2.7	7.3	2.6	5.8	42.3	1.0	2.6	3.3	2.5	0.0	0.0	1.1	5.0	4.8	25.3	9.5	3.6	0.5	0.4	1.5	0.0	4.0	4.5	3.2	0.6	0.0	3.2	0.0	0.0	0.8	0.6	2.2	1.0	1.0	2.3	3.2	0.0	0.5	0.0	2.1	0.0	1.9	0.9	0.0	0.1	24.8	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.3	4.9	1.0	1.3	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	7.0	0.0	0.0	7.8	0.0	0.8	0.7	0.7	0.0	3.1	0.0	10.7	0.3	2.0	0.3	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	1.2	0.7	0.0	0.5	3.6	4.0	0.0	0.4	0.0	1.5	0.0	0.3	4.5	1.2	1.4	10.4	1.3	1.2	1.6	1.2	0.0	3.9	0.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell line enriched"	"Detected in some"	8	"LHCN-M2: 26.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"			Vesicles	Vesicles	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.5	3.2	2.1	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	26.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161049	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.1;parathyroid gland: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CAPAN-2: 10.1;HL-60: 8.3;U-266/84: 5.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported									"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.2	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0.0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	4.2	0.1	0.2	0.1	1.0	1.6	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	5.6	0.3	0.0	4.9	0.2	1.5	0.0	0.7	4.6	0.8	0.9	0.5	10.1	0.0	0.2	1.7	0.1	3.2	2.7	0.7	0.2	2.5	2.4	0.0	0.0	0.1	8.3	0.0	0.3	1.6	0.2	0.4	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.7	1.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.9	1.1	1.9	0.0	0.0	0.0	2.0	0.3	2.2	5.9	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		130000000	130000000	Nucleoplasm	Nucleoplasm	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GPR22		ENSG00000172209	"G protein-coupled receptor 22"	Q99680	7	107470018-107475659	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 31.5;heart muscle: 18.7"	"Cell line enriched"	"Detected in single"	55	"SH-SY5Y: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.00e-1)"		"unprognostic (4.27e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.76e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.85e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"	0.6	2.7	10.9	0.6	4.4	0.7	0.6	15.5	31.5	6.3	0.6	0.0	0.0	0.6	4.1	0.6	0.6	0.6	0.6	18.7	19.4	2.0	1.0	0.6	0.6	0.6	1.8	13.0	0.6	0.6	0.6	0.3	0.6	6.0	0.6	0.6	0.0	0.6	0.8	0.6	0.6	0.6	1.0	0.7	0.6	0.6	0.6	1.1	0.0	0.6	0.0	0.6	0.6	1.7	1.0	0.2	0.3	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.3	0.9	0.4	0.5	0.0	1.0	0.4	1.0	0.3	0.2	0.2	0.2	0.4	0.0	10.9	4.4	15.5	31.5	19.4	2.0	1.8	13.0	6.0	1.1
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"		3	14489111-14556075	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;skeletal muscle: 25.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.5;PC-3: 10.0;SCLC-21H: 5.6;U-2 OS: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol				Cytosol	Cytosol	"HPA035673: "	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	0.5	0.8	3.2	0.4	2.6	0.0	0.5	0.7	6.0	0.4	0.4	1.2	1.9	0.1	1.3	0.5	1.7	0.3	1.0	10.3	3.2		1.5	0.1	0.2	0.1	0.0	3.3	2.0	0.2	0.1	0.1	3.0	1.1	0.4	0.7	0.6	0.4	0.2	25.7	1.4	0.4	0.6	0.0	1.0	2.7	0.4	1.0	0.0	0.0	4.6	0.4	0.5	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.5	0.3	0.0	0.5	5.1	0.6	3.3	2.0	0.0	0.0	1.2	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	10.0	0.0	0.1	0.0	0.0	0.0	5.6	1.1	0.5	0.0	1.7	0.0	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0										
GRXCR2	DFNB101	ENSG00000204928	"Glutaredoxin and cysteine rich domain containing 2"	A6NFK2	5	145858521-145937126	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;skin 1: 2.0;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;RPMI-8226: 1.5;T-47d: 1.1;U-87 MG: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.3"	"Low region specificity"	"Detected in all"			HPA059421	Uncertain									"HPA059421: AB_2684010"						"unprognostic (4.71e-2)"						"unprognostic (2.91e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.0	0.0	1.6	0.2	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.7	0.0		1.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	3.5			0.2		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.5	0.4	0.1	0.2	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0										
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617377	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"T-reg: 27.6"	"Lineage enriched"	"Detected in many"	16	"T-cells: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	6.6	4.7	2.1	3.8	3.9	5.4	12.6	3.4	3.1	5.1	17.6	3.9	7.4	2.3	13.1	6.0	12.6	6.5	4.8	80.1	2.4	3.7	3.6	1.1	7.9	1.1	5.1	1.8	3.9	2.5	0.6	2.4	1.5	3.8	8.8	3.3	9.4	2.1	13.2	22.8	2.5	4.2	21.5	4.8	1.5	9.4	3.0	3.4	2.6	5.9	6.2	1.2	12.6	9.8	0.6	1.6	1.7	0.5	1.6	27.6	0.7	11.0	9.5	2.7	13.1	12.2	2.3	0.2	15.7	9.5	20.6	19.5	6.3	13.5	0.1	2.3	25.5	2.7	6.8	4.7	11.4	7.2	4.0	25.5	6.8	17.3	15.8	0.1	1.9	5.7	6.8	11.8	4.6	4.0	0.2	0.5	27.1	8.0	18.8	2.6	5.7	2.6	16.9	2.8	0.3	8.1	2.1	3.0	7.6	13.4	0.2	22.0	9.5	6.3	3.8	12.2	7.0	7.4	7.1	0.4	0.3	0.1	8.9	2.9	1.7	1.7	0.5	0.4	0.6	0.1	0.1	0.2	2.8	0.5	1.6	0.6	0.5	0.4	1.6	1.6	0.1	0.8	27.6	0.7	2.1	3.9	3.4	2.8	2.4	3.7	5.1	1.8	3.8	3.4
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		8700000	8700000	Mitochondria	Mitochondria	"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.8	8.3	18.0	13.1	43.3	13.9	8.7	13.0	19.4	14.2	14.0	5.9	16.7	50.4	7.0	10.7	11.9	23.9	18.1	15.7	15.4	12.5	11.7	15.9	13.2	6.9	24.7	5.5	14.5	9.7	10.0	9.2	9.5	14.5	26.8	16.0	16.1	41.9	9.9	8.5	11.1	32.0	25.2	25.2	15.3	36.1	21.7	12.5	12.6	45.1	12.8	21.5	19.6	5.3	10.0	5.7	14.1	7.1	15.2	17.6	21.9	13.6	16.8	7.7	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		1100000	1100000	Mitochondria	Mitochondria	"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	22.7	18.0	12.6	22.5	77.7	43.0	12.7	19.2	29.4	19.8	19.4	21.5	22.2	11.4	13.5	31.4	18.0	20.9	27.1	24.3	25.7	18.2	26.2	10.7	42.0	33.3	21.1	20.1	41.6	44.8	20.5	33.5	36.6	21.9	18.5	41.2	16.7	11.8	40.8	8.7	19.6	13.1	41.6	21.7	40.7	32.4	6.0	20.7	32.9	37.5	50.4	23.2	37.8	25.3	18.7	19.5	17.5	13.8	13.9	20.9	20.1	21.5	33.8	18.5	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell line enriched"	"Detected in some"	7	"SH-SY5Y: 50.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Approved		Uncertain	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 28.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;HEK 293: 6.5;SK-MEL-30: 6.0;TIME: 13.6;U-266/70: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.6;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.6"	"Region enriched"	"Detected in all"	4	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"				"Nuclear bodies"	"Nuclear bodies"	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.0	1.8	7.4	1.8	9.2	0.7	5.5	5.7	11.8	10.4	2.9	13.1	0.7	2.2	11.3	24.0	2.8	19.3	7.6	28.5	8.2	6.2	3.6	7.8	3.7	1.2	8.2	11.4	10.7	4.1	7.1	5.4	5.4	12.8	2.3	2.4	10.4	3.0	4.5	19.1	2.1	2.2	2.9	11.3	2.9	2.0	6.5	7.2	0.0	3.6	4.9	1.4	3.5	4.9	0.0	0.0	0.0	0.1	0.0	2.6	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.2	0.2	0.1	0.0	0.4	6.5	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.4	0.0	0.0	3.0	0.3	0.5	0.6	0.8	0.0	0.1	2.1	0.0	0.0	0.0	6.0	1.8	0.0	13.6	0.3	0.0	0.1	0.7	16.6	0.3	0.1	0.6	0.0	1.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.4	0.0	0.0	0.1	0.0	0.0	0.4	7.4	9.2	5.7	5.9	8.2	6.2	8.2	11.4	12.8	7.2
HSPB2	"Hs.78846, MKBP"	ENSG00000170276	"Heat shock protein family B (small) member 2"	Q16082	11	111912242-111914093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.5;heart muscle: 51.6;skeletal muscle: 52.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.3;ASC TERT1: 6.1;fHDF/TERT166: 20.3;HSkMC: 7.2;LHCN-M2: 11.7;U-138 MG: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (5.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.69e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	11.5	2.5	3.1	2.8	3.6	0.8	40.5	7.8	3.7	8.4	5.8	1.4	3.9	1.7	8.2	10.6	5.4	5.3	6.3	51.6	2.8	2.5	5.0	1.2	4.7	7.5	3.8	2.5	6.0	1.3	0.8	0.8	4.2	4.0	4.8	2.5	5.1	2.5	5.3	52.6	4.4	2.4	8.5	3.0	2.2	2.9	3.6	2.0	0.0	2.7	22.0	1.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	6.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.6	7.8	3.7	2.8	2.5	3.8	2.5	4.0	2.0
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455601-54456384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 37.1;fHDF/TERT166: 16.6;HSkMC: 7.3;LHCN-M2: 5.4"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062124			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.7	0.1	1.1	0.1	1.0	0.0	0.5	0.0	2.7	0.2	1.0	0.0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1	1.1	0.3	0.0	0.0	0.9	0.0	0.2	2.0	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0.0	0.2	0.2	0.3	0.0	0.0	0.1	22.3	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.1	0.0	0.0	0.1	16.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	7.3	2.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	0.0	2.7	0.5	0.4	0.1	1.1	0.2	0.0
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 62.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"			Vesicles	Vesicles	"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.0	3.8	0.1	0.8	0.0	0.9	0.2	0.0	0.0	0.0	4.7	2.1	0.0	0.4	0.0	0.3	0.0	0.7	0.4	4.9	0.0	2.1	0.0	0.2	0.4	0.0	1.4	0.0	3.3	0.1	0.0	3.5	0.0	0.0	12.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	5.5	0.1	8.9	0.1	0.0	0.0	0.3	2.7	0.5	1.6	62.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		53000000	53000000	Mitochondria	Mitochondria	"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favourable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.2	5.8	30.2	30.0	4.2	5.2	25.7	12.8	19.5	12.1	13.0	2.7	8.9	12.2	3.6	10.6	3.5	4.4	3.9	5.8	23.9	2.9	20.8	2.2	20.3	5.1	14.2	21.1	10.8	2.2	2.9	2.3	24.8	3.1	10.5	9.3	29.8	68.3	22.1	9.0	2.4	57.9	21.7	36.3	18.7	12.3	43.6	22.1	15.9	63.6	5.1	51.3	43.9	5.9	21.7	3.1	2.8	5.9	17.3	3.2	1.4	6.9	30.0	12.5	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 5.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"					"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.2"					"Low region specificity"	"Detected in all"			HPA057282	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.0	2.0	0.9	0.0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0.0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0.0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0.0	0.4	0.0	1.3	0.7	4.4	1.1	4.4	3.5	1.1	0.8	1.2	1.2	1.9	0.7	1.3	1.4	1.2	1.6	1.2	1.5	2.9	2.5	2.2	2.1	1.3	3.2	0.5	2.7	1.8	0.6	3.2	5.3	2.8	3.2	0.6	2.5	0.9	1.7	1.5	0.3	0.6	2.4	0.8	0.7	2.0	0.8	1.8	1.9	2.0	0.5	1.2	2.9	1.7	10.6	1.1	0.4	1.9	2.2	0.9	1.8	0.9	0.8	0.9	1.1	1.4	1.9	0.1	0.4	0.4	0.4	0.0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0.0	0.1	0.3	0.0	0.0										
IL25	"IL-17E, IL-25, IL17E"	ENSG00000166090	"Interleukin 25"	Q9H293	14	23372809-23376403	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.2;testis: 2.3"	"Cell line enhanced"	"Detected in single"		"HEL: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB024864	Uncertain				"Secreted to blood"					"CAB024864: "	"unprognostic (1.49e-1)"				"unprognostic (6.82e-2)"													0.5	0.2	0.4	0.3	0.6	0.0	0.6	0.1	0.7	0.4	0.0			0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.5	0.3	0.0	0.0	0.0	1.4	0.3		0.1	0.0	0.5	0.0	0.0		0.8	0.0		0.3	0.5	0.8	1.0	0.2	0.7	0.5	0.5	0.0	2.3			0.1		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930862-54934485	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 19.0;heart muscle: 26.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7"	HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favourable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	3.3	0.7	0.2	0.2	1.4	0.2	19.0	5.8	0.3	3.6	0.5	1.7	0.2	0.2	0.4	1.9	7.6	0.3	0.4	26.5	0.9	1.3	4.7	0.2	10.3	0.3	2.6	0.0	0.5	0.3	0.5	0.3	0.2	5.3	4.2	0.2	6.5	13.6	0.5	6.7	13.9	0.2	0.3	4.5	0.2	3.3	0.9	2.2	0.4	0.2	1.0	2.4	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	5.7	2.1	2.1	0.4	0.2	2.2	5.4	0.7	0.5	1.2	0.5	0.0	0.5	2.9	5.5	2.0	2.3	0.4	3.8	2.7	0.6	2.3	0.0	0.0	1.3	2.2	0.6	10.1	3.6	1.5	0.0	0.3	0.0	4.1	2.0	6.0	7.8	0.1	1.6	3.2	2.9	0.3	17.8	0.1	2.0	2.0	0.9	4.9	2.4	24.3	13.0	0.3	4.0	0.1	2.8	0.8	2.4	1.4	1.8	6.4	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	5.8	0.2	0.9	1.3	2.6	0.0	5.3	2.2
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	10.4	0.0	0.2	0.1	0.1	1.7	6.6	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		770000	770000	"Plasma membrane"	"Plasma membrane"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.1	1.7	3.2	5.2	29.5	5.9	0.3	2.2	3.7	5.0	5.2	3.5	2.8	0.9	3.2	1.4	0.4	2.2	0.1	4.5	0.1	1.6	0.3	1.1	1.3	0.2	0.1	1.1	8.3	0.0	27.9	0.1	0.0	0.4	0.6	16.9	2.1	0.1	1.2	9.0	0.2	0.0	12.2	0.2	0.1	0.0	0.4	1.2	0.2	0.0	20.4	0.3	5.7	0.0	0.5	5.5	0.3	3.5	1.3	0.9	0.3	25.2	3.4	0.3	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol	Cytosol	"HPA040721: "	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
KBTBD13	"hCG_1645727, NEM6"	ENSG00000234438	"Kelch repeat and BTB domain containing 13"	C9JR72	15	65076816-65078192	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 4.6;skeletal muscle: 19.2;tongue: 9.4"	"Cell line enriched"	"Detected in single"	6	"HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062737	Uncertain									"HPA062737: AB_2684856"										"unprognostic (1.18e-1)"		"unprognostic (7.88e-2)"			"unprognostic (6.07e-2)"			0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.1	0.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.4	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043989-5046788	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 33.0"	"Cell line enriched"	"Detected in single"	21	"NTERA-2: 9.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	134	"plasmacytoid DC: 13.3"	"Lineage enriched"	"Detected in single"	134	"dendritic cells: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021516, CAB022562"	Approved									"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	3.4	1.4	1.9	0.9	8.6	0.7	1.2	0.4	2.3	1.6	3.3	7.2	0.0	1.1	1.7	2.6	7.6	2.1	2.3	33.0	3.5	5.8	1.9	0.8	2.3	0.9	2.3	2.2	3.2	2.4	0.6	7.5	3.4	8.8	3.7	1.3	7.2	0.9	2.0	5.3	0.6	1.1	3.0	3.9	1.2	3.3	0.8	4.9	0.0	1.1	3.4	1.2	4.5	3.4	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	1.9	8.6	0.4	2.3	3.5	5.8	2.3	2.2	8.8	4.9
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 41.5;HSkMC: 8.4;SH-SY5Y: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain									"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	5.1	3.4	0.0	5.6	4.5	6.4	3.3	41.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.9	0.0	2.0	1.3	0.0	0.0	0.1	0.0	0.0	8.4	0.0	2.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.8	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8
KIR3DL2	"CD158K, cl-5, nkat4, nkat4a, nkat4b"	ENSG00000240403	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2"	P43630	19	54850443-54867207	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.0;lymphoid tissue: 5.3;salivary gland: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"																				"unprognostic (6.99e-2)"	"unprognostic (1.83e-1)"		"unprognostic (3.64e-1)"		"unprognostic (4.56e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.39e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.62e-2)"	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIR3DX1	"FLJ00060, LENG12"	ENSG00000104970	"Killer cell immunoglobulin like receptor, three Ig domains X1"		19	54532692-54545771	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6"	"Cell line enriched"	"Detected in some"	6	"U-266/84: 9.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA052110	Uncertain				"Secreted - unknown location"					"HPA052110: AB_2681731"	"unprognostic (5.85e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.47e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.22e-4)"	"unprognostic (1.36e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.73e-9)"	"unprognostic (1.09e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.20e-3)"	1.9	0.0	0.0	1.3	0.6	2.2	0.3	0.0	1.2	0.6	0.2	3.9	0.0	0.0	1.0	0.0	0.5	0.1	0.4	3.6	0.1		0.1	0.2	2.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.5	0.6	4.6	0.0	0.5	0.1	0.0	0.2	0.0	2.7	0.0	0.0	0.4	0.3	1.7	0.2	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	9.7	0.0	0.0	0.8	0.0	1.7	0.2	0.0	1.1	0.2	0.2	0.2	0.2	0.2	0.0	0.4	0.1	0.2	0.6	1.2	0.0	0.3	0.3	0.0										
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.7	16.1	3.5	3.5	6.7	3.3	4.1	5.4	6.2	0.4	1.7	1.9	7.0	4.2	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.2	3.7	2.0	4.9	14.1	2.0	2.7	2.4	8.9	5.3	9.3	3.8	9.5	3.1	1.0	4.1	5.0	6.1	10.4	5.1	14.8	3.5	2.6	5.4	5.0	6.6	2.8	0.0	4.6	9.6	3.1	8.3	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883141-129516569	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.7;placenta: 71.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 65.2;ASC TERT1: 47.5;HHSteC: 14.2;HSkMC: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 2.2;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	38000000	38000000			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (3.65e-5)"	35.3	7.4	1.7	3.5	8.1	0.9	38.9	6.4	3.8	22.0	10.4	1.7	6.3	2.0	13.3	12.8	17.1	17.7	13.6	65.7	2.1	1.5	3.6	3.8	17.1	8.8	4.7	3.3	33.0	5.4	2.1	7.0	71.2	6.2	8.2	4.2	3.5	9.4	7.5	26.1	8.2	7.2	26.8	6.9	7.3	10.2	16.7	5.4	0.0	9.6	9.2	1.4	18.5	22.1	0.1	0.1	0.0	0.0	2.2	2.2	0.1	0.0	0.0	0.7	0.0	65.2	47.5	0.0	6.4	2.3	0.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	39.9	0.0	3.3	0.0	0.0	0.0	0.2	10.8	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.0	2.2	0.0	0.0	0.5	0.1	1.7	8.1	6.4	3.8	2.1	1.5	4.7	3.3	6.2	5.4
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		780000000	780000000	Cytosol	Cytosol	"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.7	88.0	77.4	50.9	55.5	61.8	90.0	45.8	45.8	64.1	63.5	139.3	0.1	116.1	30.1	30.8	16.5	106.4	84.9	81.7	29.7	74.1	119.5	84.1	0.1	53.1	111.5	51.7	70.6	30.4	56.1	76.4	73.1	65.3	17.5	70.5	0.1	94.7	135.0	223.2	38.2	85.6	108.0	93.6	318.2	146.3	24.9	57.7	21.0	32.6	79.0	0.2	87.5	28.4	43.2	56.7	30.7	86.3	15.5	20.9	152.5	47.9	53.4	51.2	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.1	6.9	0.2	0.2	14.4	10.2	2.4	54.7	27.0	13.9	15.1	16.9	15.7	1.0	4.2	90.2	11.8	3.0	2.6	16.1	16.3	0.7	7.4	36.7	15.8	4.1	2.3	3.9	7.0	5.1	6.0	6.9	5.8	0.2	0.0	84.9	4.7	1.8	1.0	0.3	10.4	1.1	25.5	0.2	5.9	2.8	0.8	1.9	9.9	1.7	2.2	2.2	1.7	8.8	34.4	6.4	4.1	13.3	3.7	2.7	4.3	10.1	2.6	15.6	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106872-69123032	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 8.0"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036034	Uncertain									"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	4.8	1.9	0.1	0.0	28.3	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.9	0.0	0.0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1.0	0.2	0.2	0.1	0.9	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.6	0.0	0.2	0.7	8.0	0.0	0.1	0.1	0.0	0.1	0.6	1.7	0.1	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	1.0	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.0	0.1
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 89.3"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in all"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	880000	880000	Vesicles	Vesicles	"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	89.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4
LRRC49	FLJ20156	ENSG00000137821	"Leucine rich repeat containing 49"	Q8IUZ0	15	70853239-71053657	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015596	Uncertain									"HPA015596: AB_2669230"	"unprognostic (9.74e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.66e-4)"	"unprognostic (3.02e-1)"	"unprognostic (5.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.09e-2)"	2.1	5.0	9.1	2.0	17.8	1.1	3.6	27.4	17.9	6.0	3.1	5.6	2.9	1.8	9.2	28.8	2.7	10.7	4.7	50.3	10.3	11.1	4.8	1.3	3.7	1.4	11.6	10.8	12.8	2.3	14.3	27.3	2.1	23.0	6.5	2.9	6.1	2.1	6.1	1.6	2.3	2.1	6.7	5.9	1.6	2.8	13.2	7.2	0.1	5.3	1.1	1.5	5.7	3.5	1.0	0.6	0.6	2.4	0.9	1.7	0.6	1.9	3.7	7.5	11.7	2.8	4.6	0.0	2.6	6.1	2.2	4.4	1.0	1.6	0.0	2.8	2.5	3.0	9.0	4.6	2.3	0.0	3.4	0.6	3.1	0.1	23.2	0.0	0.9	2.7	1.1	7.2	12.5	5.5	0.1	0.0	3.1	0.7	0.0	0.6	4.2	2.1	0.0	4.8	0.0	5.3	3.2	13.4	12.9	4.2	1.3	3.2	3.4	1.0	3.7	2.2	8.1	5.2	5.4	1.3	3.7	0.0	5.8	0.1	2.3	0.6	0.2	0.1	1.5	2.4	1.7	1.0	1.1	0.1	0.6	0.4	0.1	0.7	0.4	0.9	0.8	0.2	0.0	0.6	9.1	17.8	27.4	17.9	10.3	11.1	11.6	10.8	23.0	7.2
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.0	7.1	3.0	8.5	4.6	11.5	6.7	5.6	8.0	8.7	7.4	11.1	21.5	9.3	5.7	18.7	8.2	20.5	22.1	7.8	20.4	4.9	48.7	10.2	10.1	9.1	35.0	25.9	9.1	13.8	20.2	27.5	7.6	13.6	6.1	18.2	9.4	14.9	35.3	11.2	29.5	6.6	7.2	13.9	40.3	13.2	5.6	4.0	5.0	14.2	6.4	8.9	21.7	5.5	6.8	15.7	35.3	13.8	4.1	7.6	7.7	36.4	55.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favourable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.8	16.3	7.0	26.9	7.5	7.8	12.0	5.6	9.5	11.7	8.5	28.7	15.1	27.5	20.9	8.2	9.8	12.2	18.9	14.7	14.5	15.6	14.9	8.5	31.5	13.2	7.4	14.2	9.9	9.9	10.7	8.5	10.3	18.8	10.3	8.1	32.3	0.1	13.5	9.2	9.2	14.4	20.2	40.4	30.4	21.4	11.1	12.3	24.7	36.7	12.0	30.4	18.8	7.5	4.8	7.4	8.6	15.2	7.4	13.7	17.0	7.8	20.6	11.8	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		63000000	63000000	"Centrosome, Cytosol"	"Centrosome, Cytosol"	"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030554	Uncertain									"HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favourable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	25.8	15.9	18.0	23.6	18.3	13.8	20.9	20.5	19.0	28.2	22.0	26.1	17.3	19.0	22.2	24.8	27.8	29.7	47.6	25.3	68.9	22.6	27.2	25.5	20.3	18.9	27.6	17.1	17.3	36.7	39.6	36.7	19.8	28.1	16.8	20.8	13.0	16.7	12.6	12.4	23.3	19.6	26.2	17.7	16.9	17.3	21.0	13.7	24.0	25.7	23.7	13.9	16.6	19.8	18.9	18.9	28.6	21.4	20.0	21.0	31.1	22.4	31.0	20.4	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Cell line enhanced"	"Detected in many"		"A-431: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069479			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA069479: AB_2686140"	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	34.1	4.5	11.5	0.0	6.1	7.2	3.4	3.5	3.4	13.0	11.8	0.0	19.5	0.0	13.5	6.1	6.6	0.1	6.0	17.3	0.0	7.5	2.0	3.3	0.3	4.2	0.0	2.6	4.4	8.8	6.2	3.4	3.0	2.5	0.0	8.5	5.0	0.0	0.1	2.7	10.0	0.0	6.4	0.4	9.9	2.4	14.9	8.8	16.1	5.7	16.9	16.4	3.4	1.1	12.1	12.4	14.3	13.7	6.1	3.8	0.0	8.7	0.0	8.7	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899126-83927026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 39.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA031625	Enhanced									"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favourable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	6.6	10.1	3.3	3.7	4.2	2.3	4.6	2.4	5.4	4.1	6.9	6.3	6.2	4.6	4.4	4.4	5.1	4.9	7.0	39.1	3.7	3.3	6.7	17.4	4.1	3.6	6.9	3.1	6.2	21.5	6.9	5.1	3.1	4.6	5.6	4.4	8.0	6.4	4.1	31.0	4.0	5.1	5.8	3.3	3.8	6.7	7.1	5.7	3.3	5.6	5.7	4.6	6.4	5.4	0.7	0.7	2.3	0.8	0.1	0.9	0.2	0.5	2.3	1.6	2.6	4.9	2.4	3.6	1.1	1.7	1.1	0.5	2.2	1.6	0.4	2.8	2.1	2.4	2.7	0.8	1.0	1.8	2.1	1.6	0.9	1.3	2.8	1.4	3.2	3.0	2.7	0.7	1.1	1.2	2.1	0.8	1.3	4.3	1.5	4.4	2.0	1.0	3.4	1.4	2.1	2.9	2.7	2.4	2.2	4.4	0.6	2.0	4.2	1.8	1.6	1.7	0.4	1.3	0.5	2.7	2.6	3.1	1.7	2.1	1.9	0.8	0.7	2.3	0.5	0.5	0.3	0.7	0.8	0.7	0.7	0.3	0.8	0.9	0.3	0.1	0.8	0.3	0.0	0.2	3.3	4.2	2.4	5.4	3.7	3.3	6.9	3.1	4.6	5.7
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favourable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	28.1	23.8	13.7	12.1	7.6	12.3	11.9	11.6	10.0	4.6	13.8	13.7	11.7	6.3	12.2	9.5	8.4	9.3	20.9	6.8	10.1	33.1	9.9	26.4	9.0	10.9	13.5	9.7	7.0	9.6	23.8	22.0	7.3	10.4	18.3	48.9	4.2	9.3	10.1	13.6	34.5	22.1	5.2	25.6	22.8	8.7	38.2	8.7	9.0	39.6	6.6	6.9	7.2	24.4	7.7	15.1	10.3	11.5	6.3	32.6	11.0	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 69.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.7;BJ: 30.7;EFO-21: 38.2;fHDF/TERT166: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 18.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	49.3	32.6	32.0	6.4	37.6	1.3	17.7	12.3	37.3	6.4	5.4	9.4	1.7	2.3	11.9	5.2	5.1	6.8	8.6	69.1	29.0	23.9	8.9	3.7	8.9	3.3	31.3	18.0	17.2	3.4	7.6	4.7	6.9	25.2	7.6	3.4	8.2	8.0	12.0	22.5	2.7	2.7	16.9	21.5	7.3	3.4	5.9	19.3	0.0	12.1	2.4	2.8	10.0	6.4	0.0	2.1	0.3	18.9	0.6	0.0	0.5	0.2	2.5	6.6	8.6	28.7	13.2	13.6	30.7	7.7	3.2	3.9	1.1	1.0	0.1	38.2	30.0	0.0	3.2	0.7	2.5	2.7	1.0	0.1	1.6	6.2	7.2	0.0	0.6	18.9	2.9	0.2	0.5	0.5	3.4	0.2	14.1	1.1	0.0	7.5	7.2	0.9	0.3	12.0	0.0	13.8	0.6	6.9	15.2	20.1	0.2	16.1	5.9	14.9	0.1	8.0	9.1	8.7	0.8	0.0	0.3	0.3	8.1	0.0	4.4	0.1	1.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.6	18.9	0.1	0.0	0.5	32.0	37.6	12.3	28.9	29.0	23.9	31.3	18.0	25.2	19.3
MSRB2	"CBS-1, CBS1, CGI-131, MSRB, PILB"	ENSG00000148450	"Methionine sulfoxide reductase B2"	Q9Y3D2	10	23095506-23122013	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 72.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA027933	Enhanced				"Intracellular and membrane"					"HPA027933: AB_10601867"	"unprognostic (4.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	13.2	11.6	16.4	6.8	16.2	6.0	9.9	6.5	11.4	10.7	14.4	8.0	14.3	8.2	10.6	15.2	14.1	10.5	15.8	72.3	13.9	14.5	16.0	25.7	7.9	6.3	14.2	8.2	11.3	7.0	11.5	9.4	12.4	9.3	16.3	10.2	10.6	7.7	18.0	31.5	3.6	13.5	25.1	10.8	8.2	7.5	5.6	6.1	6.0	16.7	11.0	5.5	19.0	10.3	0.4	3.1	6.7	2.6	0.3	1.3	0.5	4.1	6.1	11.4	6.9	11.8	10.7	3.4	6.7	3.8	4.3	5.0	4.1	9.2	3.4	6.0	14.3	2.7	3.7	5.0	3.6	23.0	4.2	2.5	10.2	2.3	16.7	0.5	3.0	13.6	8.5	5.1	1.2	6.1	3.3	6.1	9.5	12.6	3.9	3.1	6.3	3.6	4.6	6.5	0.9	5.4	1.6	2.3	15.7	8.3	7.4	13.5	5.0	9.8	4.5	3.8	3.5	8.4	4.0	8.0	2.5	0.1	5.3	7.4	3.1	1.6	2.6	4.1	0.7	2.1	0.6	0.4	0.7	0.5	1.6	0.1	1.3	0.9	6.7	0.3	1.5	3.1	0.7	0.5	16.4	16.2	6.5	11.4	13.9	14.5	14.2	8.2	9.3	6.1
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell line enhanced"	"Detected in all"		"HeLa: 859.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	112.7	170.5	232.0	252.3	531.8	243.6	246.0	257.3	85.7	65.0	108.8	205.2	367.8	298.0	123.7	195.5	428.5	26.5	228.0	93.1	140.8	162.5	178.9	859.1	383.8	73.7	103.2	226.6	284.1	237.4	64.2	142.7	78.2	113.5	213.9	192.4	273.1	84.4	462.1	58.9	139.6	110.6	69.3	178.8	329.5	298.3	110.9	147.9	89.2	345.8	160.5	198.4	347.4	311.5	260.6	177.4	255.7	129.0	101.3	97.0	67.6	128.7	272.4	126.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5										
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 362.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	47.2	30.4	71.2	14.8	94.5	11.3	16.5	23.2	45.8	13.6	30.3			38.9	16.6	24.9	26.2	21.4	19.1	190.3	65.0	52.8	56.3	66.6	19.3	9.4	56.1		18.6	22.9	23.1	7.9	15.1		27.5	28.0		25.7	21.5	223.2	63.9	29.5	25.3	37.9	12.6	41.4	14.6			12.8		13.2	24.9	8.0	124.1	89.3	193.9	123.4	79.6	99.3	33.7	69.1	73.7	90.2	87.1	272.5	71.4	48.6	142.1	21.8	15.9	26.7	108.2	91.2	168.2	72.1	66.3	148.5	8.4	74.6	26.6	94.1	57.4	123.2	362.2	182.8	31.4	86.1	128.3	106.6	59.7	18.1	43.4	32.1	44.8	80.5	54.4	131.1	32.2	106.4	17.8	40.4	61.9	42.3	72.1	96.6	137.8	27.0	41.2	66.2	118.6	39.5	86.3	129.4	224.8	92.1	64.2	108.4	55.0	30.7	53.1	46.9	49.2	78.7	40.0	193.9	123.4	79.9	81.3	100.2	99.3	99.4	79.3	87.3	73.4	124.1	78.5	86.6	45.3	79.6	95.9	89.3	62.1	33.7										
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 395.3;skeletal muscle: 593.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 514.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favourable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0.0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48.0	0.0	3.5	10.3		28.0	0.3		48.1	0.0	593.2	176.3	63.8	0.0	24.8	19.9	53.2	22.7			17.5		0.0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	97.5	79.2	70.1	88.9	11.8	1.1	50.3	131.9	0.2	0.4	0.4	107.6	99.0	210.5	89.8	3.5	146.0	0.7	2.4	0.7	124.3	60.8	126.1	514.1	307.3	0.9	79.8	119.1	2.0	3.2	3.2	2.7	0.7	54.2	82.7	2.9	208.4	24.5	110.1	15.2	38.9	59.6	44.8	90.4	1.9	287.8	28.9	46.4	68.7	121.0	54.5	93.7	155.6	268.3	77.9	65.8	110.3	52.8	28.3	75.5	50.5	52.9	81.4	45.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7										
MT1HL1	MT1P2	ENSG00000244020	"Metallothionein 1H like 1"	P0DM35	1	237004103-237004418	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 10.5;liver: 4.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;U-2 OS: 1.6;U-266/84: 3.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																										"unprognostic (5.79e-2)"					"unprognostic (2.78e-1)"				"unprognostic (2.65e-1)"		"unprognostic (3.77e-2)"		0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.5	0.1	0.0	1.7	4.3	0.1	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.7	0.1	0.2	0.6	0.8	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.0	3.4	0.0	1.2	0.0	0.0	0.8	0.2	0.2	0.2	0.2	0.4	0.1	0.8	0.9	0.6	0.2	0.8	0.5	0.0	0.1	0.2	0.0	1.6	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MTRNR2L7		ENSG00000256892	"MT-RNR2-like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;Hep G2: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"														"Secreted - unknown location"															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.3	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.1	0.1	0.9	0.4	0.1	0.0	0.1		0.1	0.1	0.0	0.3	0.0		0.1	0.5		0.1	0.0	1.9	0.1	0.1	0.0	0.1	0.1	0.2	0.2			0.1		0.0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.3	0.0	0.3	0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	3.1	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.5	0.4	0.3	0.0	0.2	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.8	0.0	1.2	0.2	0.6	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2										
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820348-29505947	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 46.8;pituitary gland: 19.3"	"Group enriched"	"Detected in some"	4	"HaCaT: 16.3;HeLa: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.9;intermediate monocyte: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"	"Microtubules, Cytokinetic bridge"	"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.6	0.8	2.3	0.7	6.1	0.7	0.6	12.2	8.8	1.1	0.8	0.1	0.0	0.7	2.1	0.6	0.8	1.4	0.7	46.8	3.4	1.9	0.6	1.1	0.7	1.0	1.2	4.6	8.2	4.7	0.5	19.3	0.5	2.3	0.8	0.8	2.0	1.0	0.7	0.6	0.7	0.9	1.7	0.7	1.0	1.5	1.6	0.9	0.0	1.1	0.0	0.6	2.6	0.7	0.0	1.3	1.9	1.7	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	16.3	0.5	0.0	0.0	0.1	0.7	0.0	6.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	1.2	0.0	2.8	2.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.3	0.1	0.4	0.0	0.0	0.0	0.2	1.9	0.0	1.7	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	2.3	6.1	12.2	8.8	3.4	1.9	1.2	4.6	2.3	0.9
MYL12A	"MLCB, MRCL3, MRLC3, MYL2B"	ENSG00000101608	"Myosin light chain 12A"	P19105	18	3247481-3256236	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004503, HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		70000000	70000000	"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: , HPA059197: AB_2683944"	"unprognostic (2.14e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.58e-3)"	"unprognostic (7.13e-2)"	60.9	19.9	7.1	31.1	13.1	21.7	63.9	5.1	7.6	25.1	31.2	7.4	22.5	15.6	24.1	29.0	43.6	22.8	32.4	248.0	8.2	6.8	52.7	43.1	58.3	58.4	14.6	5.7	28.6	24.8	24.9	11.1	49.5	18.9	24.3	27.2	14.7	26.5	18.6	423.8	24.2	41.5	27.9	22.1	68.6	22.5	20.4	10.3	40.3	38.6	80.1	42.0	30.6	31.2	103.4	166.8	173.4	91.9	104.2	168.7	245.4	30.7	19.6	44.7	18.7	52.8	55.6	27.4	70.1	92.6	66.7	72.8	29.6	39.0	14.9	18.5	101.7	13.4	25.8	44.0	59.9	21.0	9.2	15.2	23.3	26.0	88.5	43.2	29.7	87.0	62.4	51.8	31.3	104.6	19.0	52.1	136.8	52.6	20.1	43.5	18.3	14.5	11.6	23.4	26.2	146.3	49.8	6.3	15.3	55.4	23.9	48.5	16.8	63.9	111.9	16.5	37.7	45.2	55.4	11.9	17.2	24.1	49.7	17.4	59.1	173.4	74.5	154.6	166.4	77.4	166.7	103.4	156.8	168.7	109.0	80.4	142.5	167.0	122.8	104.2	91.9	166.8	133.2	245.4	7.1	13.1	5.1	7.6	8.2	6.8	14.6	5.7	18.9	10.3
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3"	"Cell line enhanced"	"Detected in some"		"BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	4.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	23.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.1	2.1	0.0	114.9	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.9	46.3	3.4	0.0	0.0	0.3	0.1	3.8	0.1	0.2	0.1	0.0	1.1	0.5	0.0	0.0	0.3	1.7	0.0	16.3	8.2	6.1	2.3	0.0	0.0	0.0	0.0	45.8	0.3	0.0	0.1	10.8	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.8	0.0	3.3	0.3	0.1	0.0	0.1	19.7	3.4	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.0	1.7	3.8	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591941-57685364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.6;smooth muscle: 52.2"	"Cell line enriched"	"Detected in some"	4	"HEL: 52.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.9;pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.7;naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA039827	Approved									"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	11.8	12.3	0.6	1.4	1.2	0.5	13.0	6.9	1.0	5.5	5.6	0.6	3.3	3.3	6.1	1.9	12.6	1.1	3.2	132.6	0.6	0.9	1.4	0.4	9.8	2.1	0.9	0.5	1.5	7.4	0.0	1.0	11.7	6.1	13.0	2.4	0.0	6.1	8.4	3.3	2.2	9.1	52.2	0.5	2.4	4.9	1.6	0.2	0.4	1.0	6.6	6.4	31.4	12.1	6.7	0.1	1.0	1.3	0.0	3.6	5.0	2.2	0.7	0.0	4.2	0.9	0.0	1.2	0.3	3.5	0.5	0.7	2.9	1.6	0.0	0.2	0.0	0.9	0.0	1.6	0.7	0.0	0.1	52.2	0.6	0.0	0.1	0.0	0.0	0.0	1.3	0.1	9.6	11.5	0.7	0.0	0.3	0.8	0.0	0.0	0.0	1.0	0.0	4.4	0.1	0.0	10.1	0.0	1.5	0.2	2.3	0.0	3.1	0.0	12.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.7	0.6	0.0	0.1	6.7	3.6	0.0	1.0	0.0	1.3	0.0	0.3	5.0	0.6	1.2	6.9	1.0	0.6	0.9	0.9	0.5	6.1	0.2
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121598	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 34.8;SH-SY5Y: 31.7;TIME: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	14.8	3.1	7.9	4.7	12.5	3.1	13.8	13.8	16.1	10.2	17.6	16.1	8.6	5.1	9.3	13.4	7.8	5.7	3.2	64.6	9.9	7.0	12.3	18.7	11.2	3.0	16.5	11.5	4.7	10.8	10.1	6.6	16.2	23.5	7.9	6.3	8.6	16.5	11.8	3.4	7.9	4.7	13.0	32.2	2.5	9.9	2.1	12.6	0.0	20.1	1.8	5.3	6.0	8.6	0.3	1.9	0.0	0.5	0.0	0.3	0.0	5.9	1.7	3.9	0.4	13.2	8.5	4.2	5.0	8.6	6.6	5.0	6.7	0.8	0.0	0.2	7.5	0.7	0.2	3.9	7.8	1.0	0.4	0.1	8.8	7.6	2.4	0.0	0.2	5.5	10.2	3.1	34.8	8.8	0.7	3.0	19.0	6.3	0.0	0.0	9.2	5.0	0.0	18.0	0.9	5.6	1.7	6.8	31.7	3.8	3.0	5.7	0.1	0.0	24.5	15.5	2.3	18.3	4.7	1.0	0.5	0.0	5.3	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.0	7.9	12.5	13.8	16.1	9.9	7.0	16.5	11.5	23.5	12.6
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Cell line enhanced"	"Detected in some"		"HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	2800000000	2800000000	"Plasma membrane"	"Plasma membrane"	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.7	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	0.9	6.0	6.3	0.1	0.0	0.0	0.0	0.1	3.8	19.1	0.0	0.0	0.7	0.0	3.1	4.1	0.0	0.0	6.1	0.0	0.0	0.3	6.7	0.0	0.0	1.6	0.5	0.1	0.0	43.1	3.1	0.0	0.0	35.1	17.2	0.0	0.1	0.0	0.0	0.2	0.0	24.0	11.2	0.1	10.0	0.0	0.1	0.0	2.7	9.0	25.4	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	34.5	37.3	26.7	28.4	32.2	20.4	33.4	27.3	24.9	19.2	23.9	20.8	28.9	28.1	42.1	28.5	33.4	37.4	26.2	22.0	38.9	51.7	29.2	68.1	46.7	25.0	44.6	32.5	33.2	35.7	20.4	15.9	23.8	15.8	43.8	26.3	61.1	31.7	42.3	39.4	66.7	32.1	25.4	84.6	57.8	49.2	19.5	25.7	56.1	69.6	37.4	17.6	52.6	30.6	16.4	16.6	34.0	53.2	40.4	50.0	36.8	29.7	53.0	20.2	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055323			Supported	Mitochondria		18000	18000	Mitochondria	Mitochondria	"HPA055323: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	12.6	21.8	37.2	42.7	21.1	19.8	17.1	16.1	15.3	15.1	13.3	27.3	34.8	24.7	15.3	23.1	22.4	24.7	19.1	16.5	12.2	18.0	20.7	25.6	25.4	18.4	28.5	20.4	21.3	19.3	18.5	16.4	21.0	30.7	33.6	31.5	24.4	12.7	25.1	40.7	44.2	17.3	26.5	27.7	38.3	27.5	23.3	24.2	25.5	73.5	14.5	46.4	35.0	18.3	18.1	24.9	25.9	26.5	20.4	26.1	28.3	24.9	30.9	56.0	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159819	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 105.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		14000	14000	Mitochondria	Mitochondria	"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	15.4	20.0	35.9	9.5	40.5	7.3	16.5	18.8	36.8	14.2	23.4	12.4	19.6	19.4	12.6	26.9	17.0	18.9	16.9	105.4	32.3	27.5	29.0	23.6	10.9	11.2	31.3	30.3	11.3	16.8	21.8	15.3	14.1	22.4	17.9	26.6	14.6	25.1	19.7	68.3	11.1	17.4	22.0	19.1	10.9	18.0	25.1	16.8	10.0	18.5	30.9	15.8	15.6	15.3	29.7	39.7	22.2	34.3	25.5	30.8	24.3	19.4	36.0	23.9	31.4	25.8	23.7	29.6	22.6	26.9	31.1	26.2	45.6	19.4	28.4	22.4	26.4	48.9	45.2	48.9	30.6	27.8	31.3	22.4	60.4	39.3	27.8	39.5	23.1	25.9	47.9	31.1	20.0	44.6	34.1	21.4	35.4	49.4	24.5	25.7	21.8	69.3	19.6	37.7	41.4	44.7	27.0	41.4	16.3	35.6	42.3	28.1	44.8	19.1	28.9	17.3	17.4	32.4	25.3	24.2	39.0	28.1	36.0	25.6	28.5	5.1	29.4	22.2	29.1	34.3	27.8	29.7	27.0	28.4	38.1	29.3	29.0	30.5	4.8	25.5	28.8	39.7	30.8	24.3	35.9	40.5	18.8	36.8	32.3	27.5	31.3	30.3	22.4	16.8
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054364	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA054364: AB_2682463"	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	27.7	20.5	25.7	22.9	18.3	19.9	35.8	21.4	15.9	21.6	17.8	17.8	22.6	46.0	35.2	15.4	23.0	44.7	25.4	17.1	26.0	51.6	24.7	36.8	87.3	19.2	45.7	20.5	18.4	35.4	15.9	17.2	27.4	51.6	23.4	23.3	42.0	35.4	69.6	66.8	47.7	48.7	28.9	62.5	19.8	25.0	35.4	27.6	23.9	43.9	40.0	35.4	38.3	21.5	19.8	20.9	19.2	29.3	29.9	43.4	51.5	22.2	37.1	22.4	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell line enhanced"	"Detected in many"		"AF22: 92.4;HUVEC TERT2: 46.7;LHCN-M2: 74.6;RH-30: 76.4;WM-115: 36.0"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.4	19.7	0.2	5.0	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.4	4.3	0.0	0.8	0.0	46.7	0.6	0.0	74.6	0.6	0.0	0.0	15.0	12.8	0.1	76.4	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.1	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.8;skeletal muscle: 198.5"	"Cell line enhanced"	"Detected in many"		"BJ: 42.9;LHCN-M2: 39.4;RH-30: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011185, HPA011904"	Approved		Supported	"Actin filaments"		12000000	12000000	"Actin filaments"	"Actin filaments"	"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	8.9	4.3	0.4	10.4	0.8	0.0	5.0	0.5	0.4	14.1	17.0	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4.0	1.2	6.2	3.8	0.6	0.5	8.2	2.0	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0.0	5.1	40.1	1.0	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7.0	7.0	0.4	1.2	0.0	23.2	22.5	3.5	42.9	19.0	8.7	5.9	1.2	0.0	0.0	2.4	15.5	0.9	0.9	4.0	15.7	0.2	0.9	1.7	2.2	0.4	17.4	0.3	0.0	16.8	0.9	12.1	6.8	6.6	0.0	0.0	39.4	0.0	8.0	0.5	6.8	5.2	6.7	31.2	0.0	10.2	0.3	0.0	0.3	3.7	0.0	0.2	0.0	0.9	6.7	21.0	15.4	8.9	21.3	0.0	0.0	0.0	1.1	0.8	0.0	0.0	3.4	0.0	0.4	2.0	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0.0	7.0	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 97.3;skeletal muscle: 144.4"	"Cell line enhanced"	"Detected in all"		"A-431: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	14.5	19.3	18.4	8.4	22.9	8.6	16.6	11.8	24.5	12.6	14.6	8.9	11.8	8.1	11.0	11.1	12.9	13.4	8.0	97.3	18.7	15.9	16.6	5.2	13.2	16.6	17.0	16.7	9.5	13.5	11.8	8.6	8.0	17.2	14.3	14.2	6.8	18.9	15.5	144.4	6.3	8.3	21.6	19.3	6.5	11.6	5.8	12.1	7.4	22.6	39.8	7.2	12.4	7.8	14.3	34.1	14.1	33.1	15.2	14.1	24.7	78.8	14.0	18.5	30.7	10.7	18.7	9.1	6.6	15.7	19.2	14.9	9.7	17.5	11.6	11.2	12.4	10.5	13.9	14.0	19.1	7.3	20.5	8.2	8.4	12.3	15.4	17.7	8.3	17.0	21.6	6.5	17.9	20.2	14.5	11.4	14.9	3.5	17.6	18.4	18.1	14.2	17.9	8.6	23.7	25.9	12.5	19.8	22.3	15.1	18.3	20.6	35.4	19.2	11.8	8.8	13.3	3.1	13.7	9.4	7.9	21.4	9.7	11.2	25.9	13.4	33.1	14.1	8.7	31.8	10.6	14.3	11.7	9.3	34.1	12.3	14.1	10.1	5.8	15.2	23.9	14.1	13.6	24.7	18.4	22.9	11.8	24.5	18.7	15.9	17.0	16.7	17.2	12.1
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764157-104777457	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 28.6;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in some"		"REH: 7.5;THP-1: 5.2;U-266/70: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5"					"Low region specificity"	"Detected in all"			HPA042491	Uncertain									"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	14.4	8.4	6.1	2.1	11.3	1.2	10.1	3.7	7.8	4.0	1.7	1.5	4.2	1.5	5.0	4.5	3.1	3.5	3.0	28.6	4.4	6.8	2.3	1.3	2.1	2.2	4.4	7.7	5.4	4.7	2.5	8.0	5.1	5.0	5.1	1.7	3.8	2.2	5.9	34.6	1.7	1.9	3.2	3.4	2.5	1.9	2.0	2.8	0.4	3.1	14.1	2.8	2.2	2.5	3.5	1.7	6.5	0.5	0.8	0.6	0.5	0.0	0.3	0.5	0.2	1.9	1.7	1.3	0.4	0.9	1.3	0.6	0.3	0.8	0.8	0.3	0.8	0.0	0.5	0.5	0.5	0.0	0.6	3.4	1.9	0.2	1.6	0.6	0.8	1.4	0.7	0.5	0.1	0.5	3.1	0.2	0.2	0.4	1.5	3.1	0.7	0.5	7.5	0.0	0.2	0.5	0.4	1.2	3.9	4.6	0.0	0.4	3.6	5.2	0.3	0.6	1.6	0.7	0.1	5.7	2.2	0.1	0.0	0.2	0.1	6.5	0.1	2.4	0.2	0.1	0.0	3.5	0.4	0.0	1.7	2.0	0.6	0.3	0.0	0.8	0.5	1.2	0.0	0.5	6.1	11.3	3.7	7.8	4.4	6.8	4.4	7.7	5.0	2.8
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23702451-23706598	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.4;heart muscle: 2.7;lymphoid tissue: 3.0;salivary gland: 4.3"	"Group enriched"	"Detected in some"	8	"hTEC/SVTERT24-B: 8.9;LHCN-M2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;breast: 1.9;heart muscle: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA056989	Uncertain									"HPA056989: AB_2683301"	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.0			0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.9	0.0		0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.1	0.0	0.7	0.3	1.7	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.7	0.7	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	1.7	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.0	0.7	0.3	0.3	0.8	0.4	0.1	0.3	0.1	0.0										
NRTN	NTN	ENSG00000171119	Neurturin	Q99748	19	5823802-5828324	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.3;pancreas: 12.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;K-562: 6.9;REH: 18.2;SH-SY5Y: 9.8;U-266/70: 10.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065260			Approved	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"HPA065260: AB_2685448"	"unprognostic (4.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.96e-2)"	"prognostic favourable (3.86e-4)"	"unprognostic (1.60e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (8.21e-3)"	"unprognostic (5.60e-3)"	"prognostic favourable (9.92e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.32e-2)"	0.0	3.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	4.9			1.5	0.3	0.6	2.1	0.4	0.5	15.3	0.0	0.0	1.8	7.6	0.0	0.0	0.0		0.0	12.3	0.6	0.3	0.0		1.3	0.0		6.8	1.2	0.0	3.0	1.5	0.9	0.0	0.0	5.0	0.3			0.0		0.0	1.8	1.3	0.7	1.9	0.0	0.1	0.0	1.7	0.3	0.5	0.7	0.8	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	0.1	2.9	0.0	0.0	7.1	5.1	0.0	0.0	2.3	0.9	0.1	1.9	0.1	0.7	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.6	0.7	2.4	1.8	18.2	2.4	4.2	0.3	0.0	0.5	9.8	0.1	0.9	1.0	0.3	0.6	0.0	0.0	1.5	0.0	0.0	10.4	2.2	0.5	0.0	1.2	0.7	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.1	0.4	0.7	0.3	0.3	0.0	0.0	0.0	1.9	1.7	0.3										
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: "	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.1	9.2	10.3	34.3	14.2	11.6	16.4	13.1	9.4	7.0	47.4	14.7	8.2	3.6	13.1	7.4	25.8	8.3	14.5	12.6	5.4	30.9	4.4	24.1	33.1	16.1	7.5	30.8	27.8	9.7	21.8	53.6	31.4	11.6	10.8	6.0	14.9	15.4	14.5	12.1	12.6	8.2	8.9	11.4	42.7	7.4	9.6	13.3	26.2	36.9	19.0	21.0	20.3	8.1	4.7	12.1	10.4	6.5	8.1	12.2	4.2	12.7	24.7	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3
OR5C1	"hRPK-465_F_21, OR5C2P, OR9-F"	ENSG00000148215	"Olfactory receptor family 5 subfamily C member 1"	Q8NGR4	9	122788933-122789895	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 6.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (2.73e-1)"				1.0	0.2	0.3	0.2	1.3	0.2	2.8	0.4	0.8	0.5	0.2	0.3	0.0	0.2	0.2	0.4	0.2	0.5	0.6	6.1	1.2	0.2	0.8	0.5	0.3	0.5	0.1	0.4	0.4	0.3	0.2	0.4	1.0	0.1	1.0	0.2	0.0	1.5	0.2	2.4	0.8	0.3	0.2	0.9	0.6	0.2	1.0	0.1	0.0	1.2	0.7	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.7	1.2	0.2	0.1	0.4	0.1	0.1
OR6C68		ENSG00000205327	"Olfactory receptor family 6 subfamily C member 68"	A6NDL8	12	55492378-55493316	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"heart muscle: 3.2"	"Cell line enriched"	"Detected in single"	10	"U-266/70: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
OR6C70		ENSG00000184954	"Olfactory receptor family 6 subfamily C member 70"	A6NIJ9	12	55469200-55470138	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"heart muscle: 1.6"	"Cell line enriched"	"Detected in single"	8	"Karpas-707: 7.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.8;U-2 OS: 2.5;U-87 MG: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA040364: , HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 56.1;SiHa: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	1000000	1000000	Mitochondria	Mitochondria	"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favourable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.8	0.3	6.5	7.7	20.1	10.8	0.0	14.1	8.9	11.7	7.1	1.2	5.4	20.4	3.5	10.7	4.6	17.8	12.7	13.8	17.4	2.0	14.3	56.1	2.6	8.8	27.7	4.8	10.1	3.4	11.5	19.4	10.7	2.9	26.3	13.4	1.0	23.1	1.3	1.4	5.6	18.4	18.2	15.4	9.5	0.6	6.5	6.7	72.9	0.0	8.6	0.1	6.0	6.4	9.3	12.2	15.9	11.3	4.3	3.6	0.8	14.1	20.4	7.1	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3
P2RX3	P2X3	ENSG00000109991	"Purinergic receptor P2X 3"	P56373	11	57338374-57370600	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 7.9;testis: 16.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;hTEC/SVTERT24-B: 1.4;NTERA-2: 1.2;U-87 MG: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057776	Uncertain									"HPA057776: AB_2683526"	"unprognostic (5.44e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-3)"		"unprognostic (2.24e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-7)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.29e-1)"	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.6	7.9	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.4	0.4	0.0	2.3	0.0	0.0	1.8	0.0	0.7	0.0	0.4	0.0	1.2	16.3	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.2	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.0
PALM2-AKAP2		ENSG00000157654	"PALM2-AKAP2 readthrough"		9	109780309-110172512	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.0;heart muscle: 26.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.4;hTEC/SVTERT24-B: 14.8;RH-30: 29.1;U-251 MG: 13.0;WM-115: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	41.0	2.8	1.6	3.3	1.6	0.1	19.6	0.7	4.7	4.8	2.3	1.5	2.1	1.1	15.2	4.7	2.1	2.5	5.0	26.8	1.8	2.4	2.4	24.8	9.7	1.2	1.9	0.5	5.9	1.1	1.6	1.1	9.2	3.0	3.2	0.6	1.1	2.0	3.6	4.5	1.8	1.0	7.8	1.4	0.5	1.1	1.4	0.9	0.0	3.8	2.5	0.3	5.2	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.3	0.0	15.4	5.5	1.3	5.4	5.3	1.6	3.6	0.0	0.1	0.0	0.5	5.6	2.0	0.0	1.2	4.5	0.2	1.6	0.0	5.0	0.1	0.1	0.0	0.0	7.0	0.1	14.8	2.4	0.1	0.0	0.0	5.7	0.0	0.0	0.0	4.3	1.4	0.0	29.1	0.0	4.0	0.0	1.7	0.0	2.1	0.2	7.4	0.6	0.0	0.1	3.4	8.5	0.3	13.0	0.0	0.2	0.0	4.2	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.6	1.6	0.7	3.0	1.8	2.4	1.9	0.5	3.0	0.9
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 76.6;fHDF/TERT166: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	59000000	59000000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.9	2.2	27.6	12.2	76.6	45.9	11.0	42.6	63.8	12.6	38.5	7.3	19.9	0.0	9.2	98.2	5.1	1.5	18.7	34.9	1.8	6.2	3.1	9.0	2.3	11.6	0.9	3.4	25.1	8.1	9.2	7.0	26.0	0.1	2.1	35.7	3.0	0.0	0.4	4.9	8.3	1.1	15.4	8.3	48.7	1.7	13.1	9.0	18.1	1.1	11.1	4.7	1.0	20.0	40.1	10.4	18.8	12.6	4.7	1.1	0.0	46.0	4.2	34.5	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6
PAQR9	FLJ41938	ENSG00000188582	"Progestin and adipoQ receptor family member 9"	Q6ZVX9	3	142949164-142963682	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"A549: 5.3;AF22: 3.3;HEL: 3.6;NTERA-2: 4.0;U-266/70: 9.9;U-266/84: 5.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052798	Uncertain									"HPA052798: AB_2681955"		"unprognostic (4.13e-2)"		"unprognostic (2.54e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.12e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.91e-2)"	0.4	0.6	2.5	0.3	7.0	7.0	0.3	0.5	10.1	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.4	12.1	3.3	1.7	0.3	18.6	0.3	0.3	0.7	3.1	0.3	0.5	0.3	1.4	0.8	6.0	0.4	0.3	2.7	0.3	0.3	5.9	0.3	0.3	0.3	1.0	0.3	0.3	20.8	0.3	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.3	3.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.4	9.9	5.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.0	0.5	10.1	3.3	1.7	0.7	3.1	6.0	0.3
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;RPMI-8226: 13.2;U-2197: 28.4;U-266/70: 28.2;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavourable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.2	1.4	0.0	25.4	7.0	0.0	0.3	0.1	1.1	1.5	0.2	0.5	0.0	1.2	1.9	0.0	5.0	0.0	1.4	0.0	8.4	0.8	2.8	0.0	0.0	0.5	0.0	2.8	0.0	2.6	0.6	0.0	0.2	0.0	0.5	0.7	1.5	0.4	2.1	8.8	0.0	3.2	13.2	1.2	0.0	2.7	1.7	6.6	0.0	2.4	0.0	1.7	0.0	2.2	5.1	28.4	2.1	28.2	13.0	0.0	6.3	0.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;HEL: 14.2;HeLa: 38.7;HUVEC TERT2: 6.9;SH-SY5Y: 14.5;U-138 MG: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Uncertain		Approved	"Plasma membrane"		23000	23000	"Plasma membrane"	"Plasma membrane"	"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.7	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.2	38.7	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 104.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056731	Approved									"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	7.8	0.3	2.0	104.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.3	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.0	0.5	0.1	0.5	0.0	0.6	1.6	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		2200000	2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"	"Nucleoplasm, Plasma membrane, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.6	25.7	10.0	3.9	22.1	15.2	3.9	21.2	17.6	12.2	9.8	23.7	19.3	3.4	21.7	21.2	9.0	13.6	19.8	20.4	6.1	5.7	12.7	16.8	8.9	31.9	4.1	11.4	20.4	17.5	29.1	22.7	27.3	5.4	3.8	25.8	8.5	4.2	1.4	3.4	10.8	2.0	7.4	3.1	13.6	27.8	5.0	6.7	11.5	26.5	5.9	3.1	1.3	34.2	31.8	5.0	13.7	12.8	2.6	3.4	3.5	17.3	3.0	7.4	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.0;hTEC/SVTERT24-B: 1.5;U-138 MG: 3.1;U-2197: 6.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	3.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306954-41510628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4;heart muscle: 36.6;ovary: 27.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;PC-3: 5.5;SH-SY5Y: 25.7;TIME: 13.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 33.4"	"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	7.0	15.3	6.9	1.2	4.5	0.8	4.5	33.4	6.5	4.5	1.4	2.0	1.4	1.3	1.6	1.7	1.4	2.5	3.4	36.6	4.8	8.1	7.3	2.2	2.0	7.9	4.2	4.2	27.6	4.8	1.3	13.7	0.8	9.0	1.9	1.5	0.5	1.2	2.0	0.9	0.9	1.7	2.1	5.8	0.9	5.9	1.1	2.1	0.0	1.4	0.0	1.0	1.4	6.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	25.7	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	6.9	4.5	33.4	5.5	4.8	8.1	4.2	4.2	9.0	2.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.7;ASC diff: 11.3;ASC TERT1: 8.7;SCLC-21H: 11.1;SH-SY5Y: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	10.7	11.3	8.7	2.2	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.3	4.3	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.4	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.1	2.5	0.0	0.0	0.0	0.0	2.4	0.0	11.1	8.5	0.0	0.1	0.0	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.8	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.1;Karpas-707: 23.6;U-698: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.1	0.7	2.8	4.9	4.2	5.5	1.1	3.4	6.3	11.6	13.7	5.6	0.5	27.1	3.8	2.2	0.2	8.2	2.6	4.6	20.9	3.4	4.8	2.1	5.0	3.3	6.6	2.6	3.6	1.3	7.1	6.2	1.9	7.2	23.6	3.3	3.1	8.7	3.6	1.7	1.1	5.0	4.6	10.3	4.0	0.9	2.2	1.9	2.1	0.2	2.5	11.2	1.8	0.3	4.0	2.1	1.3	2.0	7.4	6.8	22.7	4.4	5.4	6.7	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143076-150250357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;HBEC3-KT: 32.6;hTCEpi: 39.9;hTERT-HME1: 16.0;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.4	4.2	1.9	7.7	0.3	3.7	1.3	12.8	4.5	6.8	0.8	0.0	5.7	1.0	0.7	8.0	9.0	0.3	50.0	4.7	3.7	5.3	0.3	6.7	0.4	2.7	7.6	0.2	0.5	4.7	0.8	13.9	7.7	0.9	5.0	0.1	1.5	0.3	32.0	37.1	1.2	0.7	1.3	0.3	0.7	3.5	1.0	0.0	32.4	8.8	3.2	0.4	8.3	0.0	0.0	0.0	0.2	0.0	1.2	0.1	10.2	0.0	4.5	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.5	1.4	0.2	3.1	2.0	15.4	2.3	32.6	0.0	0.0	13.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	39.9	0.0	16.0	0.0	8.6	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	13.7	0.5	2.4	0.0	0.2	14.5	0.8	0.0	0.7	0.0	0.0	7.9	12.5	3.5	0.0	0.0	0.0	5.5	6.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.2	7.7	1.3	12.8	4.7	3.7	2.7	7.6	7.7	1.0
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5084581-5089487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 8.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.7;PC-3: 4.6;THP-1: 16.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;intermediate monocyte: 1.2;myeloid DC: 2.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain									"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	1.9	3.5	3.3	0.6	4.0	0.1	1.0	0.1	2.3	2.1	1.7			0.4	1.2	1.9	2.0	1.1	0.6	8.3	1.8	1.4	0.8	6.4	0.4	0.7	2.4		1.7	0.0	0.0	0.0	1.3		2.0	0.8		0.4	3.0	0.9	0.9	0.5	0.9	0.1	5.3	0.5	0.3			0.1		0.5	3.2	2.2	0.3	2.4	0.4	2.9	0.3	0.2	0.5	0.0	0.3	0.1	0.0	1.9	1.2	0.1	0.3	0.5	0.3	0.4	0.1	0.3	0.0	4.7	0.7	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.8	0.1	4.6	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.0	0.0	0.1	16.0	0.0	0.0	0.0	0.9	0.6	2.9	2.3	0.1	0.8	0.0	0.1	0.4	1.7	0.0	0.0	1.2	0.0	0.3	0.2	0.0	2.4	0.2	0.0	0.1	0.3	0.3	2.9	0.1	0.0	0.5										
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5;RPTEC TERT1: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Nuclear speckles"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.5	4.3	3.8	4.7	0.0	0.6	0.6	0.0	7.8	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	0.8	0.0	0.0	1.0	0.1	0.0	0.0	5.5	5.4	0.0	0.0	0.0	14.0	1.2	2.0	5.4	5.7	0.1	0.0	3.2	0.0	0.0	1.5	2.3	2.7	6.3	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556111-151877125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	12.8	5.5	15.3	8.7	28.8	6.3	9.7	31.1	19.2	8.8	11.5	7.5	9.4	16.7	10.4	10.9	10.8	8.6	12.0	77.2	15.1	13.5	15.4	18.5	8.6	7.7	12.3	14.3	6.8	6.2	6.7	5.1	20.0	18.3	17.5	13.5	7.8	11.9	14.8	21.5	6.9	17.8	32.8	8.5	12.8	13.8	9.7	9.5	2.3	12.6	5.2	7.1	22.4	12.4	7.9	7.8	18.4	6.0	3.1	6.1	3.5	18.2	5.3	3.6	4.2	16.4	14.0	6.4	8.4	7.6	9.1	8.9	3.4	23.4	0.0	13.9	11.2	5.9	2.2	9.8	14.8	4.4	2.5	4.9	0.6	0.4	24.4	3.6	4.7	6.8	21.0	9.1	9.7	15.6	1.6	2.3	27.5	6.9	1.9	2.6	3.7	15.5	1.8	2.6	3.8	17.3	4.4	16.1	2.5	4.9	9.2	3.7	2.9	4.9	20.8	2.1	1.8	1.0	5.3	1.6	1.9	0.0	25.9	11.3	20.4	18.4	6.0	10.5	5.1	5.4	3.7	7.9	4.5	4.5	4.3	3.8	4.2	6.1	13.6	3.1	5.4	7.8	2.4	3.5	15.3	28.8	31.1	19.2	15.1	13.5	12.3	14.3	18.3	9.5
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;heart muscle: 4.5"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;MCF7: 4.3;RPMI-8226: 3.6;SK-BR-3: 1.8;T-47d: 2.0;U-87 MG: 2.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	58	"hypothalamus: 13.4;pons and medulla: 22.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 5.1"	HPA014976	Approved				"Secreted - unknown location"					"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.8	0.0	4.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.1	0.0		1.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 103.8;HSkMC: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	4300000000	4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	103.8	0.0	0.2	50.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.1	13.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2
PTGES3L		ENSG00000267060	"Prostaglandin E synthase 3 like"		17	42968088-42980433	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 18.3;skeletal muscle: 61.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.7;RH-30: 8.5;THP-1: 22.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.2"	"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.80e-4)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.08e-2)"	0.5	0.2	0.7	0.8	4.2	1.1	0.5	0.3	1.2	1.3	5.1	0.2	0.0	0.6	3.5	2.2	2.2	1.1	3.3	18.3	0.5	0.7	0.2	0.1	0.4	0.5	0.6	0.7	0.6	0.2	0.2	0.4	0.2	0.3	1.8	1.5	1.5	1.0	2.2	61.3	0.5	1.2	10.0	0.2	0.3	1.7	0.6	0.1	0.4	0.4	13.6	0.6	4.7	1.3	0.7	8.9	1.3	0.3	0.6	0.3	0.8	0.7	0.6	1.9	3.5	0.1	0.3	1.6	1.2	0.8	1.1	0.6	1.5	0.7	0.6	0.5	0.5	1.4	1.4	1.3	1.7	0.4	0.6	5.1	2.9	3.0	0.1	0.8	8.7	0.7	1.0	2.3	1.6	0.3	1.8	1.5	3.3	0.9	3.1	2.0	2.1	0.5	1.3	8.5	0.6	2.0	1.4	1.7	5.8	1.6	3.2	2.5	1.7	22.2	0.7	1.8	1.7	0.6	1.2	3.9	2.5	0.9	0.3	0.9	0.7	1.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.7	0.3	0.3	1.2	0.6	0.2	8.9	0.2	0.8	0.7	4.2	0.3	1.2	0.5	0.7	0.6	0.7	0.3	0.1
QRFPR	GPR103	ENSG00000186867	"Pyroglutamylated RFamide peptide receptor"	Q96P65	4	121329312-121381059	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;heart muscle: 4.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 5.2;hTERT-HME1: 7.1;RPTEC TERT1: 4.5;SCLC-21H: 2.9;U-2 OS: 7.7;WM-115: 4.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA014300, HPA050236"	Approved									"HPA014300: AB_1849251, HPA050236: "	"unprognostic (1.24e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.93e-2)"		"unprognostic (3.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (3.09e-4)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"		1.6	1.2	0.7	0.3	1.9	0.0	0.5	0.1	2.0	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.8	0.1	1.1	4.6	1.3	6.9	3.2	0.2	0.1	0.0	0.8	0.8	0.4	0.0	1.0	0.8	0.2	4.9	0.6	0.1	3.3	0.0	2.3	0.1	0.0	0.4	0.2	2.6	0.0	1.3	0.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.1	2.0	1.3	6.9	0.8	0.8	4.9	0.0
RAB9B	RAB9L	ENSG00000123570	"RAB9B, member RAS oncogene family"	Q9NP90	X	103822322-103832228	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 6.0;RH-30: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061932	Approved				"Intracellular and membrane"					"HPA061932: AB_2684640"	"unprognostic (1.69e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.28e-5)"	"unprognostic (5.81e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.34e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.52e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.21e-4)"	"unprognostic (1.37e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	2.7	4.3	7.8	1.6	19.1	0.6	2.2	20.0	12.6	2.8	5.9	1.3	5.4	1.8	7.2	3.7	11.4	6.7	3.5	27.6	7.2	11.0	1.0	0.7	1.3	1.2	5.0	9.3	9.9	1.7	6.6	7.2	0.8	10.8	10.0	3.5	1.8	1.8	13.2	11.0	1.0	1.9	14.8	7.6	1.2	2.6	2.7	4.3	0.0	2.4	1.4	1.0	7.6	1.8	2.2	0.4	0.6	0.2	2.9	0.8	0.4	0.0	0.0	5.1	2.6	1.5	0.3	0.2	1.3	3.2	3.2	3.0	0.3	0.0	0.3	3.0	2.5	0.0	0.8	0.2	2.9	0.2	3.3	0.2	0.0	0.0	0.4	0.4	0.2	0.8	0.0	1.4	0.0	0.2	0.0	1.9	0.2	2.2	6.0	0.0	0.9	0.9	5.3	5.7	0.2	1.8	0.5	5.2	3.7	0.3	0.1	1.0	0.6	0.3	0.2	0.2	0.9	1.7	1.0	0.3	0.0	0.4	2.8	0.3	1.6	0.0	0.1	0.6	0.2	0.2	0.0	1.9	0.2	0.0	0.4	2.2	0.8	0.2	0.0	2.9	0.0	0.3	0.4	0.4	7.8	19.1	20.0	12.6	7.2	11.0	5.0	9.3	10.8	4.3
RABGAP1L	"FLJ38519, HHL, KIAA0471, TBC1D18"	ENSG00000152061	"RAB GTPase activating protein 1 like"	"B7ZAP0, Q5R372"	1	174159410-174995308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 89.4"	"Cell line enhanced"	"Detected in all"		"Daudi: 45.9;Karpas-707: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054695	Uncertain									"HPA054695: AB_2682577"	"unprognostic (2.57e-2)"	"unprognostic (7.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (6.96e-3)"	"unprognostic (8.55e-2)"	"prognostic favourable (1.16e-4)"	"unprognostic (2.66e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.14e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-1)"	9.9	5.4	27.2	19.9	22.7	16.2	9.5	31.4	34.1	9.6	11.8	9.5	8.9	12.8	9.0	10.4	11.2	11.5	13.1	89.4	21.2	14.5	10.2	9.6	15.3	22.2	13.7	26.1	18.0	13.4	10.8	25.1	22.2	19.0	7.5	12.8	15.0	13.3	6.8	6.0	10.0	16.3	8.2	28.0	15.8	13.3	16.9	10.7	9.6	7.4	5.4	27.9	15.1	8.8	10.7	16.0	31.0	48.9	22.6	12.1	9.3	5.2	2.7	2.2	2.3	5.9	8.6	4.7	6.2	5.5	2.7	3.7	2.6	19.2	45.9	4.4	4.8	6.8	1.8	4.2	3.9	12.7	3.0	11.4	3.9	4.1	3.6	5.1	4.7	6.7	2.9	2.1	3.0	6.1	6.7	30.4	4.4	1.9	3.9	4.8	12.9	1.7	13.8	4.2	15.3	5.3	24.0	6.2	3.7	5.9	10.0	4.0	4.9	6.1	8.4	3.7	3.4	3.9	3.6	26.5	8.6	28.7	3.9	3.4	2.7	4.4	15.0	31.0	8.1	24.3	7.1	10.7	10.0	9.8	11.8	7.9	5.0	7.5	26.5	22.6	48.9	16.0	12.1	9.3	27.2	22.7	31.4	34.1	21.2	14.5	13.7	26.1	19.0	10.7
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	"Golgi apparatus"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.4	0.8	0.0	0.1	0.5	1.5	0.0	0.2	0.7	0.1	0.1	0.1	158.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	17.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	2.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644397-110839469	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.9;skeletal muscle: 20.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 4.6"	"Low region specificity"	"Detected in many"			"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"				"Golgi apparatus"	"Golgi apparatus"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0.0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1.0	0.5	4.3	6.3	0.7	20.9	0.7	1.0	2.1	0.6	0.1	0.6	0.9	1.4	0.0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	5.7	4.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.4	1.3	0.0	15.5	0.0	0.0	0.0	0.1	14.3	0.1	0.0	0.6	8.7	0.0	0.0	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	5.9	0.0	0.0	0.0	0.0	9.0	3.3	6.1	6.5	0.0	0.5	0.0	2.8	6.4	0.0	5.6	0.2	11.1	0.0	0.2	0.0	0.5	3.0	0.2	0.0	0.5	3.2	0.0	1.2	0.2	0.7	0.0	0.0	28.6	1.3	0.0	0.0	2.0	0.7	0.0	29.5	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	13.8	0.2	0.0	2.1	4.9	0.0	7.7	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739892-64775587	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;AN3-CA: 22.7;HAP1: 11.7;HEL: 34.2;NTERA-2: 31.4;U-2 OS: 12.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 37.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 3.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	6.9	1.1	0.7	5.8	0.9	0.5	8.3	0.6	1.2	7.0	32.2	1.2	11.5	2.2	13.5	5.7	17.4	7.2	20.5	75.1	1.5	0.6	9.5	3.8	1.7	0.3	1.1	1.1	6.0	1.1	5.5	1.0	2.8	2.1	19.8	3.1	5.9	1.8	17.9	2.4	1.2	7.3	69.6	1.0	1.1	14.7	3.2	0.5	0.2	3.5	2.2	0.3	51.6	12.8	3.0	0.0	0.0	0.0	0.7	0.4	1.8	0.0	2.5	16.1	22.7	0.0	0.0	2.4	0.5	0.0	2.9	0.6	1.9	0.2	0.0	2.2	0.4	0.0	11.7	0.0	1.1	0.0	3.7	34.2	3.8	3.8	1.6	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.2	1.1	0.0	0.1	31.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.6	3.4	0.0	0.6	3.2	0.1	0.0	0.0	12.1	1.6	1.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	3.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.8	0.7	0.9	0.6	1.2	1.5	0.6	1.1	1.1	2.1	0.5
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 24.7;HDLM-2: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdTCR: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favourable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	5.9	0.4	0.0	0.0	0.0	0.0	0.3	24.7	0.0	0.0	0.0	0.1	49.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.1	5.5	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617058	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.0;skeletal muscle: 78.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HSkMC: 18.1;MOLT-4: 11.9;RPTEC TERT1: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	9.8	2.0	8.5	3.7	11.2	1.1	8.7	9.6	19.6	7.4	12.4	14.9	0.3	6.5	2.3	5.4	2.0	4.1	7.1	45.0	11.2	9.4	30.3	21.8	4.9	3.1	13.2	11.4	1.7	19.0	17.7	8.0	6.7	18.5	5.9	16.9	1.5	3.9	3.0	78.5	5.6	12.8	1.5	16.8	1.6	6.1	5.7	15.4	14.1	3.6	12.5	2.3	2.0	4.4	0.9	0.1	4.0	0.4	0.1	4.4	0.6	0.8	0.3	0.1	2.1	16.4	2.0	9.6	0.1	2.1	1.9	2.6	1.4	0.1	0.2	1.5	0.0	2.4	4.8	0.5	0.6	2.4	2.2	0.0	7.2	0.0	0.1	3.1	0.0	18.1	7.4	0.3	2.0	0.0	0.0	0.1	0.7	0.6	11.9	0.0	0.5	0.3	1.9	0.0	0.7	16.6	0.5	10.9	1.3	0.6	0.7	7.8	3.6	1.4	0.0	1.5	0.2	4.0	1.8	0.4	0.0	0.0	9.3	10.8	3.9	4.0	0.4	0.1	0.6	0.0	1.6	0.0	1.5	0.8	0.1	0.9	4.4	2.7	2.3	0.1	0.1	0.0	1.9	0.6	8.5	11.2	9.6	14.4	11.2	9.4	13.2	11.4	18.5	15.4
RNF207	"C1orf188, FLJ32096, FLJ46380"	ENSG00000158286	"Ring finger protein 207"	Q6ZRF8	1	6205475-6221299	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;HaCaT: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028378, HPA042535"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA028378: AB_10601157, HPA042535: AB_2678042"	"unprognostic (5.53e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	1.6	2.1	0.6	6.6	1.5	0.3	1.9	5.6	1.8	5.7	5.8	0.9	13.3	2.8	3.6	3.8	4.4	4.7	6.6	24.2	0.7	2.1	5.9	4.3	2.0	2.2	0.7	0.2	3.3	5.3	3.3	4.0	9.2	0.9	7.7	2.4	10.6	6.1	16.6	2.5	1.1	8.2	7.6	1.2	1.9	3.5	1.2	0.6	1.4	6.4	2.8	8.7	5.0	5.0	0.0	0.0	0.0	2.7	0.0	0.3	0.1	2.3	4.4	0.4	3.2	0.2	0.4	2.9	1.5	1.1	0.3	0.4	2.2	17.5	0.3	1.2	1.2	7.5	0.4	1.0	0.1	2.4	1.8	0.1	5.4	2.3	1.5	1.8	0.1	1.3	0.3	0.0	0.0	0.1	0.6	3.9	0.1	1.7	0.2	0.2	0.2	4.0	0.0	0.8	3.1	2.5	3.9	0.5	1.2	2.4	1.6	1.1	2.8	0.1	0.5	0.0	0.7	0.5	0.0	3.7	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.2	0.1	0.6	1.5	5.6	1.8	0.7	2.1	0.7	0.2	0.9	0.6
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.6;Karpas-707: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049136	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	1.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	1.4	0.0	0.1	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.8	0.0	148.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	36.7	2.1	0.0	0.0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.4	0.5	2.3	0.1	0.1	1.4	0.9	0.0	0.1	0.0	7.6	4.1	1.3	1.4	0.0	2.1	0.2	0.2	0.0	1.0	1.2	0.8	1.7	2.6	0.0	0.5	0.9	0.2	0.3	0.2	0.2	0.0	0.8	5.6	0.1	1.2	1.6	1.9	1.3	4.9	0.7	0.7	1.7	0.3	0.8	3.3	1.0	1.0	2.7	1.2	1.4	1.1	1.1	1.1	2.8	1.6	0.8	2.5	1.1	1.1	1.6	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1.0	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		780000	780000	Mitochondria	Mitochondria	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavourable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.4	29.9	12.3	20.1	21.2	15.9	33.4	14.2	18.1	24.5	25.0	32.4	25.1	22.8	45.0	16.2	23.9	21.7	29.0	14.5	48.6	19.9	11.6	82.6	42.0	13.1	14.4	15.1	15.8	18.7	18.3	9.7	26.5	18.6	19.0	11.5	28.2	19.1	39.0	4.2	37.9	24.7	17.9	44.2	52.2	24.5	13.6	7.8	67.0	43.3	17.6	26.3	18.3	19.2	18.2	17.9	10.8	11.7	20.2	8.6	16.8	17.6	20.9	11.5	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909193-123028605	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;heart muscle: 11.7"	"Cell line enhanced"	"Detected in some"		"AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.5	1.2	12.0	0.7	12.3	0.3	1.1	0.8	13.6	2.1	1.5	4.3	0.4	1.9	2.8	5.5	1.5	3.0	4.7	11.7	13.0	3.3	6.1	1.4	2.2	1.1	2.5	3.3	1.3	3.1	1.1	2.5	5.0	2.0	1.8	1.8	6.0	0.9	3.1	1.6	1.2	1.3	3.8	1.7	0.5	0.7	1.1	5.7	0.1	2.2	2.5	1.3	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	41.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	11.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.0	12.3	0.8	13.2	13.0	3.3	2.5	3.3	2.0	5.7
SGCD	"CMD1L, DAGD, LGMD2F"	ENSG00000170624	"Sarcoglycan delta"	Q92629	5	155870344-156767788	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 32.6"	"Cell line enhanced"	"Detected in some"		"BJ: 12.4;fHDF/TERT166: 19.8;RH-30: 15.3;SK-MEL-30: 19.8;U-138 MG: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.5;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.1"	"Low region specificity"	"Detected in many"																		"unprognostic (2.23e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.37e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.66e-3)"	4.7	5.0	3.5	2.0	4.2	0.1	2.9	1.3	3.1	9.0	7.8	10.8	3.2	1.6	19.8	4.9	7.9	3.8	8.6	32.6	4.5	2.3	1.2	1.9	5.2	0.5	9.2	3.4	10.4	1.0	6.3	1.9	0.6	8.1	7.1	3.5	12.2	2.4	4.9	28.5	2.0	3.9	12.3	10.8	1.4	3.8	1.5	8.2	0.0	16.1	13.9	0.9	7.4	4.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	6.1	0.0	0.0	4.3	7.5	0.0	12.4	4.1	0.0	0.1	0.0	0.0	0.0	0.0	19.8	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.4	0.5	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	19.8	0.0	0.0	0.0	19.7	0.0	3.4	0.0	0.0	0.0	0.0	3.1	0.0	7.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	3.5	4.2	1.3	3.1	4.5	2.3	9.2	3.4	8.1	8.2
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596067-59789855	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.5"	HPA005911	Approved		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favourable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	10.0	2.2	9.2	4.3	4.5	9.2	6.4	8.3	5.4	4.8	1.1	1.1	2.2	8.6	2.7	12.3	4.4	8.9	34.7	2.0	1.9	16.4	5.7	9.4	12.1	3.2	3.3	4.7	13.7	2.2	9.5	2.1	5.5	3.8	3.7	2.7	6.2	2.6	4.2	9.4	4.6	10.5	3.7	16.8	12.8	6.2	2.3	12.8	4.0	8.6	9.4	9.7	8.5	5.8	2.8	0.3	9.1	3.0	7.2	2.4	0.1	2.3	0.5	0.3	10.5	16.0	0.1	9.7	6.3	3.4	3.0	0.2	5.8	5.0	2.3	16.4	0.5	0.6	1.2	5.1	1.3	0.3	9.0	10.2	0.3	5.5	14.7	0.1	8.3	3.1	0.9	9.6	1.2	0.1	11.0	5.4	2.0	4.2	2.2	0.6	3.0	0.3	0.0	2.4	7.4	14.1	2.5	0.6	0.0	0.2	4.6	0.3	1.8	0.0	8.0	2.7	14.5	0.3	10.6	0.1	8.4	9.1	0.0	1.3	0.3	2.0	0.0	5.4	3.7	7.2	2.4	4.3	4.8	2.1	5.8	4.9	6.9	0.2	3.0	9.1	2.8	4.8	2.4	2.2	4.3	6.4	8.3	2.0	1.9	3.2	3.3	5.5	2.3
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		5500000	5500000	Mitochondria	Mitochondria	"HPA045709: "	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	75.6	59.1	78.4	64.9	71.4	118.8	101.1	66.4	88.5	86.1	72.0	106.1	39.8	103.4	39.5	80.4	65.2	79.5	89.7	90.8	38.9	63.4	61.6	43.6	70.3	88.0	72.1	49.0	112.3	80.3	62.5	90.0	121.5	66.4	30.7	102.6	56.4	66.9	80.5	72.6	97.1	76.5	81.7	114.7	111.3	76.0	40.3	54.0	79.5	71.5	109.6	96.6	78.9	81.6	48.0	45.3	52.6	66.4	52.0	61.1	72.3	37.8	42.6	61.7	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 38.0;skeletal muscle: 43.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045260: "	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	7.7	6.3	6.2	4.7	5.7	5.3	7.1	3.6	6.3	6.5	4.2	2.1	9.7	2.5	7.7	7.2	5.3	3.9	4.5	38.0	5.8	3.8	24.6	19.5	5.9	9.3	5.4	4.3	10.8	7.5	2.4	5.7	3.4	8.1	8.0	3.5	9.5	6.8	9.1	43.1	4.4	3.5	9.4	7.6	6.1	4.0	5.0	4.9	1.2	6.5	6.7	4.4	6.6	9.0	1.6	5.3	4.3	3.4	1.7	2.7	1.1	2.2	5.0	3.0	12.9	15.1	9.7	1.0	10.8	6.3	9.3	5.6	5.2	6.2	0.0	9.5	11.0	4.4	6.9	10.8	11.1	7.4	5.6	8.5	3.2	13.9	8.9	12.1	11.5	6.3	7.4	13.7	10.2	16.1	5.1	0.0	18.8	2.7	4.4	8.4	4.4	6.4	11.1	5.0	4.5	20.2	1.9	0.6	3.0	6.0	9.2	8.6	7.2	16.4	5.9	8.7	5.0	9.7	7.4	2.2	4.5	0.1	9.5	11.5	13.3	0.0	2.8	4.3	2.2	3.4	1.5	1.6	2.2	2.2	4.0	1.5	2.7	1.2	0.0	1.7	1.5	5.3	0.8	1.1	6.2	5.7	3.6	6.3	5.8	3.8	5.4	4.3	8.1	4.9
SLC26A10		ENSG00000135502	"Solute carrier family 26 member 10"	Q8NG04	12	57619527-57626151	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.4;NTERA-2: 5.5;RH-30: 4.3;SH-SY5Y: 7.8;U-266/70: 5.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044719	Uncertain									"HPA044719: AB_10962362"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-5)"	"unprognostic (3.22e-3)"	"unprognostic (2.65e-12)"	"unprognostic (1.28e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.40e-1)"	2.0	0.7	0.4	0.5	0.9	0.0	0.4	3.8	0.9	0.4	0.8	0.4	0.4	0.0	2.9	1.2	0.4	1.9	1.8	8.5	0.4	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.9	0.4	0.0	0.4	0.4	0.4	2.1	0.5	0.4	0.8	1.6	2.6	0.1	1.1	1.9	0.4	0.7	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.0	0.0	0.0	0.5	1.1	0.2	0.7	0.3	0.1	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.2	0.0	3.4	0.4	0.2	0.7	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.0	0.0	2.2	7.8	0.0	0.0	0.5	0.1	0.6	0.0	0.6	1.3	0.6	0.0	5.3	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	3.8	0.9	0.4	0.2	0.4	0.4	0.4	0.4
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced									"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.6	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.4	0.0	0.2	0.7	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.7	9.5	6.0	9.6	7.5	7.4	8.1	11.0	10.9	11.3	9.9	4.7	6.1	15.5	7.0	10.1	11.2	5.9	8.1	3.9	28.4	8.8	3.8	9.4	0.7	7.2	0.0	10.9	9.4	6.8	12.8	9.2	6.9	6.9	6.5	9.0	6.6	6.9	1.1	7.2	4.3	8.2	18.1	3.7	2.6	13.4	5.0	6.4	8.5	7.6	6.9	5.4	4.0	8.6	13.4	8.7	12.2	11.4	21.7	14.4	5.1	10.4	4.9	8.3	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.8	0.3	2.5	7.1	0.4	0.5	4.9	4.3	4.5	5.8	4.1	5.0	4.0	0.0	1.7	1.6	4.0	1.2	7.7	1.7	0.0	1.1	0.0	0.0	0.1	1.2	0.1	0.4	3.4	7.4	0.0	2.3	0.0	0.2	0.0	1.7	2.3	0.0	0.0	4.0	5.8	0.0	0.0	0.0	4.0	1.6	1.5	7.0	2.7	7.5	3.7	0.7	1.8	0.0	3.6	6.3	0.0	3.4	0.0	0.0	0.0	3.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell line enhanced"	"Detected in many"		"BJ: 15.1;fHDF/TERT166: 36.6;hTERT-HME1: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"			"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.1	1.1	0.1	1.7	3.5	0.0	15.1	5.8	5.0	3.3	0.0	2.5	0.0	1.2	36.6	0.6	0.2	2.5	5.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.7	10.7	0.4	0.0	0.2	6.4	0.0	0.4	0.0	0.7	2.1	4.0	7.9	0.0	1.7	0.2	1.7	0.3	0.0	0.0	0.0	0.0	0.3	5.1	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SMIM10L2B	"LINC00087, NCRNA00087, RP11-85L21.2"	ENSG00000196972	"Small integral membrane protein 10 like 2B"	P0DMW5	X	135094987-135098634	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;heart muscle: 9.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;HHSteC: 4.4;HSkMC: 6.9;NTERA-2: 3.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.60e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.25e-3)"	"unprognostic (9.55e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (2.41e-5)"	"unprognostic (2.03e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.98e-2)"	1.0	3.6	4.9	0.2	8.6	0.0	1.0	2.8	17.5	1.8	0.4	1.3	0.0	0.2	2.2	2.2	0.9	2.7	0.6	9.5	6.6		2.9	0.5	1.2	0.1	0.0	7.5	5.0	0.7	5.0	0.0	0.1	12.3	3.4	0.2	1.3	3.0	2.3	0.6	1.5	0.1	1.3	1.6	0.6	0.5	3.6	0.9	0.0	1.5	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.0	2.7	4.2	0.6	1.4	0.9	0.5	0.4	0.7	1.3	0.0	0.0	0.5	0.5	0.3	1.0	1.0	0.1	0.0	0.9	0.1	0.2	0.1	4.4	0.0	0.2	6.9	0.4	0.1	0.3	0.3	0.1	0.0	0.3	0.1	0.8	0.1	3.7	0.4	0.0	0.8	0.1	1.7	0.5	1.4	0.4	0.6	0.3	0.0	0.0	0.5	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favourable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	22.7	8.0	9.3	23.6	11.0	5.7	19.1	10.3	4.8	11.9	10.4	9.7	6.1	9.8	4.7	4.3	12.0	3.0	8.3	4.8	6.5	24.2	9.2	22.8	19.6	16.7	11.0	12.9	12.3	5.1	10.0	7.3	10.8	12.2	14.7	8.0	9.9	10.1	15.3	15.9	17.0	7.0	9.0	19.4	6.6	10.0	10.1	12.8	20.2	6.7	19.5	6.9	9.2	9.5	6.6	21.7	31.1	20.9	17.2	18.7	21.5	36.2	20.5	9.0	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"				Cytosol	Cytosol	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.1	7.0	9.5	6.7	9.9	17.2	40.6	13.6	11.3	17.3	19.7	27.5	20.7	12.5	14.1	15.4	11.4	9.0	25.4	16.8	10.4	10.5	4.0	11.8	21.9	8.9	17.6	2.8	18.4	14.3	12.0	9.6	12.5	12.7	3.2	15.5	12.6	12.2	11.1	8.6	9.5	7.6	23.1	10.6	17.1	17.7	9.4	22.0	10.6	38.3	28.2	29.8	11.7	14.4	13.5	19.9	7.4	21.1	12.9	4.8	14.4	17.5	14.0	15.3	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407955-33443892	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 67.6;skeletal muscle: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	4	"B-cells: 6.7;dendritic cells: 11.1"	"Low region specificity"	"Detected in all"							CAB037059	Approved									"CAB037059: AB_261497"	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favourable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favourable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	13.7	6.5	28.8	3.3	36.2	2.1	4.8	5.9	28.4	6.4	4.3	14.4	2.9	4.4	4.5	5.3	12.2	5.6	4.8	67.6	20.0	15.9	8.5	5.1	3.7	3.8	23.6	19.1	8.5	7.5	7.6	2.5	2.7	11.9	7.3	2.7	10.0	16.0	10.7	130.8	3.8	4.2	9.4	8.8	2.6	4.8	6.7	11.8	0.3	33.0	22.0	3.7	8.6	5.4	6.7	11.1	0.0	0.0	0.0	2.2	0.4	6.0	3.0	1.4	13.4	32.6	6.5	1.3	4.6	6.4	8.8	7.3	7.8	2.0	4.3	5.6	7.8	7.9	4.0	2.5	1.5	0.8	5.1	0.2	7.5	10.9	9.3	0.4	0.7	5.9	3.2	3.8	1.4	1.3	10.3	1.6	4.4	0.7	8.0	1.0	0.8	17.7	5.1	10.0	4.7	1.8	5.4	5.9	5.1	18.1	5.5	9.1	8.5	0.7	2.1	4.4	8.6	17.3	4.2	10.3	5.2	2.5	9.5	0.8	0.6	0.0	0.0	0.0	1.0	0.0	2.2	6.7	1.0	1.0	0.0	2.7	0.3	0.8	0.0	0.0	0.0	11.1	1.2	0.4	28.8	36.2	5.9	28.4	20.0	15.9	23.6	19.1	11.9	11.8
SORBS2	"ARGBP2, KIAA0777"	ENSG00000154556	"Sorbin and SH3 domain containing 2"	O94875	4	185585444-185956652	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 141.4;urinary bladder: 126.4"	"Cell line enhanced"	"Detected in many"		"AF22: 66.7;TIME: 35.9;WM-115: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.30e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (6.07e-5)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.47e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (3.10e-6)"	"unprognostic (1.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.51e-2)"	10.3	45.6	6.3	13.7	11.3	0.4	10.0	4.3	9.9	16.5	27.4	2.7	16.7	2.9	11.1	13.7	44.5	9.9	26.6	141.4	5.6	4.7	8.7	31.8	5.1	1.5	4.4	5.4	8.2	28.9	46.9	12.8	17.0	7.9	52.7	6.9	43.3	17.9	21.9	6.5	3.1	6.1	111.0	3.6	6.5	15.3	4.4	2.8	2.4	71.2	9.0	4.5	126.4	29.0	1.3	0.0	0.5	0.0	0.0	0.2	1.3	0.1	0.1	66.7	0.0	9.5	16.7	3.3	0.1	0.0	0.0	0.1	1.7	5.2	0.0	7.2	0.6	0.0	0.0	2.4	0.0	0.0	1.0	0.9	5.2	4.2	0.0	0.0	0.0	6.2	0.7	10.0	0.7	12.3	0.0	0.0	0.7	0.0	0.0	0.1	6.3	0.0	6.1	0.0	0.0	9.1	1.6	8.3	2.5	0.0	0.0	3.7	2.0	0.0	35.9	5.0	0.6	0.0	2.4	0.0	0.0	0.0	11.1	0.0	19.9	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	6.3	11.3	4.3	9.9	5.6	4.7	4.4	5.4	7.9	2.8
SYNDIG1	"C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469199-24666616	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;heart muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.0;RH-30: 22.8;RPMI-8226: 21.6;SCLC-21H: 5.3;U-87 MG: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles				Vesicles	Vesicles	"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (6.16e-6)"	"unprognostic (1.40e-3)"	2.6	1.7	12.5	2.1	12.0	0.7	0.8	21.3	22.7	4.5	1.5	23.3	0.3	1.9	2.6	1.5	0.9	5.1	10.0	28.2	12.8	8.8	6.2	0.7	1.1	2.5	14.5	12.9	1.3	1.4	0.9	0.6	0.9	11.5	3.2	1.6	0.5	0.8	14.8	0.6	0.8	2.8	3.1	22.4	1.4	2.2	1.3	16.6	0.1	5.1	0.0	3.1	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	22.8	21.6	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	12.0	21.3	19.7	12.8	8.8	14.5	12.9	11.5	16.6
TANGO2	"C22orf25, DKFZp761P1121"	ENSG00000183597	"Transport and golgi organization 2 homolog"	Q6ICL3	22	20017014-20065926	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 54.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003080	Approved					120000	120000			"HPA003080: AB_1078350"	"unprognostic (4.05e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.76e-2)"	"prognostic favourable (3.01e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.95e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.62e-2)"	10.2	15.5	13.1	10.7	18.0	31.8	9.7	11.5	21.0	6.6	9.7	15.3	8.1	8.0	7.6	7.9	7.1	7.4	9.0	54.0	13.7	14.2	11.9	10.7	11.6	12.3	25.0	12.3	5.2	9.0	11.3	11.4	9.1	16.6	9.6	9.0	12.9	7.1	10.5	17.2	7.9	9.2	9.2	14.5	20.0	11.1	5.9	16.8	5.4	18.5	6.6	9.3	10.5	13.0	7.7	16.1	28.4	25.6	11.9	10.9	13.5	8.6	7.9	2.8	5.8	19.5	6.7	5.3	8.7	11.3	8.2	7.2	5.8	6.7	3.3	6.5	22.8	11.5	6.8	9.7	5.1	20.1	7.0	9.4	6.4	6.6	14.3	8.5	16.5	8.5	7.8	12.1	6.5	11.0	23.9	7.2	11.2	10.0	5.5	5.9	1.3	5.6	5.5	7.5	2.1	6.5	11.1	4.8	2.8	9.0	15.1	18.5	4.0	8.8	8.3	11.3	8.5	15.1	6.0	3.9	2.2	3.6	15.1	7.5	7.6	27.1	17.2	28.4	6.3	21.0	6.8	7.7	6.9	7.9	16.1	5.0	4.1	5.4	21.4	11.9	25.6	5.5	10.9	13.5	13.1	18.0	11.5	21.0	13.7	14.2	25.0	12.3	16.6	16.8
TBX20		ENSG00000164532	"T-box 20"	Q9UMR3	7	35202430-35254147	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.7;HMC-1: 5.3;RH-30: 5.2;SH-SY5Y: 9.9;WM-115: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.20e-1)"		"unprognostic (1.25e-2)"	"unprognostic (1.87e-2)"				"unprognostic (8.47e-2)"		"unprognostic (3.95e-2)"				"unprognostic (2.75e-1)"	"unprognostic (1.74e-1)"		"unprognostic (9.75e-2)"	0.2	4.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	26.5	46.4	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.0	0.2	0.2	0.1	1.8	15.1	0.0	24.2	0.1	2.7	0.2	0.1	0.2	0.2	0.2	47.0	0.2	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.1	32.3	14.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.6	0.0	0.3	4.2	0.0	0.1	2.2	3.4	4.2	1.4	0.0	4.7	0.0	5.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.2	9.9	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TBX5	HOS	ENSG00000089225	"T-box 5"	Q99593	12	114353931-114408442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.5;lung: 14.0;placenta: 19.7"	"Cell line enhanced"	"Detected in some"		"BJ: 12.8;BJ hTERT+: 28.6;BJ hTERT+ SV40 Large T+: 6.6;BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HAP1: 11.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	2.2	0.1	0.1	0.0	0.1	0.0	3.8	0.8	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	6.4	0.1	0.0	44.5	2.2	0.1	0.1	0.1	14.0	1.6	0.1	0.1	0.1	0.1	0.0	0.1	19.7	0.5	5.4	0.0	1.4	0.1	0.0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	6.5	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.8	28.6	6.6	8.1	0.0	0.0	0.0	0.0	0.7	0.0	11.2	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0.0
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
TCF24	bHLHa25	ENSG00000261787	"Transcription factor 24"	Q7RTU0	8	66946501-66962590	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.0;kidney: 4.1;testis: 7.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HEK 293: 9.3;HMC-1: 8.1;K-562: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (1.07e-1)"	"unprognostic (9.14e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.74e-1)"		"unprognostic (2.25e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.14e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.5	0.1	0.9	0.3	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.0	0.2	0.3	0.1	1.6	0.1	8.0	0.6	0.8	4.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.5	0.1	0.6	7.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.0	3.7	0.0	0.1	0.0	9.3	0.4	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.7	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.9	0.1	0.9	0.6	0.8	0.1	0.1	1.0	0.1
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	420000000	420000000	Vesicles	Vesicles	"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.0	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.7	0.0	0.1	1.5	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.7	0.1	0.0	3.9	0.1	0.0	1.5	0.0	0.3	0.1	4.0	1.2	0.1	0.0	0.4	0.0	10.7	0.0	0.1	4.6	0.3	0.3	4.1	0.1	0.7	1.8	3.4	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364606-96513918	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 7.4"	"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 21.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.7	1.1	3.2	1.4	4.9	1.6	0.7	0.7	5.8	0.8	1.1	5.7	2.5	1.7	1.2	1.1	0.9	0.7	2.6	7.4	3.3	3.8	0.7	0.6	0.5	1.8	3.4	2.1	1.4	1.5	0.4	2.8	1.1	4.6	1.1	1.1	0.0	3.9	2.7	4.1	1.0	2.1	0.9	6.1	0.9	2.1	1.1	5.7	0.0	1.5	4.0	0.7	0.8	0.5	0.9	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	1.1	0.1	0.1	0.2	0.1	0.0	1.9	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.4	0.0	21.2	0.1	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.9	0.2	0.1	0.0	0.9	0.2	0.2	0.6	0.3	0.2	0.3	0.1	0.0	3.2	4.9	0.7	4.0	3.3	3.8	3.4	2.1	4.6	5.7
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601748	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.7;skeletal muscle: 112.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;HDLM-2: 46.9;K-562: 15.9;SH-SY5Y: 50.2"	"Cancer enhanced"	"Detected in many"		"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051202	Enhanced					900000	900000			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	7.9	35.6	10.9	3.4	11.9	11.1	5.9	18.1	17.2	17.3	9.8	6.0	8.9	3.3	27.6	7.1	10.8	16.0	5.3	71.7	7.1	6.1	3.6	21.9	5.2	2.3	4.6	9.3	24.8	7.6	9.5	13.6	2.4	12.8	10.7	4.5	10.4	3.3	6.1	112.7	2.9	3.8	22.6	15.9	1.9	6.0	3.2	5.3	0.0	8.7	36.9	2.3	15.4	19.7	4.6	1.2	2.0	0.9	1.7	5.2	3.1	1.6	0.4	0.0	0.2	2.0	0.2	0.6	0.3	2.8	0.0	0.0	0.3	0.5	0.0	12.1	0.0	0.1	0.5	0.0	0.0	46.9	1.7	2.3	2.9	0.2	0.0	0.0	4.0	0.1	0.0	0.1	0.0	0.2	15.9	0.0	0.0	0.7	0.0	0.3	0.6	0.2	0.0	1.6	0.0	0.0	0.3	0.2	50.2	1.5	0.0	0.8	0.6	2.4	0.2	0.0	1.8	1.4	0.3	6.1	1.2	0.0	2.3	1.6	2.6	2.0	0.7	1.2	3.3	0.7	3.1	3.1	2.6	1.9	1.2	4.6	1.8	2.1	0.2	1.7	0.9	0.4	5.2	3.1	10.9	11.9	18.1	17.2	7.1	6.1	4.6	9.3	12.8	5.3
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Supported	"Golgi apparatus,Intermediate filaments"		66000	66000	"Intermediate filaments"	"Intermediate filaments"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavourable (2.58e-4)"	"prognostic favourable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favourable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.4	3.6	2.8	8.9	9.0	5.7	19.3	9.1	10.9	9.1	12.3	8.1	2.0	25.3	18.9	46.8	2.9	11.3	6.5	3.1	5.2	3.4	12.1	2.3	5.5	0.7	2.3	10.6	7.8	9.9	7.4	10.9	1.2	3.0	13.8	11.7	1.4	1.8	0.6	8.2	1.9	8.7	5.0	14.2	21.9	4.1	3.8	8.6	11.2	6.9	5.7	1.5	13.9	10.1	2.7	20.3	7.0	2.6	2.1	0.8	11.7	1.0	24.2	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell line enhanced"	"Detected in many"		"BJ: 123.0;fHDF/TERT166: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		280000000	280000000	"Actin filaments"	"Actin filaments"	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	43.6	28.8	34.8	1.7	12.2	7.7	114.6	123.0	45.3	75.7	56.3	20.2	8.7	0.1	56.5	122.9	24.2	29.5	19.7	50.4	1.1	4.1	6.4	31.0	9.8	34.2	0.2	1.4	10.7	11.4	62.2	16.6	19.8	0.6	1.5	57.8	22.5	1.9	0.5	41.5	5.0	0.7	12.3	1.2	108.1	24.1	8.3	5.7	14.7	23.3	5.2	17.0	1.2	91.2	100.1	49.2	14.9	87.2	0.4	0.3	0.5	28.3	1.7	69.3	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell line enhanced"	"Detected in all"		"RT4: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favourable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.4	6.5	12.9	5.6	9.0	8.9	17.0	10.1	11.4	6.6	7.2	4.3	10.6	14.6	5.3	24.9	3.6	8.9	23.1	7.2	13.2	6.4	10.0	6.6	11.9	4.5	11.4	8.0	7.5	10.0	14.5	13.4	13.2	5.1	11.7	8.3	3.1	1.2	6.0	5.6	5.0	5.3	4.8	12.2	9.1	56.2	8.3	9.8	3.8	5.6	5.4	5.0	9.7	13.5	5.7	6.8	34.3	5.8	8.7	7.4	13.2	6.3	10.0	5.5	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Group enriched"	"Detected in some"	8	"HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm		37000	37000	Nucleoplasm	Nucleoplasm	"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.4	0.0	0.1	0.7	6.7	1.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.4	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.2;heart muscle: 58.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 62.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.2"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 125.3"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		1900000	1900000	"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	12.7	5.3	2.6	4.0	5.9	0.3	16.2	58.2	11.5	17.6	6.6	3.0	16.1	3.6	20.9	11.2	6.8	8.8	13.8	58.5	2.9	2.7	21.3	25.3	13.6	3.9	2.8	3.3	15.3	6.5	17.4	3.8	27.7	4.5	10.7	2.7	21.8	8.4	17.7	7.1	13.3	5.4	9.5	2.6	8.4	5.6	5.7	2.3	6.0	9.4	9.4	4.3	8.1	13.6	0.0	0.0	0.6	0.1	0.0	1.1	3.6	0.4	3.5	5.9	5.0	4.9	4.6	13.9	6.7	20.3	4.3	5.7	8.1	3.1	0.2	6.7	3.9	0.9	2.3	2.5	2.6	1.0	2.6	9.1	2.7	5.7	13.3	0.0	0.7	5.9	2.1	8.9	4.2	14.8	0.2	0.2	3.8	5.2	0.0	0.2	8.3	1.8	2.7	62.6	0.8	18.1	1.5	10.5	7.1	4.4	11.3	4.3	3.9	0.0	8.7	2.4	7.2	3.8	6.3	0.0	0.0	0.0	6.0	0.1	2.6	0.0	0.1	0.0	1.1	0.1	0.3	0.0	0.2	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	3.6	2.6	5.9	58.2	11.5	2.9	2.7	2.8	3.3	4.5	2.3
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					25000000	25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.7	0.0	0.0	0.0	2.3	2.0	3.7	2.6	1.0	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0.0	0.6	1.0	1.7	0.4	1.3	0.0	0.7	2.4	1.6	0.0	0.0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110331-18146554	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.3;skeletal muscle: 125.4"	"Group enriched"	"Detected in many"	6	"NB-4: 20.4;SCLC-21H: 10.1;TIME: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2;NK-cell: 5.8"	"Group enriched"	"Detected in many"	14	"granulocytes: 4.2;NK-cells: 5.8"	"Group enriched"	"Detected in many"	4	"cerebellum: 61.3;olfactory region: 66.2"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		260000000	260000000	Microtubules	Microtubules	"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: "	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	3.2	1.2	5.3	1.2	10.5	2.4	2.5	20.5	23.4	1.4	1.2	1.5	0.2	1.5	1.2	4.3	2.6	1.6	1.3	50.3	7.5	5.6	1.2	2.0	1.2	2.2	3.9	9.2	1.3	2.2	1.8	4.3	1.0	2.5	1.7	1.1	0.4	2.1	1.2	125.4	1.4	1.4	1.2	1.1	1.6	1.7	19.2	1.0	0.0	3.5	13.3	1.3	1.1	0.3	0.0	0.2	4.2	0.1	5.8	0.3	15.7	0.4	0.9	0.7	0.8	1.3	0.8	0.3	0.7	0.7	1.2	1.1	0.3	0.9	0.6	3.3	0.6	0.3	2.1	0.1	0.3	1.9	1.9	2.3	0.4	0.3	0.7	1.4	1.2	0.7	0.6	0.8	0.1	1.8	0.9	0.7	0.4	2.6	1.7	20.4	0.9	1.0	1.6	0.0	0.2	0.4	0.3	10.1	1.1	0.4	0.5	1.2	0.5	3.3	25.4	0.1	0.2	0.7	0.5	2.3	1.1	0.7	0.8	0.9	0.2	1.2	0.1	2.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	4.2	5.8	0.1	0.2	0.0	15.7	5.3	10.5	20.5	23.4	7.5	5.6	3.9	9.2	2.5	1.0
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.3	5.3	10.1	7.7	4.6	6.4	4.9	7.3	8.4	10.8	9.1	7.8	4.4	15.3	8.2	8.8	0.9	11.3	4.4	12.9	36.2	4.8	4.0	8.0	7.3	3.3	11.2	0.0	6.8	1.6	8.4	10.7	8.6	1.9	19.8	8.9	8.1	6.8	2.0	7.8	4.8	11.7	10.0	12.5	7.3	3.5	5.7	7.4	7.0	9.4	4.2	16.2	8.1	9.3	13.0	10.4	11.1	28.1	9.6	8.0	31.4	6.0	7.6	12.1	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	10.3	11.6	15.7	20.7	12.8	12.7	11.1	7.6	10.5	10.3	17.7	17.1	14.9	13.7	17.4	10.3	20.3	22.1	14.3	14.4	15.3	10.0	7.3	8.1	9.2	7.9	9.4	7.3	7.6	10.9	11.9	14.2	18.6	12.6	8.9	10.8	5.2	7.1	15.3	18.8	8.4	17.6	21.8	16.6	11.4	10.2	6.9	7.4	18.1	6.2	5.9	15.1	3.3	9.8	11.5	17.2	10.4	7.8	6.1	8.7	11.6	1.1	18.3	7.4	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8
VN1R2	V1RL2	ENSG00000196131	"Vomeronasal 1 receptor 2"	Q8NFZ6	19	53258292-53261837	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.0;testis: 3.2"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA044551	Uncertain									"HPA044551: AB_2678982"					"unprognostic (9.54e-2)"							"unprognostic (3.17e-1)"			"unprognostic (1.06e-1)"			0.2	0.2	0.4	0.8	0.4	0.5	0.3	0.6	0.8	0.2	0.3			0.2	0.5	1.6	0.3	0.2	0.0	5.0	0.4	0.4	0.3	0.3	0.2	1.7	0.3		0.6	0.2	0.3	0.2	0.0		0.3	0.0		0.4	0.0	0.4	0.9	0.6	0.0	0.3	0.3	0.2	3.2			0.5		0.0	0.3	0.3	0.8	0.5	1.3	0.5	0.6	1.1	0.2	0.8	0.8	0.8	1.3	0.0	0.0	0.3	1.0	0.0	0.0	0.3	0.0	2.2	1.9	0.5	0.5	0.6	0.0	0.0	0.0	0.8	0.7	1.2	2.6	1.5	0.0	0.2	1.7	0.6	0.4	0.1	0.0	0.0	0.8	0.6	0.4	0.9	0.4	1.1	0.5	0.7	1.1	2.1	0.0	0.5	2.2	1.3	1.2	0.2	0.8	0.3	1.3	0.1	1.6	1.0	0.8	1.3	0.4	1.7	0.6	0.8	1.2	0.5	0.8	0.4	0.5	0.5	1.1	0.3	0.4	0.2	0.4	0.2	0.2	0.8	0.3	1.0	1.3	0.6	0.4	0.5	0.1	0.2										
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653684-42665854	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.1;skeletal muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.5;fHDF/TERT166: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favourable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	5.8	3.3	11.4	3.1	18.0	0.5	2.8	3.3	11.3	4.8	4.4	15.7	0.7	1.1	5.4	1.5	4.4	3.1	4.4	28.1	16.1	4.7	1.2	2.0	2.6	2.1	8.6	9.1	5.0	4.5	2.7	3.0	2.1	6.3	4.8	1.0	2.9	7.6	6.2	33.1	2.8	1.4	5.8	12.8	1.7	3.0	3.1	16.7	0.7	5.2	4.2	1.6	3.7	3.3	0.0	0.9	2.8	1.6	0.3	0.3	0.4	3.6	3.2	2.0	1.3	33.5	13.0	0.7	8.7	7.5	3.8	2.8	0.7	1.5	0.0	3.6	17.7	0.9	0.5	3.3	0.8	0.0	4.3	2.2	9.4	0.8	10.3	0.0	3.0	13.9	6.1	4.9	4.2	4.2	2.0	2.6	7.6	0.9	0.1	0.2	1.1	2.1	2.6	3.9	1.0	2.1	0.8	2.2	3.7	4.0	0.7	3.2	4.6	4.8	9.4	8.0	4.6	7.7	3.4	0.1	0.0	0.0	7.3	2.6	2.3	0.0	1.6	0.1	0.3	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	2.8	0.3	0.9	0.0	0.0	0.4	11.4	18.0	3.3	9.3	16.1	4.7	8.6	9.1	6.3	16.7
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672392-29681110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.7;heart muscle: 14.4"	"Cell line enriched"	"Detected in single"	22	"BEWO: 11.9"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.8"					"Low region specificity"	"Detected in all"			HPA047172	Uncertain									"HPA047172: AB_10960886"	"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favourable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.9	0.6	3.8	0.3	4.1	1.1	4.2	0.1	2.3	0.5	0.4	0.4	2.4	0.3	0.5	0.5	0.9	0.3	1.9	14.4	5.5	3.2	0.5	0.3	0.9	6.1	7.6	0.1	0.7	5.2	0.3	0.1	1.5	0.5	0.7	0.6	0.2	2.3	2.1	0.4	0.7	1.2	1.5	12.7	0.8	0.3	1.4	0.1	1.2	0.3	0.7	1.1	1.5	5.5	0.3	0.7	3.8	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.6	0.3	0.3	0.3	0.4	0.5	0.7	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.6	0.3	3.8	4.1	0.1	1.4	5.5	3.2	7.6	0.1	0.5	0.1
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.1	8.2	14.4	15.9	36.4	32.1	8.8	11.5	11.0	10.1	10.8	19.3	4.1	9.5	10.3	14.1	16.2	14.9	11.8	15.5	15.4	7.2	18.2	19.2	6.9	10.5	21.8	10.9	24.1	7.9	15.3	17.1	16.2	21.6	1.3	16.4	5.6	8.3	5.3	6.1	8.4	8.0	26.2	5.2	5.3	16.0	9.2	4.9	23.3	11.0	13.0	10.1	14.2	24.4	10.9	16.8	14.4	16.8	7.9	15.2	35.6	9.7	17.4	18.8	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli				Nucleoli	Nucleoli	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (3.66e-6)"	"prognostic favourable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.6	9.5	11.5	9.1	20.6	18.6	16.2	20.7	12.0	13.4	12.7	12.8	14.8	33.0	12.7	13.0	6.2	20.3	13.4	20.5	15.2	13.3	15.3	14.6	17.9	22.1	38.5	12.4	18.6	15.8	12.5	18.4	13.9	31.0	22.5	17.0	17.4	29.7	18.1	10.2	18.1	24.3	16.5	20.9	14.3	8.6	20.1	9.3	7.2	16.7	20.3	8.3	10.5	14.8	17.1	11.6	10.2	14.7	37.7	27.1	31.3	14.3	24.1	12.1	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3
